Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 77.9"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 68.3;Horizontal cells: 235.2;Intestinal endocrine cells: 205.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 77.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 31.2;U-87 MG: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	2.2	5.3	7.6	1.0	12.2	0.7	0.9	77.9	19.7	0.8	1.5	1.8	0.0	3.9	1.2	2.8	0.7	2.2	0.8	1.1	5.7	5.1	0.7	0.5	0.7	1.3	3.9	7.3	1.1	3.0	0.7	1.5	0.6	7.2	0.8	1.7	1.2	0.9	0.8	1.3	0.7	2.8	0.9	3.3	1.3	7.7	1.9	2.8	0.0	0.7	0.0	1.0	0.8	0.3	2.8	0.8	1.9	1.1	0.8	0.8	0.4	0.0	0.1	0.0	3.9	0.1	0.3	0.0	1.6	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	2.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.1	0.9	0.0	0.2	0.4	0.0	0.1	0.0	0.1	31.2	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.0	17.6	0.0	0.4	1.9	0.4	0.7	0.5	0.5	0.8	2.8	0.5	0.3	0.4	1.7	0.6	0.7	1.6	0.8	1.1	0.8	0.6	0.4	7.6	12.2	77.9	17.4	5.7	5.1	3.9	7.3	7.2	2.8	6.0	2.7	1.3	1.4	0.6	68.3	2.2	0.0	6.7	2.3	1.8	15.7	0.0	0.0	0.6	22.1	4.2	0.0	0.0	0.3	0.1	2.1	0.8	1.1	0.0	0.5	235.2	205.4	1.8	1.3	17.9	1.1	2.1	0.0	1.0	1.1	2.9	1.9	0.0	0.4	2.0	6.2	0.0	4.2	4.1	5.1	0.1	0.2	4.3	0.8	0.9
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877789-138124624	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 5.9;Horizontal cells: 6.4;Late spermatids: 3.6;Spermatocytes: 5.1;Spermatogonia: 9.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 21.2"	"Low region specificity"	"Detected in all"							"HPA022919, HPA044347"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA022919: , HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.5	6.2	5.7	0.7	8.7	0.5	0.5	18.7	18.9	1.2	0.8	0.2	0.0	0.6	0.6	1.7	0.4	6.6	1.4	1.0	4.5	7.3	0.4	1.2	0.5	0.5	2.9	9.1	0.5	1.2	0.4	4.8	0.4	3.6	1.6	0.8	0.4	0.4	1.3	0.4	0.9	0.7	0.8	4.5	0.6	0.6	8.1	1.4	0.0	0.9	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	4.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	8.7	18.7	10.9	4.5	7.3	2.9	9.1	3.6	1.4	0.0	0.0	0.0	0.0	0.0	5.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.0	0.0	2.4	0.0	0.0	0.4	0.0	1.5	0.0	0.0	5.1	9.3	0.0	0.0	0.0	0.0	0.0
CACNA1C	"CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS"	ENSG00000151067	"Calcium voltage-gated channel subunit alpha1 C"	Q13936	12	1970786-2697950	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Host-virus interaction, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Brugada syndrome, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 32.5"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 284.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.2"	"Group enriched"	"Detected in many"	19	"NK-cells: 4.2;T-cells: 1.2"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039796, CAB079031"	Enhanced	Approved				NA	NA					"CAB079031: , HPA039796: AB_10673019"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-7)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.39e-2)"	3.8	2.5	8.6	6.0	7.7	1.4	2.4	7.1	11.7	11.2	26.5	1.3	7.4	2.4	29.7	4.5	5.2	4.3	7.1	32.5	5.5	4.0	2.7	1.4	4.7	2.0	2.4	6.6	2.7	3.2	1.5	8.1	5.1	3.9	7.9	3.8	6.5	2.4	8.1	2.3	1.7	5.2	28.8	1.9	3.5	7.2	11.3	1.7	0.0	2.0	1.1	1.7	12.6	5.4	0.0	0.1	0.0	0.1	4.2	1.2	0.2	0.0	0.0	0.0	0.0	1.6	1.1	0.1	1.7	2.0	1.1	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	47.6	0.4	0.6	0.0	0.0	1.2	0.0	0.0	2.7	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.3	2.6	0.0	0.0	0.0	0.0	2.2	0.1	0.6	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.5	0.7	0.0	0.0	0.9	0.7	0.0	4.2	0.1	0.1	0.4	0.2	8.6	7.7	7.1	11.7	5.5	4.0	2.4	6.6	3.9	1.7	0.0	0.0	0.0	1.2	0.6	15.3	42.8	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	27.5	2.9	0.0	0.0	0.0	0.2	2.5	1.4	0.0	0.0	0.2	284.4	35.2	2.5	0.0	64.7	0.9	0.0	0.0	0.0	0.6	6.1	0.3	0.2	3.9	0.0	1.2	12.9	17.5	2.6	5.8	0.1	0.1	0.0	0.4	2.4
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 45.9;Cone photoreceptor cells: 33.4;Intestinal endocrine cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"basophil: 7.2"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 7.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 14.4;RPMI-8226: 33.6;SK-BR-3: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (5.85e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.34e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.09e-3)"	"unprognostic (6.70e-3)"	0.6	13.4	10.0	0.8	12.6	1.4	3.6	12.2	16.5	11.2	2.8	3.7	0.1	3.3	6.8	13.2	1.2	14.9	6.2	1.8	5.3	3.5	4.2	3.0	9.0	0.5	2.5	9.6	1.2	5.3	3.0	13.6	1.4	8.7	5.7	3.1	10.1	1.1	3.5	0.6	1.5	4.2	1.7	2.2	4.4	1.8	3.0	1.6	0.0	5.2	0.0	0.6	2.3	0.6	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.5	0.0	0.0	0.1	33.6	0.3	2.2	3.1	1.3	0.2	6.3	0.7	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	7.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.0	12.6	12.2	16.5	5.3	3.5	2.5	9.6	8.7	1.6	3.0	45.9	0.0	0.6	0.8	23.0	1.2	12.7	14.7	14.8	1.8	33.4	0.6	0.0	5.5	3.6	0.5	3.3	0.0	2.0	0.1	1.0	2.6	11.6	2.4	0.2	7.9	57.1	0.0	1.0	4.9	4.0	0.3	5.0	0.0	2.7	2.5	2.6	3.5	25.5	1.6	13.0	0.0	2.8	1.1	2.5	0.9	0.2	1.3	4.5	0.6
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181808084	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 30.8"	"Cell type enhanced"	"Detected in single"	15	"Cardiomyocytes: 1.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "	"unprognostic (3.96e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.54e-5)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-7)"	"unprognostic (1.74e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.75e-2)"	0.6	3.0	17.9	2.1	19.7	3.1	0.5	3.9	22.5	0.6	0.8	1.3	0.0	0.6	0.6	4.4	1.1	2.3	0.6	0.6	30.8	5.8	3.8	0.6	0.6	1.4	2.4	10.6	0.5	0.6	0.5	0.2	0.8	4.2	0.5	0.8	0.5	0.5	0.5	0.6	0.5	1.1	1.0	5.2	0.9	0.8	2.8	2.4	0.0	0.6	0.0	1.0	0.6	0.1	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.9	0.1	0.0	0.0	0.0	1.1	1.4	0.0	2.3	0.1	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.1	0.0	0.0	7.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	17.9	19.7	3.9	22.5	30.8	5.8	2.4	10.6	4.2	2.4	0.0	0.0	0.0	0.0	0.1	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
CACNA1F	"AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2"	ENSG00000102001	"Calcium voltage-gated channel subunit alpha1 F"	O60840	X	49205063-49233371	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Transport, Vision"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"retina: 55.8"	"Group enriched"	"Detected in some"	15	"Bipolar cells: 66.5;Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 91.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.8;U-266/70: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068379	Enhanced					NA	NA					"HPA068379: AB_2732782"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.04e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-7)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.77e-3)"	0.7	0.8	1.8	0.7	1.5	4.0	1.8	5.3	2.0	0.7	1.0	0.7	0.7	1.9	0.7	2.7	0.7	1.0	0.7	0.7	0.8	0.6	0.7	0.7	1.4	2.7	0.7	0.7	0.7	1.4	0.0	0.7	0.7	0.7	0.7	1.5	55.8	1.2	0.9	0.7	2.4	3.7	0.7	0.7	1.8	1.0	0.7	0.7	0.7	1.2	0.7	0.9	0.7	0.7	1.4	4.6	2.0	0.9	0.5	1.0	0.2	0.2	2.5	0.2	0.0	0.6	0.0	2.5	0.4	0.2	0.0	0.0	0.1	0.9	1.4	0.5	0.5	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.5	0.6	0.1	0.8	0.6	0.0	0.4	0.0	0.2	0.8	0.8	1.0	0.3	0.0	2.8	1.3	1.5	1.1	1.9	0.0	0.1	0.0	0.5	0.4	1.5	0.6	0.0	0.0	0.1	0.0	0.9	0.9	1.5	1.0	0.2	0.3	0.3	0.1	4.6	1.6	0.1	0.8	0.4	0.0	0.9	0.7	0.6	0.6	0.5	0.5	0.7	0.8	0.4	0.8	1.4	0.5	1.0	2.0	0.5	0.9	4.6	0.7	0.2	1.8	1.5	5.3	2.0	0.8	0.6	0.7	0.7	0.7	0.7	0.0	0.3	0.0	0.1	0.0	66.5	1.2	0.0	0.0	0.0	1.8	125.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	6.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.3	5.5	0.0	0.0	0.4	0.0	91.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1
CACNA1G	"Cav3.1, NBR13"	ENSG00000006283	"Calcium voltage-gated channel subunit alpha1 G"	O43497	17	50561068-50627474	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.8;cervix, uterine: 13.6"	"Cell type enriched"	"Detected in some"	26	"Bipolar cells: 147.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 13.4;GAMG: 5.0;HeLa: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004714	Uncertain					NA	NA					"HPA004714: AB_1078368"	"unprognostic (1.90e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.00e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (4.87e-12)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.63e-2)"	1.7	1.0	3.5	0.9	5.2	1.3	2.1	22.8	17.1	13.6	1.0	2.7	0.0	0.9	7.4	1.0	1.6	5.7	1.2	3.8	2.4	8.8	0.7	1.1	0.9	1.2	5.3	7.9	7.1	0.6	0.6	0.4	1.4	6.1	2.5	0.8	4.3	1.1	1.6	0.8	3.9	0.8	2.1	5.9	0.9	0.9	1.7	2.3	0.0	1.2	0.0	1.0	1.0	3.9	1.3	1.3	2.7	0.8	0.7	1.4	0.0	0.0	13.4	3.1	3.5	0.9	0.1	0.2	0.1	0.0	0.1	0.2	2.8	0.5	0.0	1.0	0.1	5.0	0.5	1.6	0.0	0.3	1.8	0.6	0.9	4.6	0.7	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.1	0.7	0.0	0.0	1.2	1.0	0.8	1.4	1.1	0.0	0.0	0.2	4.1	1.8	2.8	0.1	0.0	2.4	0.2	0.1	0.3	1.4	3.9	0.5	0.1	1.0	0.1	0.0	0.6	0.1	0.5	0.5	0.8	0.6	1.4	0.4	0.7	0.8	0.7	0.8	0.2	1.3	0.9	1.0	2.7	0.7	0.4	1.3	0.5	0.0	3.5	5.2	22.8	17.1	2.4	8.8	5.3	7.9	6.1	2.3	0.0	0.0	0.0	0.1	1.6	147.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	3.6	0.4	0.0	0.0	0.4	4.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.7	0.0	3.6	0.3	0.2	2.5	0.1	0.0	0.0	0.0
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153121-1221772	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 49.5"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 16.2;Late spermatids: 13.2;Peritubular cells: 24.4;Sertoli cells: 25.8;Smooth muscle cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.9;AN3-CA: 15.7;MCF7: 28.9;OE19: 9.6;T-47d: 8.6"	"Low region specificity"	"Detected in many"							HPA039125	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA039125: AB_10795578"	"unprognostic (1.66e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (1.93e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.55e-2)"	5.0	6.8	5.1	4.2	12.0	0.3	3.3	0.3	4.3	17.5	28.1	1.6	10.2	5.4	25.7	5.9	16.3	11.7	26.0	2.2	2.5	2.1	4.7	5.5	3.5	0.7	1.0	2.8	31.8	2.1	6.6	14.8	1.9	2.0	21.0	2.2	4.2	1.7	24.9	2.9	4.8	8.5	49.5	1.1	0.5	9.7	11.7	2.1	0.0	5.2	1.4	0.5	34.6	20.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	10.9	1.9	15.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	6.5	1.9	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	1.9	2.9	0.0	0.0	28.9	0.0	0.0	5.9	9.6	2.2	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.7	8.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	12.0	0.3	4.3	2.5	2.1	1.0	2.8	2.0	2.1	0.0	0.0	0.0	0.0	1.3	16.2	1.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.0	1.2	0.0	0.0	0.0	0.0	0.2	3.3	4.6	8.1	0.1	0.0	10.4	0.6	0.0	13.2	7.8	0.0	0.0	0.0	0.3	0.8	0.7	0.0	24.4	0.8	1.0	25.8	16.5	1.8	4.5	3.0	0.0	0.0	0.0	0.5
CACNA1I	Cav3.3	ENSG00000100346	"Calcium voltage-gated channel subunit alpha1 I"	Q9P0X4	22	39570753-39689737	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 4.6;brain: 8.1;lymphoid tissue: 4.3;thyroid gland: 4.1"	"Cell type enriched"	"Detected in some"	6	"Bipolar cells: 18.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 2.1"					"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"JURKAT: 1.2;SK-BR-3: 6.1;T-47d: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.97e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.27e-4)"	0.0	4.6	3.4	1.9	5.8	1.3	0.2	8.1	7.5	0.0	0.2			0.2	0.0	0.0	0.1	0.0	0.4	0.0	5.0	3.6	0.0	0.0	0.2	4.3	0.7		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.1	0.9	0.0	0.4	1.3	0.5	1.1			4.1		1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	6.1	0.0	0.4	3.6	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.5	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.8	0.1											0.0	0.0	0.0	0.0	0.0	18.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CACNA1S	"CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5"	ENSG00000081248	"Calcium voltage-gated channel subunit alpha1 S"	Q13698	1	201039512-201112566	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 83.1"	"Cell type enhanced"	"Detected in some"	21	"Cardiomyocytes: 1.4;Cone photoreceptor cells: 5.9;Early spermatids: 1.4;Late spermatids: 3.3;Rod photoreceptor cells: 1.2"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"BEWO: 5.5;HSkMC: 7.1"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	13	"olfactory region: 5.3"	"CAB009507, HPA048892, HPA056815"	Enhanced					NA	NA					"CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242"	"unprognostic (2.14e-2)"		"unprognostic (1.38e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.52e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.84e-1)"		"unprognostic (2.23e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-1)"	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.0	83.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CATSPER2		ENSG00000166762	"Cation channel sperm associated 2"	Q96P56	15	43628503-43668118	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 43.7"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 239.5;Rod photoreceptor cells: 241.8;Spermatocytes: 77.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 9.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 12.8"															NA	NA						"unprognostic (6.88e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.87e-2)"	"unprognostic (8.23e-5)"	1.1	0.9	1.1	1.1	1.4	3.2	1.3	9.0	1.1	1.1	1.7	1.1	1.1	2.7	1.1	5.2	1.9	1.1	1.1	1.1	1.1	1.3	1.1	1.1	1.1	1.3	1.1	1.1	1.4	1.1	4.0	3.0	1.1	1.1	1.3	1.9	1.1	1.1	1.9	1.1	4.8	3.1	1.1	1.6	1.1	1.3	43.7	1.1	1.1	1.7	1.1	1.1	1.2	1.1	3.3	1.8	2.3	1.2	1.8	2.9	0.2	2.5	3.5	1.5	5.6	0.0	0.0	2.6	0.9	2.2	1.6	3.8	0.8	1.4	3.0	1.3	0.6	1.9	5.4	1.4	4.9	1.5	2.5	6.8	8.6	12.8	1.2	2.3	2.0	2.8	0.3	3.9	2.2	5.5	4.2	2.0	5.4	3.4	3.2	0.5	0.6	1.6	3.4	0.5	3.3	1.5	2.3	1.8	1.4	3.1	4.0	3.4	1.2	1.5	2.1	0.1	2.1	4.1	2.0	0.5	4.0	1.7	0.0	2.3	0.6	0.3	5.9	2.7	6.1	1.4	0.4	1.2	0.5	1.3	0.5	1.6	3.3	1.1	1.8	0.8	1.7	1.5	2.9	2.3	1.8	1.2	1.8	0.5	0.2	1.1	1.4	9.0	1.1	1.1	1.3	1.1	1.1	1.1	1.1	0.0	5.0	4.4	7.4	6.3	51.5	2.9	2.5	8.1	7.9	7.0	239.5	4.4	3.3	2.4	53.6	4.5	3.9	0.0	2.3	1.9	2.6	5.8	9.2	3.4	3.7	36.5	20.6	7.4	2.2	22.9	5.8	5.0	1.7	1.8	4.4	11.3	1.8	3.5	6.7	4.2	241.8	0.0	3.1	77.5	8.3	6.9	2.5	3.2	8.2	7.1
CATSPER4		ENSG00000188782	"Cation channel sperm associated 4"	Q7RTX7	1	26190561-26202968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"testis: 13.5"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 36.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.1;hTCEpi: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045257	Enhanced					NA	NA					"HPA045257: AB_10968995"	"unprognostic (7.20e-2)"	"unprognostic (2.06e-2)"		"unprognostic (4.56e-2)"		"unprognostic (2.69e-2)"		"unprognostic (3.49e-1)"		"unprognostic (3.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.16e-1)"		"unprognostic (3.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.67e-5)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel alpha 1"	P29973	4	47935977-48016672	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.7"	"Cell type enriched"	"Detected in many"	9	"Rod photoreceptor cells: 880.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.4;RT4: 10.7;U-2 OS: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: AB_2686781"	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	4.9	1.1	0.6	2.7	1.0	0.1	2.9	0.3	0.5	5.7	6.1	0.2	1.6	2.1	0.6	12.1	13.7	3.9	1.5	1.0	0.6	0.6	4.9	23.7	0.5	0.0	1.3	0.0	1.6	2.1	5.2	4.2	21.3	0.4	6.2	2.3	14.7	4.9	1.7	4.2	5.3	12.7	0.5	0.9	8.2	2.5	1.4	0.2	0.1	2.2	3.6	2.7	8.2	8.8	0.7	2.7	1.2	0.4	1.9	1.6	0.1	3.2	1.2	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	13.4	0.1	0.7	0.0	3.6	2.1	0.3	0.4	0.1	0.0	0.9	0.0	0.3	1.0	0.0	0.1	0.3	0.1	0.6	0.0	0.1	1.6	0.0	1.1	0.9	0.7	0.2	1.3	0.1	0.2	0.6	2.0	3.1	0.1	0.0	0.1	0.6	10.7	0.3	0.1	0.2	0.6	0.2	0.3	1.2	0.0	0.6	0.3	4.2	0.1	0.1	0.9	1.0	0.1	0.1	0.1	2.4	0.2	0.4	0.0	0.5	0.4	0.1	0.3	0.2	1.6	0.3	0.7	0.3	0.6	1.2	1.9	0.2	2.7	0.1	0.1	0.6	1.0	0.3	0.5	0.6	0.6	1.3	0.0	0.4	0.2	0.0	0.0	0.0	1.4	0.1	78.5	0.4	2.5	0.0	0.0	59.3	86.4	0.0	0.0	7.8	0.4	0.1	8.4	0.0	5.9	0.0	0.2	4.0	0.0	30.0	1.3	42.9	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	3.2	100.9	1.6	10.5	0.0	0.3	880.8	0.0	3.1	0.3	1.3	2.4	0.2	0.0	2.9	15.6
CNGA2	"CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA"	ENSG00000183862	"Cyclic nucleotide gated channel alpha 2"	Q16280	X	151738451-151745304	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Olfaction, Sensory transduction, Transport"	"Calmodulin-binding, Ion channel, Ligand-gated ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	26	"testis: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.8"	"Region enriched"	"Detected in single"	4	"olfactory region: 0.6"	"Not detected"	"Not detected"			HPA015065	Uncertain					NA	NA					"HPA015065: AB_1847034"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNGA3	"ACHM2, CCNC1, CCNCa, CNCG3, CNG3"	ENSG00000144191	"Cyclic nucleotide gated channel alpha 3"	Q16281	2	98346155-98398601	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 32.0"	"Cell type enriched"	"Detected in some"	39	"Cone photoreceptor cells: 41.2"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"U-87 MG: 12.8"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.9;hypothalamus: 2.2"	"Not detected"	"Not detected"			"HPA049378, CAB079025"	Approved	Approved				NA	NA					"CAB079025: , HPA049378: AB_2732551"	"unprognostic (2.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.18e-1)"		"unprognostic (4.17e-4)"		"unprognostic (4.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.88e-1)"		"unprognostic (3.85e-3)"	"unprognostic (8.98e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.71e-2)"	0.1	0.0	0.3	1.4	0.7	0.0	0.7	0.1	2.9	0.1	6.1	2.4	0.1	2.8	0.1	0.1	4.6	0.8	0.4	0.1	1.2	4.0	0.1	0.1	0.2	0.1	0.8	0.4	0.1	1.5	0.0	32.0	0.1	4.9	0.1	3.2	1.2	0.2	0.5	0.1	0.0	4.0	2.2	4.3	0.1	3.0	1.1	0.3	0.1	0.1	0.1	0.1	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	1.5	1.2	4.0	0.8	0.4	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CNGA4	"CNCA2, CNG5, CNGB2, OCNC2, OCNCb"	ENSG00000132259	"Cyclic nucleotide gated channel alpha 4"	Q8IV77	11	6234765-6244429	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Olfaction, Sensory transduction, Transport"	"Ion channel, Ligand-gated ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 8.0;fallopian tube: 22.5;ovary: 9.1"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 5.3;Early spermatids: 3.5;Late spermatids: 2.4"	"Cancer enriched"	"Detected in single"	6	"endometrial cancer: 2.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	21	"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.5;CAPAN-2: 2.6;HaCaT: 2.3;HMC-1: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (1.11e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.69e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.55e-3)"	0.2	0.3	1.5	0.3	2.0	0.6	0.2	0.6	1.1	1.0	0.4	1.9	0.1	0.5	1.2	8.0	0.4	22.5	0.3	0.1	1.7	1.4	0.3	0.2	6.6	0.4	1.0	0.1	9.1	0.3	0.3	2.3	0.2	3.3	0.3	0.2	0.3	0.2	0.8	0.1	0.4	0.3	0.3	1.3	0.3	0.3	7.4	1.4	0.1	0.3	0.1	0.3	0.2	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.7	2.5	0.1	0.1	0.1	0.0	0.1	0.0	0.0	2.6	0.7	0.3	0.0	0.3	2.3	0.1	0.5	0.0	1.6	0.3	0.0	0.4	0.1	0.1	0.2	3.4	1.6	1.2	0.2	0.1	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.0	0.1	1.1	0.4	0.0	0.0	0.0	0.4	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.3	0.4	0.2	0.6	0.0	1.1	0.6	0.0	0.7	0.3	1.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.0	0.6	1.1	1.7	1.4	1.0	0.1	3.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
CNGB3	"ACHM1, ACHM3, RMCH"	ENSG00000170289	"Cyclic nucleotide gated channel beta 3"	Q9NQW8	8	86553977-86743675	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"retina: 68.9"	"Cell type enriched"	"Detected in some"	21	"Cone photoreceptor cells: 149.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057244	Enhanced					NA	NA					"HPA057244: AB_2683380"	"unprognostic (5.35e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.40e-4)"	"unprognostic (1.66e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.84e-1)"	0.2	0.1	0.4	0.4	0.2	7.9	0.2	0.2	1.0	0.9	0.1	0.1	0.1	0.9	0.7	0.4	0.2	2.8	0.1	0.3	0.2	0.2	0.2	0.1	0.1	0.3	0.6	0.1	1.0	1.5	0.0	0.6	0.1	1.8	0.1	0.0	68.9	0.3	0.1	0.1	2.4	0.4	0.1	0.8	0.1	0.6	5.4	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	1.4	0.1	0.0	0.0	3.1	0.3	0.0	0.0	0.4	0.0	1.6	21.6	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.2	1.0	0.2	0.2	0.6	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	149.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.2	0.0	0.1	1.0	0.0	0.3	0.0	0.0	0.0	0.0
GALNT8	GALNAC-T8	ENSG00000130035	"Polypeptide N-acetylgalactosaminyltransferase 8"	"Q9NY28, P17658"	12	4720341-4851927	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Glycosyltransferase, Ion channel, Potassium channel, Transferase, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 12.7;intestine: 33.2;testis: 18.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 74.9;Late spermatids: 88.4;Mucus-secreting cells: 32.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 26.1;NTERA-2: 9.3;SuSa: 11.2;U-266/84: 7.5"					"Not detected"	"Not detected"			"HPA012638, HPA073461"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	Yes	No			"Golgi apparatus, Vesicles"		"HPA012638: AB_2294503, HPA073461: AB_2686604"	"unprognostic (2.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.06e-5)"	"unprognostic (1.16e-2)"	"unprognostic (6.67e-5)"	"unprognostic (5.18e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-2)"	1.1	2.2	5.3	2.2	6.5	0.5	3.1	1.4	12.7	1.0	15.5	9.4	0.0	7.2	0.9	0.4	0.7	1.2	1.1	3.7	8.0	1.7	1.2	0.8	0.9	1.0	5.7	9.6	1.6	0.9	0.2	3.7	0.5	6.0	1.1	33.2	0.1	1.0	0.9	0.7	0.9	14.7	2.1	3.5	1.2	1.3	18.5	11.5	0.0	0.8	0.5	0.9	1.2	0.9	1.0	0.7	0.1	0.1	0.9	3.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	26.1	0.0	0.0	0.2	0.1	9.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	11.2	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.3	7.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.3	0.7	1.2	0.0	1.0	0.0	0.1	0.1	0.9	0.0	0.7	3.0	0.0	5.3	6.5	1.4	12.7	8.0	1.7	5.7	9.6	6.0	11.5	6.0	0.3	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.3	0.0	0.0	88.4	1.4	0.0	0.0	0.0	32.6	0.1	0.3	0.0	2.5	1.0	0.3	6.5	0.0	11.6	3.6	0.0	0.0	0.0	1.8	0.0
HCN1	"BCNG-1, BCNG1, HAC-2"	ENSG00000164588	"Hyperpolarization activated cyclic nucleotide gated potassium channel 1"	O60741	5	45254950-45696498	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.4;retina: 16.1"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 184.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;WM-115: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019195	Enhanced					NA	NA					"HPA019195: AB_2670094"	"unprognostic (1.30e-1)"		"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"			"unprognostic (6.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.11e-3)"		"unprognostic (6.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-3)"		1.0	2.8	6.0	1.0	13.0	1.3	1.2	9.8	26.4	0.9	1.0	0.5	0.0	0.9	1.1	0.9	1.1	1.0	1.0	4.6	8.1	4.5	0.9	1.0	1.0	1.0	2.6	11.1	1.1	1.7	0.9	4.0	0.9	9.2	1.0	1.0	16.1	1.0	0.9	3.6	1.6	1.1	0.9	1.2	1.1	1.1	1.2	0.0	0.0	1.1	0.0	0.9	0.9	0.3	0.6	0.2	0.6	0.2	0.3	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.3	0.1	0.4	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.3	4.7	0.5	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.2	0.3	0.6	0.3	0.1	0.2	0.0	0.0	6.0	13.0	9.8	26.4	8.1	4.5	2.6	11.1	9.2	0.0	0.0	0.0	0.0	0.0	0.1	25.3	3.6	0.0	0.0	0.0	0.0	125.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.1	0.0	0.0	0.0	184.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3
HCN2	"BCNG-2, BCNG2, HAC-1"	ENSG00000099822	"Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2"	Q9UL51	19	589893-617159	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 38.1;heart muscle: 16.8"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 58.4;Horizontal cells: 38.1;Rod photoreceptor cells: 14.2"	"Group enriched"	"Detected in many"	6	"glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 18.0;HeLa: 9.6;MCF7: 16.7;U-138 MG: 12.6;U-87 MG: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.69e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.31e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.19e-3)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.53e-4)"	"unprognostic (9.72e-3)"	1.1	4.8	12.0	1.4	29.1	1.5	1.0	8.5	38.1	1.1	1.2	8.2	0.0	1.2	1.0	1.3	2.2	1.0	1.1	16.8	18.3	11.7	1.5	1.1	1.1	1.5	22.0	6.6	1.0	1.5	1.2	3.0	1.1	11.4	1.2	1.1	0.6	1.4	1.2	1.1	1.7	1.2	1.2	24.5	1.3	1.3	3.7	7.3	0.0	1.1	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	18.0	0.2	0.6	1.9	1.3	0.6	1.2	1.5	0.5	0.1	2.5	0.1	0.0	4.0	1.7	1.3	0.1	0.4	0.1	0.0	3.0	7.6	0.0	9.6	0.2	1.4	0.2	3.4	3.5	0.3	0.1	0.0	0.5	0.1	0.4	1.0	0.1	1.3	16.7	0.0	0.0	0.9	0.4	0.5	0.1	0.1	0.4	0.3	0.5	7.0	3.6	4.4	0.0	1.3	0.3	3.6	0.6	1.7	12.6	1.9	0.2	4.9	0.3	0.2	0.1	25.9	0.8	3.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	12.0	29.1	8.5	19.6	18.3	11.7	22.0	6.6	11.4	7.3	0.0	0.0	0.0	0.0	0.6	58.4	3.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	38.1	1.2	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.7	0.0	14.2	0.0	0.8	0.1	0.9	0.5	0.2	0.0	0.0	0.0
HCN3	KIAA1535	ENSG00000143630	"Hyperpolarization activated cyclic nucleotide gated potassium channel 3"	Q9P1Z3	1	155277583-155289848	"Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026584	Approved					NA	NA					"HPA026584: AB_1850534"	"unprognostic (1.04e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	"prognostic favorable (6.93e-4)"	1.6	3.5	4.5	2.0	7.5	1.5	2.1	20.3	9.5	3.6	4.4	3.3	3.6	7.7	4.5	2.1	3.9	2.2	3.0	1.6	4.0	8.2	4.4	10.2	1.9	2.3	4.1	8.5	4.7	4.7	6.4	12.6	2.4	9.5	2.7	5.0	4.0	4.4	3.6	1.1	9.2	6.6	2.8	3.0	1.9	3.2	1.7	2.1	1.6	2.6	1.3	3.0	2.3	3.6	0.3	0.0	0.0	0.1	0.0	0.6	0.0	1.6	1.8	7.9	3.2	1.3	1.5	1.9	1.3	1.2	1.6	1.9	2.8	5.5	1.5	1.1	1.0	3.4	6.9	2.2	1.0	0.9	2.1	2.8	0.6	5.1	1.8	0.5	0.6	1.6	0.9	1.0	1.1	0.2	1.8	0.3	2.5	3.7	4.4	1.9	2.2	1.1	0.6	2.7	4.2	2.1	3.9	1.9	2.9	2.2	1.7	6.5	4.6	1.2	1.6	0.5	1.5	2.8	1.3	0.1	1.9	1.7	4.0	1.2	1.4	0.6	1.3	1.5	1.1	1.7	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	7.5	20.3	9.5	4.0	8.2	4.1	8.5	9.5	2.1	0.0	1.1	0.0	0.6	1.1	2.4	0.8	2.5	0.0	1.2	1.8	3.9	0.3	0.0	0.9	0.1	0.0	4.6	0.0	0.3	0.3	1.3	0.8	1.1	1.5	0.7	0.0	4.1	3.1	0.0	0.4	0.9	1.3	0.0	1.0	2.3	1.4	0.9	2.9	1.1	0.8	1.8	0.0	0.3	1.5	2.1	2.4	0.0	0.5	3.8	0.9
HCN4		ENSG00000138622	"Hyperpolarization activated cyclic nucleotide gated potassium channel 4"	Q9Y3Q4	15	73319859-73369264	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Brugada syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 4.3;heart muscle: 12.5;testis: 9.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 28.7;Late spermatids: 33.9"	"Group enriched"	"Detected in some"	8	"testis cancer: 3.1;thyroid cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.6;CACO-2: 3.2;HDLM-2: 2.1;NTERA-2: 9.5;SuSa: 2.5;U-2 OS: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073174	Approved					NA	NA					"HPA073174: "	"unprognostic (2.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.05e-5)"	"unprognostic (5.56e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.95e-2)"	0.2	1.3	4.3	0.2	1.1	0.1	0.1	0.9	3.4	0.2	0.4	2.1	0.0	1.2	0.1	0.2	0.1	0.3	0.2	12.5	0.6	2.0	0.4	0.1	0.3	0.1	1.8	0.9	0.1	0.2	0.1	2.1	0.1	3.9	0.6	0.3	0.2	0.1	1.0	0.1	0.2	0.4	0.2	0.7	0.1	0.6	9.6	1.9	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	1.5	0.0	0.6	0.2	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.1	0.9	3.4	0.6	2.0	1.8	0.9	3.9	1.9	0.0	0.0	0.0	0.0	0.0	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	28.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	33.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.2	0.0	0.1	0.6	1.3	0.0	0.0	0.0	0.0	0.0
KCNA1	"AEMK, HUK1, Kv1.1, MBK1, RBK1"	ENSG00000111262	"Potassium voltage-gated channel subfamily A member 1"	Q09470	12	4909893-4918256	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 24.1"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 10.8;Ciliated cells: 6.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"basal ganglia: 13.7;cerebellum: 23.8;cerebral cortex: 21.1;pons and medulla: 24.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"LHCN-M2: 2.4;NTERA-2: 2.1;SCLC-21H: 3.9;U-2 OS: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074471	Approved					NA	NA					"HPA074471: "	"unprognostic (6.39e-3)"	"unprognostic (2.64e-1)"			"unprognostic (1.09e-1)"	"unprognostic (8.44e-2)"		"unprognostic (1.33e-1)"		"unprognostic (1.79e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.48e-1)"		"unprognostic (8.77e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-4)"		0.8	0.7	1.5	0.7	13.7	0.7	1.3	23.8	21.1	1.6	0.9	0.9	0.0	0.9	1.0	0.7	0.7	0.7	0.9	0.7	4.6	1.1	0.7	0.7	0.8	0.7	2.2	3.5	0.7	0.7	4.0	0.6	0.7	24.1	0.7	0.9	0.0	1.9	0.8	0.7	0.8	0.8	1.1	1.1	0.7	1.0	0.7	1.4	0.2	2.0	0.0	0.7	0.9	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	13.7	23.8	21.1	4.6	1.1	2.2	3.5	24.1	1.4	0.0	0.0	0.0	0.0	0.3	10.8	1.4	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA10	Kv1.8	ENSG00000143105	"Potassium voltage-gated channel subfamily A member 10"	Q16322	1	110517217-110519175	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.4;U-87 MG: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.2"	"HPA015061, CAB022564"			Uncertain	Nucleoplasm,Cytosol		No	NA			"Nucleoplasm, Cytosol"		"CAB022564: , HPA015061: AB_1855573"														"unprognostic (2.96e-2)"				0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA2	"HK4, Kv1.2"	ENSG00000177301	"Potassium voltage-gated channel subfamily A member 2"	P16389	1	110519837-110631474	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 28.0"	"Cell type enriched"	"Detected in some"	5	"Muller glia cells: 24.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 10.9;SCLC-21H: 2.8;U-2 OS: 2.4;U-266/70: 3.6;U-266/84: 5.4;WM-115: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001976	Enhanced					NA	NA					"CAB001976: "	"unprognostic (1.84e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.17e-3)"	"unprognostic (6.68e-3)"		"unprognostic (5.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.93e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.83e-1)"	3.2	1.4	7.1	2.2	13.1	0.8	1.2	17.2	28.0	1.2	1.6	3.1	0.0	1.4	1.0	1.3	1.7	1.1	1.6	1.6	7.2	6.1	0.9	0.9	1.0	1.9	7.2	14.5	1.1	1.9	0.8	1.4	0.7	21.1	1.8	2.0	1.4	1.8	2.4	2.1	1.6	1.6	1.6	2.8	1.3	1.3	2.5	3.8	0.3	5.3	0.0	3.5	1.4	0.5	0.5	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	2.8	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.1	2.4	0.0	0.0	3.6	5.4	0.2	0.1	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.3	0.5	1.8	1.3	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	4.1	0.1	7.1	13.1	17.2	26.3	7.2	6.1	7.2	14.5	21.1	3.8	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	4.9	0.0	2.9	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110672465-110675033	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 59.4"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 3.4;Melanocytes: 3.3;Sertoli cells: 6.5;T-cells: 8.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 3.3;T-cells: 11.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;Karpas-707: 26.1;U-266/70: 18.9;U-266/84: 16.9"	"Low region specificity"	"Detected in all"							HPA016625	Approved					NA	NA					"HPA016625: AB_2669407"	"unprognostic (2.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-5)"	"unprognostic (1.70e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	1.9	1.3	4.0	7.8	5.7	5.6	1.3	5.0	5.6	1.7	3.1	0.5	0.0	3.2	1.1	0.4	1.1	1.3	2.3	1.4	3.5	4.3	1.5	1.3	7.8	14.5	1.5	3.1	1.3	0.9	0.4	1.8	0.9	3.1	1.1	2.6	0.5	3.7	0.3	0.5	0.8	5.9	0.7	1.9	7.7	5.3	1.4	1.5	59.4	2.1	0.3	10.9	5.8	1.3	3.3	1.0	0.0	0.7	0.9	11.5	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	26.1	0.0	0.0	5.4	0.0	0.5	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.6	0.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.4	0.0	0.0	18.9	16.9	6.5	0.0	1.5	0.0	0.0	0.7	0.0	7.2	0.0	8.2	2.3	10.8	11.5	1.0	3.3	8.5	6.4	0.0	0.9	0.1	0.5	9.5	2.9	4.0	5.7	5.0	5.6	3.5	4.3	1.5	3.1	3.1	1.5	0.0	3.4	2.2	0.0	0.3	1.3	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	2.5	0.6	0.0	0.0	1.6	3.3	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	6.5	0.0	0.9	0.2	0.5	0.0	8.7	0.0	0.0
KCNA4	"HK1, HPCN2, KCNA4L, Kv1.4"	ENSG00000182255	"Potassium voltage-gated channel subfamily A member 4"	P22459	11	30009741-30017023	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cataract, Disease mutation, Dystonia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 16.5;brain: 39.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 9.6;Horizontal cells: 12.7;Muller glia cells: 6.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 39.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.6;WM-115: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB001977, HPA016422"	Approved					NA	NA					"CAB001977: , HPA016422: AB_1855574"				"unprognostic (1.12e-2)"	"unprognostic (1.80e-2)"			"unprognostic (1.31e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.17e-1)"			2.2	16.5	9.8	0.6	39.0	0.6	0.6	0.2	12.2	0.6	0.6	0.8	1.8	0.7	1.1	0.9	0.6	0.8	0.6	5.9	6.1	2.7	1.2	0.6	2.4	0.6	1.6	6.2	0.6	0.6	0.6	2.8	1.2	10.5	0.6	0.6	0.0	0.6	1.7	0.6	0.8	0.6	0.8	0.6	0.6	1.0	0.7	5.9	0.0	0.6	0.0	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	0.6	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	39.0	0.2	12.2	6.1	2.7	1.6	6.2	10.5	5.9	0.0	0.0	0.0	0.0	0.0	9.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA5	"HK2, HPCN1, Kv1.5"	ENSG00000130037	"Potassium voltage-gated channel subfamily A member 5"	P22460	12	5043989-5046788	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 33.0"	"Cell type enriched"	"Detected in some"	8	"Bipolar cells: 153.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	134	"plasmacytoid DC: 13.3"	"Lineage enriched"	"Detected in single"	134	"dendritic cells: 13.3"	"Cell line enriched"	"Detected in single"	12	"NTERA-2: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021516, CAB022562"	Approved					NA	NA					"CAB022562: , HPA021516: AB_2670732"	"unprognostic (3.87e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.08e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.92e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.08e-2)"	3.4	1.4	1.9	0.9	8.6	0.7	1.2	0.4	2.3	1.6	3.3	7.2	0.0	1.1	1.7	2.6	7.6	2.1	2.3	33.0	3.5	5.8	1.9	0.8	2.3	0.9	2.3	2.2	3.2	2.4	0.6	7.5	3.4	8.8	3.7	1.3	7.2	0.9	2.0	5.3	0.6	1.1	3.0	3.9	1.2	3.3	0.8	4.9	0.0	1.1	3.4	1.2	4.5	3.4	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	1.9	8.6	0.4	2.3	3.5	5.8	2.3	2.2	8.8	4.9	0.0	0.0	0.0	0.0	0.8	153.4	8.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.0	3.4	12.9	19.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
KCNA6	"HBK2, Kv1.6, PPP1R96"	ENSG00000151079	"Potassium voltage-gated channel subfamily A member 6"	P17658	12	4809176-4813412	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.4;JURKAT: 4.5;TIME: 1.0;U-698: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA																							0.7	0.8	3.8	2.7	4.7	0.8	2.0	0.7	9.6	1.0	0.7	6.8	0.0	2.2	0.8	0.6	0.8	0.8	0.6	0.7	5.8	0.7	0.8	0.9	0.9	2.1	3.9	7.2	0.9	0.8	0.6	2.0	0.7	4.3	0.8	0.6	0.0	0.8	0.6	1.2	0.7	0.8	0.7	1.7	1.5	0.8	2.0	8.4	0.0	0.8	0.0	0.6	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	2.8	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	4.7	0.7	9.6	5.8	0.7	3.9	7.2	4.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA7	"HAK6, Kv1.7"	ENSG00000104848	"Potassium voltage-gated channel subfamily A member 7"	Q96RP8	19	49067418-49072941	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 40.6"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 2: 25.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.0;U-251 MG: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.00e-1)"	"unprognostic (2.10e-2)"		"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.68e-1)"		"unprognostic (4.31e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-8)"	"unprognostic (1.70e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.29e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	40.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.6	0.3	0.0	0.0	1.1	0.9	3.3	0.8	0.9	0.8	0.2	0.7	0.3	0.4	2.0	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.5	0.9	0.4	0.2	0.2	0.7	1.3	0.1	0.2	0.0	0.4	0.6	0.2	1.5	0.4	0.2	0.6	4.0	0.1	0.3	0.1	0.1	0.4	0.0	0.4	0.5	1.1	0.1	0.5	0.3	0.7	0.5	0.3	0.3	0.4	0.2	0.5	0.2	0.5	0.4	0.4	1.5	0.3	0.1	0.6	0.5	1.1	0.7	1.4	0.5	0.9	4.0	0.7	0.3	0.3	0.6	0.4	0.5	3.3	0.8	0.7	0.8	0.4	0.5	0.5	0.7	0.7	0.2	1.1	0.7	0.8	2.6	0.9	0.7	0.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	25.9	0.0	1.2	0.3	0.4	3.1	0.0	1.4	5.7	0.0	5.9	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.1	0.4	0.5	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	1.6	0.0	0.1	0.1	0.7	0.3	0.9	0.0	0.0	0.3
KCNB1	Kv2.1	ENSG00000158445	"Potassium voltage-gated channel subfamily B member 1"	Q14721	20	49293394-49484297	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Exocytosis, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;retina: 22.4"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 119.5;Cone photoreceptor cells: 200.3;Rod photoreceptor cells: 366.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.6;CACO-2: 5.1;hTCEpi: 3.2;U-2 OS: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001979, HPA042434"	Enhanced					NA	NA					"CAB001979: , HPA042434: AB_2677996"	"unprognostic (4.51e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.17e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.25e-4)"	16.9	3.6	11.4	1.3	14.6	0.8	2.4	8.1	25.9	2.3	5.1	1.8	0.7	1.2	6.8	2.3	3.9	9.0	1.9	1.9	6.6	5.3	1.3	3.5	1.2	0.8	3.3	12.5	1.2	1.2	0.9	2.5	1.0	2.5	4.8	1.9	22.4	1.7	6.5	6.2	1.1	1.8	9.6	1.2	1.2	3.9	1.5	2.4	0.0	1.0	0.1	0.8	4.0	0.9	0.4	0.3	1.2	0.2	0.3	0.7	0.0	0.0	0.1	0.8	0.0	3.6	0.3	0.1	0.0	0.4	0.4	0.0	5.1	0.0	0.0	0.0	0.1	1.3	0.1	0.0	0.1	0.3	0.1	0.2	0.0	0.1	0.0	0.0	2.6	0.0	0.6	3.2	0.0	0.1	0.2	0.0	0.0	0.0	1.9	1.2	0.3	0.0	2.4	0.1	0.0	0.9	0.0	1.0	0.0	0.0	0.0	2.3	1.9	1.6	2.3	0.0	0.0	1.7	0.0	0.0	2.2	4.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.7	0.2	1.2	0.3	0.1	0.3	0.1	0.0	11.4	14.6	8.1	25.9	6.6	5.3	3.3	12.5	2.5	2.4	0.0	2.1	0.0	0.1	0.7	119.5	1.2	2.5	5.3	1.2	0.0	200.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.5	4.7	0.1	17.5	0.0	0.0	0.0	0.4	4.0	0.1	0.0	0.0	0.0	26.9	0.1	0.0	32.5	0.0	366.4	0.0	3.4	0.2	0.3	0.3	0.1	0.0	0.0	0.0
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537391-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2"	"Cell type enriched"	"Detected in some"	15	"Cone photoreceptor cells: 249.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"		Yes	NA			"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: AB_2685591"	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.8	1.9	3.8	0.6	5.3	0.4	0.7	0.3	9.7	0.5	0.7	0.0	0.0	1.2	0.4	0.4	1.1	2.1	0.5	0.4	7.1	3.1	0.5	0.4	0.6	0.5	0.9	7.8	0.4	2.4	0.4	9.2	0.5	3.2	0.7	0.7	4.2	0.5	0.5	0.4	0.4	1.6	0.5	1.6	8.6	2.4	1.7	0.4	0.9	0.4	0.0	0.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.3	0.3	9.7	7.1	3.1	0.9	7.8	3.2	0.4	0.0	0.0	0.0	0.0	0.0	12.9	0.2	0.0	0.0	0.0	1.8	249.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	17.1	0.0	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.4	0.0	2.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 67.5"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 36.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 67.5"	"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.7	2.3	8.2	1.0	10.0	2.9	0.9	67.5	33.3	3.0	1.0	1.0	0.0	1.4	1.5	0.6	1.1	0.9	1.3	0.6	5.6	4.9	0.9	1.1	1.0	1.2	3.3	12.6	1.1	0.9	0.6	1.4	0.7	19.5	1.2	0.8	0.7	1.2	0.7	1.7	1.8	1.2	0.8	1.9	1.0	1.3	2.9	2.0	0.0	1.5	0.0	0.8	2.4	0.5	1.7	0.8	5.8	0.8	0.7	1.1	0.3	0.4	0.1	3.1	1.2	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.2	0.0	0.9	1.1	1.8	0.0	0.3	0.3	2.1	0.6	3.0	0.2	0.4	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	1.4	0.0	0.5	0.5	1.2	1.5	0.0	0.0	0.8	7.5	0.9	0.0	0.4	7.1	4.4	0.4	0.5	0.0	0.4	0.6	0.5	0.1	0.2	2.3	0.3	0.3	0.5	0.6	1.0	0.5	0.3	1.0	5.8	0.7	1.1	1.1	0.7	0.7	0.7	0.9	0.5	0.2	1.7	0.7	0.8	3.8	0.7	0.8	0.8	0.4	0.3	8.2	10.0	67.5	33.3	5.6	4.9	3.3	12.6	19.5	2.0	0.0	0.0	0.0	0.0	0.0	36.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	7.5	0.0	0.0	8.4	0.3	0.0	0.0	1.0	0.0	1.5	0.2	0.0	0.0	0.1	7.4	0.0	0.4	5.4	4.5	0.0	0.0	0.0	0.0	0.0
KCNC2	Kv3.2	ENSG00000166006	"Potassium voltage-gated channel subfamily C member 2"	Q96PR1	12	75040077-75209868	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 39.3"	"Group enriched"	"Detected in some"	12	"Basal glandular cells: 1.9;Bipolar cells: 5.0;Glandular cells: 1.6;Muller glia cells: 1.9;Rod photoreceptor cells: 5.9"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.5;prostate cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019664, CAB022571"	Uncertain					NA	NA					"CAB022571: , HPA019664: AB_1855578"	"unprognostic (2.01e-1)"				"unprognostic (1.14e-1)"		"unprognostic (2.68e-1)"				"unprognostic (5.58e-3)"	"unprognostic (4.46e-2)"		"unprognostic (3.39e-2)"				0.7	0.7	8.7	0.7	12.9	0.7	3.3	0.4	39.3	0.7	0.8	1.9	0.0	0.7	0.9	0.9	0.7	0.7	0.7	0.7	7.4	10.4	0.7	0.9	0.7	0.7	4.7	13.5	0.7	0.7	0.7	6.0	0.7	19.1	4.4	0.8	1.3	1.1	0.7	0.7	0.7	0.8	0.7	1.0	0.7	0.7	1.0	0.6	0.0	0.7	0.0	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	12.9	0.4	27.3	7.4	10.4	4.7	13.5	19.1	0.6	0.0	0.0	0.0	1.9	0.0	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNC3	"Kv3.3, SCA13"	ENSG00000131398	"Potassium voltage-gated channel subfamily C member 3"	Q14003	19	50311937-50333515	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 32.1;parathyroid gland: 31.1;thyroid gland: 23.9"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 9.8;Collecting duct cells: 19.2;Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.9;CAPAN-2: 7.8;HDLM-2: 8.0;HMC-1: 21.4;K-562: 7.9;SK-BR-3: 14.5;T-47d: 13.8;U-2 OS: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018041	Approved					NA	NA					"HPA018041: AB_1855579"	"unprognostic (8.05e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.01e-4)"	"unprognostic (4.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.10e-5)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.19e-1)"	1.4	2.2	7.2	5.4	9.4	1.4	2.3	32.1	31.2	3.1	1.1	3.4	3.0	1.8	4.5	5.8	1.1	12.8	1.4	1.7	6.9	4.2	10.6	2.5	4.5	4.7	4.0	6.6	0.6	3.7	31.1	9.7	2.4	15.6	2.4	1.4	3.0	2.3	15.1	1.2	2.1	1.8	1.7	3.8	6.5	2.1	2.4	2.9	1.1	23.9	0.0	3.4	1.8	1.0	0.4	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	8.9	7.8	0.7	1.0	0.0	0.5	1.2	0.2	0.0	0.0	8.0	1.8	0.0	0.0	1.7	0.0	0.0	21.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	7.9	0.0	0.0	2.8	0.1	0.0	1.1	0.9	3.3	0.0	0.1	0.0	0.5	0.2	0.0	1.4	1.7	14.5	0.0	0.2	13.8	2.2	0.2	0.0	9.5	0.0	0.0	0.1	0.1	0.5	0.3	1.8	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	7.2	9.4	32.1	31.2	6.9	4.2	4.0	6.6	15.6	2.9	0.0	0.3	0.0	0.8	0.7	9.8	2.6	0.0	1.4	1.2	19.2	7.9	1.9	0.0	1.2	0.3	0.0	0.0	0.0	1.2	0.7	0.2	1.1	0.0	1.5	2.8	1.6	4.1	0.6	5.3	0.0	0.6	2.3	0.0	2.8	0.0	0.7	0.2	0.0	0.0	2.3	6.3	0.0	1.0	0.9	1.1	0.5	1.9	0.0	0.0	0.9
KCNC4	"C1orf30, HKSHIIIC, Kv3.4"	ENSG00000116396	"Potassium voltage-gated channel subfamily C member 4"	Q03721	1	110211343-110283100	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 39.3;Ito cells: 63.3;Rod photoreceptor cells: 44.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.5;U-87 MG: 14.7;WM-115: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014740			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA014740: AB_1855580"	"unprognostic (9.16e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.25e-2)"	2.3	4.7	12.1	1.6	3.2	0.7	3.3	9.2	12.7	1.9	1.4	1.9	1.1	0.8	4.5	3.1	2.1	3.7	4.8	4.5	9.1	14.2	5.1	1.1	3.0	1.9	6.8	2.0	3.4	4.3	11.2	3.8	2.8	14.3	2.4	1.3	4.7	7.1	3.7	4.5	4.0	2.0	2.6	3.6	3.3	2.8	2.2	1.1	7.2	2.3	7.8	2.3	1.2	1.5	0.8	0.7	0.9	0.4	0.3	1.5	0.1	1.9	1.5	0.4	2.9	1.1	0.3	3.5	8.5	1.5	0.6	0.8	4.8	0.9	3.3	3.4	3.1	2.6	3.2	1.4	0.7	0.4	16.5	1.6	0.1	3.3	0.7	0.5	2.7	0.8	0.3	0.3	1.9	0.2	0.5	4.4	1.8	0.6	1.4	0.0	0.4	1.8	0.6	1.7	0.7	3.9	2.7	0.1	0.5	4.1	0.1	0.6	0.8	0.4	8.3	0.8	2.7	1.1	1.4	1.6	1.1	4.0	0.7	0.3	2.1	1.9	0.6	14.7	2.3	9.5	0.8	0.4	0.2	0.5	0.2	1.5	0.6	0.9	0.4	0.0	0.8	1.3	0.5	0.9	0.3	0.3	0.7	0.4	0.1	12.1	3.2	9.2	12.7	9.1	14.2	6.8	2.0	14.3	1.1	0.0	1.4	0.0	12.5	2.9	1.4	6.7	7.6	4.0	2.3	3.5	39.3	0.3	0.0	5.0	0.3	9.8	2.2	0.0	14.8	0.3	2.4	7.4	1.1	0.5	1.2	3.2	12.7	63.3	3.1	0.4	1.4	0.5	1.7	1.8	5.7	3.7	8.7	6.6	3.9	0.5	44.8	25.8	5.1	0.0	5.7	2.6	0.9	1.3	8.3	10.3
KCND1	Kv4.1	ENSG00000102057	"Potassium voltage-gated channel subfamily D member 1"	Q9NSA2	X	48961378-48971569	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell type enhanced"	"Detected in some"	8	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Intestinal endocrine cells: 3.4;Leydig cells: 1.7;Peritubular cells: 3.5;Rod photoreceptor cells: 2.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HSkMC: 13.2;NB-4: 10.5;SuSa: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000524, HPA001066"	Supported		Uncertain	Nucleoplasm		Yes	No			Nucleoplasm		"HPA000524: AB_2666013, HPA001066: AB_1079662"	"unprognostic (6.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.19e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.41e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.30e-11)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.22e-3)"	4.9	2.4	4.2	3.4	4.7	6.0	2.2	16.8	7.8	5.1	2.2	6.3	1.9	2.0	5.0	3.8	1.4	7.4	6.3	2.9	6.9	2.5	2.5	1.8	3.0	3.1	3.1	3.5	4.6	1.4	1.8	3.0	2.5	10.4	3.3	2.1	2.6	1.2	6.0	0.7	1.6	2.6	6.6	6.5	4.2	2.5	3.0	2.7	1.1	2.3	0.5	3.6	3.0	3.0	0.6	1.3	1.4	0.1	0.0	0.8	0.1	0.4	1.9	0.8	4.7	6.4	5.1	1.6	1.0	4.0	2.8	1.9	1.2	0.6	1.6	3.4	3.1	0.8	0.6	0.8	0.4	2.7	2.6	3.1	1.4	1.9	0.1	2.4	0.4	2.9	13.2	1.8	5.2	0.6	4.7	0.9	2.2	1.1	3.6	2.0	3.5	0.4	10.5	2.5	0.3	0.7	1.3	0.9	1.5	3.1	1.5	0.5	2.1	0.9	0.0	2.1	10.2	2.0	1.5	2.4	0.6	2.6	0.6	0.2	2.9	3.8	3.8	1.7	3.7	2.1	0.0	0.1	0.0	0.5	0.0	0.3	0.6	0.2	0.8	0.0	0.1	0.2	0.0	1.4	0.0	0.0	1.3	0.0	0.1	4.2	4.7	16.8	7.8	6.9	2.5	3.1	3.5	10.4	2.7	0.0	1.4	0.0	0.0	0.7	0.2	0.4	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	3.4	0.6	0.8	0.0	1.7	0.0	0.0	0.0	0.2	0.3	0.1	0.0	3.5	0.0	2.8	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.1
KCND2	"KIAA1044, Kv4.2, RK5"	ENSG00000184408	"Potassium voltage-gated channel subfamily D member 2"	Q9NZV8	7	120273668-120750331	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 41.1"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 2.9;Cholangiocytes: 5.1;Ductal cells: 2.5;Leydig cells: 3.4;Spermatocytes: 4.2;Spermatogonia: 3.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.5;HSkMC: 4.1;NTERA-2: 3.2;RT4: 3.3;SCLC-21H: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029068	Enhanced					NA	NA					"HPA029068: AB_10601436"	"unprognostic (4.22e-1)"	"unprognostic (2.79e-4)"	"unprognostic (3.79e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-3)"	"unprognostic (9.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.77e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.51e-4)"	"unprognostic (4.07e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.83e-3)"	2.9	1.0	3.9	1.0	6.7	0.3	1.9	41.1	20.6	2.4	0.7	1.5	0.0	0.7	5.6	0.5	0.5	1.7	7.0	0.5	3.7	5.4	0.3	0.4	0.6	0.5	4.2	3.6	5.9	0.6	2.5	6.6	0.8	12.1	0.5	0.6	0.0	0.7	1.7	0.5	0.3	0.5	3.7	3.7	0.3	0.5	2.9	4.5	0.0	0.8	1.1	0.3	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	3.3	16.6	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	6.7	41.1	5.3	3.7	5.4	4.2	3.6	12.1	4.5	0.0	0.0	0.0	0.0	0.0	2.9	1.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.3	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.5	0.0	0.4	4.2	3.3	0.1	0.0	0.0	0.0	0.1
KCND3	"KSHIVB, Kv4.3, SCA19, SCA22"	ENSG00000171385	"Potassium voltage-gated channel subfamily D member 3"	Q9UK17	1	111770662-111989155	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 38.5;Cardiomyocytes: 34.4;Early spermatids: 29.0;Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"OE19: 6.6;SCLC-21H: 15.9;U-2 OS: 2.4;WM-115: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029452	Approved					NA	NA					"HPA029452: AB_10602239"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-3)"	"unprognostic (6.64e-3)"	3.3	0.8	6.8	3.1	6.9	0.0	2.1	25.9	11.9	1.3	2.5	1.3	1.3	0.3	4.1	9.6	3.2	3.4	4.2	5.5	5.6	5.6	1.3	11.6	1.3	1.3	8.9	5.7	1.3	2.2	4.1	1.5	1.3	1.6	9.2	1.6	1.9	1.3	10.0	2.8	5.1	1.3	7.7	1.3	2.0	1.7	1.3	1.3	1.3	1.3	2.3	1.3	3.7	1.3	0.5	0.4	1.2	0.3	0.9	0.3	0.7	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.4	0.0	0.0	0.0	0.8	0.1	0.0	1.6	0.6	0.0	0.5	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.3	6.6	0.0	0.0	0.1	0.0	0.0	0.3	15.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.5	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.4	0.5	0.3	0.2	1.2	0.9	0.3	0.3	0.1	0.7	6.8	6.9	25.9	9.3	5.6	5.6	8.9	5.7	1.6	1.3	0.0	9.4	0.0	10.7	6.6	38.5	34.4	0.0	0.0	1.2	0.0	3.9	0.1	0.0	0.7	29.0	1.8	0.0	0.0	21.1	0.1	1.4	14.3	0.0	23.7	0.2	28.6	0.0	1.8	0.6	20.3	16.7	0.0	3.3	0.0	0.2	6.1	4.4	0.3	1.8	0.2	4.2	0.0	3.1	1.1	0.7	5.8	0.0	0.0	0.0	12.3
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911937-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"brain: 36.9"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 10.2;Syncytiotrophoblasts: 6.4"	"Cancer enriched"	"Detected in many"	7	"glioma: 27.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 16.9;MCF7: 6.0;T-47d: 7.3"	"Group enriched"	"Detected in many"	4	"amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1"	"Low region specificity"	"Detected in all"			"HPA014738, HPA062278"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA014738: AB_1852114, HPA062278: AB_2732679"	"unprognostic (2.54e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.41e-4)"	"unprognostic (1.54e-3)"	"unprognostic (4.83e-5)"	"unprognostic (1.57e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.10e-4)"	"unprognostic (2.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.08e-2)"	0.9	0.9	11.5	1.0	25.5	0.8	1.2	0.8	36.9	0.9	1.2	2.4	0.0	1.2	1.9	0.8	1.6	1.1	1.0	1.1	13.1	4.7	1.1	0.9	1.0	1.0	3.1	10.5	0.9	2.2	0.8	0.2	0.9	3.6	1.0	1.2	0.0	0.8	1.4	0.8	0.8	1.1	1.0	1.0	1.5	1.1	1.0	3.1	0.5	0.8	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	16.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	2.6	0.1	1.8	0.0	0.1	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.2	7.3	0.8	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.5	25.5	0.8	28.5	13.1	4.7	3.1	10.5	3.6	3.1	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
KCNG1	"K13, KCNG, kH2, Kv6.1"	ENSG00000026559	"Potassium voltage-gated channel modifier subfamily G member 1"	Q9UIX4	20	51003656-51023129	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 25.8;endometrium 1: 48.3"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 45.1;Syncytiotrophoblasts: 81.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	27	"naive B-cell: 10.8"	"Lineage enriched"	"Detected in single"	87	"B-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.7;U-138 MG: 20.3;WM-115: 17.0"	"Group enriched"	"Detected in many"	5	"amygdala: 21.4;basal ganglia: 17.0;cerebral cortex: 15.2;hippocampal formation: 19.7"	"Group enriched"	"Detected in all"	4	"amygdala: 16.3;basal ganglia: 12.0;cerebral cortex: 22.5;hippocampal formation: 21.1"	"HPA039530, HPA040024"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA039530: AB_10795144, HPA040024: AB_10796338"	"unprognostic (1.19e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.05e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.83e-9)"	"unprognostic (1.52e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-2)"	0.5	4.5	13.3	2.9	7.0	0.3	0.7	2.3	11.9	9.6	2.4	1.6	25.8	0.6	48.3	2.8	3.7	11.9	1.9	1.0	7.9	2.9	0.5	0.4	0.5	3.0	2.0	9.5	0.9	3.7	1.3	0.8	9.3	6.7	5.6	1.3	0.7	1.4	18.3	0.3	0.5	7.2	5.8	1.0	3.5	0.8	5.4	2.6	0.0	0.5	0.0	1.4	2.8	3.4	10.8	0.0	0.0	0.1	0.0	0.0	0.1	0.4	1.7	1.3	6.5	0.7	1.7	0.1	5.7	0.0	3.4	2.6	0.1	0.1	0.0	3.5	1.7	9.4	1.6	0.8	1.7	3.4	0.2	2.2	0.0	6.3	0.0	11.9	0.0	0.2	3.4	26.7	12.8	13.1	0.6	0.9	0.0	0.1	0.0	0.3	6.3	0.0	0.1	6.8	0.0	11.8	0.0	0.0	0.0	0.0	2.0	2.0	7.4	12.4	14.5	9.3	2.2	1.0	0.9	0.3	20.3	12.0	0.1	1.6	0.0	0.0	0.0	6.0	0.4	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	13.3	7.0	2.3	11.9	7.9	2.9	2.0	9.5	6.7	2.6	3.0	1.4	1.5	9.3	1.0	0.3	0.8	0.0	1.4	1.2	0.0	0.0	45.1	0.0	2.9	14.5	0.3	3.5	0.0	0.0	2.4	1.0	5.6	0.0	0.0	2.9	1.6	0.0	0.0	0.0	14.4	1.4	0.0	0.0	0.0	0.2	0.2	0.3	3.5	3.9	0.0	0.1	0.0	1.0	1.2	0.9	0.3	81.1	0.0	0.3	7.9
KCNG2	"KCNF2, Kv6.2"	ENSG00000178342	"Potassium voltage-gated channel modifier subfamily G member 2"	Q9UJ96	18	79863668-79900184	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 5.3"	"Cell type enriched"	"Detected in some"	16	"Horizontal cells: 108.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 3.5;U-2 OS: 1.1;U-937: 1.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"hippocampal formation: 31.7"	HPA048628	Enhanced					NA	NA					"HPA048628: AB_2680466"	"unprognostic (1.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.78e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.18e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.63e-2)"	0.2	0.1	1.5	0.8	2.2	0.6	0.0	0.1	2.4	0.0	0.3			1.1	0.3	0.0	0.1	0.0	0.0	0.0	5.3	1.0	0.9	0.1	0.2	0.4	0.0		0.2	0.0	0.0	0.1	0.6		0.0	0.0		0.3	0.0	0.0	0.1	1.1	0.0	0.2	0.3	0.3	1.2			0.0		0.0	0.5	0.0	0.6	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.0	0.0	0.7	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.7	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	1.2	108.1	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.3	2.1	0.0	5.3	0.0	0.0	0.0
KCNG3	Kv6.3	ENSG00000171126	"Potassium voltage-gated channel modifier subfamily G member 3"	Q8TAE7	2	42442017-42494097	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.4"	"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 3.0;Intestinal endocrine cells: 1.7;Leydig cells: 1.7;Muller glia cells: 2.1;Peritubular cells: 2.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"amygdala: 9.0;basal ganglia: 11.4;cerebral cortex: 7.1;hippocampal formation: 4.4;olfactory region: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 5.1;HMC-1: 17.7;NTERA-2: 11.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"amygdala: 3.9;basal ganglia: 4.7;cerebral cortex: 5.3;hippocampal formation: 6.6;midbrain: 3.0"	HPA041625			Approved	"Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"		"HPA041625: "	"unprognostic (1.56e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.67e-3)"	"unprognostic (7.95e-2)"	"unprognostic (9.14e-3)"		"unprognostic (4.83e-3)"	"unprognostic (6.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.23e-1)"	0.4	5.2	9.0	2.5	11.4	0.3	0.5	0.2	7.1	0.8	2.3	0.1	1.6	0.4	1.6	0.7	0.4	0.5	0.7	0.3	4.4	0.9	1.2	0.3	1.2	0.4	1.2	3.6	0.9	2.9	0.3	1.8	0.3	0.5	1.2	1.3	0.6	0.3	1.7	0.3	0.6	0.5	0.6	0.3	0.4	0.3	3.3	1.1	4.9	0.3	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.2	0.0	5.1	0.0	0.0	0.0	2.7	0.0	0.5	0.9	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.9	0.0	11.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.6	0.7	1.1	1.7	0.5	1.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	11.4	0.2	7.1	4.4	0.9	1.2	3.6	0.5	1.1	3.0	0.6	0.0	0.2	1.1	1.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	2.1	0.2	0.0	2.5	0.0	0.0	0.0	0.4	0.2	1.0	1.0	0.1	0.0	0.0	0.1
KCNG4	Kv6.4	ENSG00000168418	"Potassium voltage-gated channel modifier subfamily G member 4"	Q8TDN1	16	84218667-84239750	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"retina: 8.8"	"Cell type enriched"	"Detected in some"	18	"Bipolar cells: 29.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2"	"Region enhanced"	"Detected in many"		"cerebellum: 101.5"	"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (3.54e-1)"									"unprognostic (6.67e-2)"				0.7	2.8	2.6	0.2	1.8	1.8	0.1	0.7	3.5	0.0	0.1	1.6	0.0	0.1	0.3	0.8	0.4	0.2	0.3	0.1	2.8	2.0	0.2	0.1	0.1	0.5	2.8	0.0	0.6	0.3	0.0	1.1	0.2	2.3	0.4	0.2	8.8	0.4	0.1	1.0	2.1	0.4	0.1	1.3	0.4	0.4	0.7	1.0	0.0	0.4	0.0	0.1	0.4	0.0	0.9	0.8	2.4	0.6	1.3	0.6	0.2	0.3	0.3	0.9	3.2	0.3	0.3	0.9	0.6	0.0	0.0	0.0	0.6	0.7	0.5	0.4	0.2	0.1	0.4	0.0	0.0	0.2	0.2	0.7	0.5	1.1	1.0	0.2	0.1	0.3	0.1	0.0	0.1	0.3	0.6	0.1	0.5	0.6	1.4	0.0	0.8	0.3	1.0	0.8	0.0	0.8	0.4	0.9	0.1	0.0	0.8	0.8	0.7	0.7	0.4	1.8	0.3	0.6	0.3	0.5	0.5	0.4	0.9	0.4	0.6	0.3	0.4	0.7	0.5	0.6	2.4	0.6	0.6	0.4	0.3	0.3	0.4	0.4	0.3	0.2	0.9	0.4	0.6	2.1	1.3	0.3	0.8	0.4	0.2	2.6	1.8	0.7	3.5	2.8	2.0	2.8	0.0	2.3	1.0	0.0	0.0	0.0	0.0	0.0	29.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNH1	"eag, eag1, h-eag, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134180	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 20.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 9.0;Late spermatids: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.3;RH-30: 7.2;RPTEC TERT1: 4.2;SH-SY5Y: 9.2;SK-MEL-30: 8.6;T-47d: 6.5"	"Low region specificity"	"Detected in all"							"HPA014551, HPA019445, HPA076421"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: "	"unprognostic (9.12e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.70e-2)"	0.9	2.3	6.3	1.3	13.3	0.7	0.6	19.1	20.2	1.0	1.3	3.3	0.2	1.2	1.5	1.0	0.9	1.2	1.0	0.7	3.8	1.7	1.0	0.7	0.7	0.7	1.1	7.5	0.8	0.9	0.9	0.8	1.1	1.7	1.3	1.3	0.0	0.8	0.9	0.7	0.9	1.0	1.0	2.1	0.6	1.5	2.4	1.5	0.0	0.8	0.0	0.7	0.9	0.7	0.1	0.7	0.7	0.1	0.1	0.3	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.7	0.1	1.5	1.7	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	4.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	4.2	0.0	0.3	9.2	1.6	0.1	8.6	1.2	6.5	0.0	0.0	1.1	0.1	1.4	0.8	0.0	0.0	0.0	0.2	0.0	0.6	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.7	0.1	0.0	6.3	13.3	19.1	20.2	3.8	1.7	1.1	7.5	1.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0
KCNH2	"erg1, HERG, Kv11.1, LQT2"	ENSG00000055118	"Potassium voltage-gated channel subfamily H member 2"	Q12809	7	150944961-150978315	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 199.1;Cardiomyocytes: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.0"	"Group enriched"	"Detected in some"	7	"K-562: 59.8;NB-4: 29.8;SH-SY5Y: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (9.79e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.52e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (6.08e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.02e-2)"	1.1	4.9	5.0	3.2	8.3	37.9	0.7	19.3	8.0	4.3	17.3	2.8	3.1	3.5	9.3	4.6	3.4	4.1	28.5	24.9	4.8	9.3	0.8	0.7	1.7	0.9	4.7	3.9	6.6	5.1	10.5	23.8	2.2	14.1	6.8	1.8	8.0	1.8	10.2	0.8	0.7	6.9	9.4	2.2	1.6	6.8	18.0	1.6	0.1	0.7	0.0	0.7	7.5	2.4	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.1	5.7	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	59.8	0.0	0.0	0.3	0.5	29.8	0.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	1.2	25.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.5	0.0	0.0	1.7	0.0	0.6	0.0	3.7	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	8.3	19.3	8.0	4.8	9.3	4.7	3.9	14.1	1.6	0.0	0.0	0.0	0.1	0.0	199.1	76.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	1.8	0.8	0.0	0.0	23.3	0.2	1.0	0.9	0.1	26.4	0.0	0.3	15.9	15.6	2.5	0.0	2.5	2.3	0.0	0.0	0.0	0.7	2.7	0.5	0.0	12.4	0.0	9.6	0.0	1.9	0.7	2.6	0.0	0.2	0.0	0.2	0.3
KCNH3	"BEC1, elk2, Kv12.2"	ENSG00000135519	"Potassium voltage-gated channel subfamily H member 3"	Q9ULD8	12	49539157-49558308	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.7"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 9.4;Early spermatids: 4.1;Late spermatids: 3.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"A549: 9.6;AN3-CA: 4.5;HMC-1: 4.6;RPTEC TERT1: 11.8;U-2 OS: 12.5"	"Group enriched"	"Detected in many"	11	"amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0"	"Low region specificity"	"Detected in many"			HPA051088			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051088: AB_2681340"	"unprognostic (5.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-4)"	"unprognostic (8.24e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.91e-3)"	"unprognostic (5.28e-2)"	"unprognostic (6.39e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.07e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	0.9	3.8	24.3	1.5	18.5	1.4	1.0	5.8	30.7	0.9	0.8	0.5	0.0	0.9	1.3	0.9	0.7	8.7	1.7	1.2	22.0	3.0	1.6	0.7	1.2	1.9	1.9	13.0	0.8	1.4	6.3	9.3	0.8	0.0	1.2	0.7	0.0	1.1	1.6	0.8	1.1	1.0	1.0	0.6	1.4	1.4	2.6	2.1	0.0	1.7	0.0	1.4	0.9	0.0	0.0	0.1	0.6	0.8	0.4	3.6	0.5	1.0	9.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.6	0.0	0.3	2.3	0.7	0.2	0.0	0.1	0.4	0.0	0.5	0.1	0.1	0.0	4.6	0.0	0.0	0.1	0.0	1.8	0.0	0.2	0.0	0.3	0.0	1.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	11.8	0.0	1.8	0.3	0.3	0.0	0.3	0.0	1.1	0.2	0.1	0.0	12.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.7	0.0	3.6	0.0	0.3	1.1	0.1	0.0	1.1	2.6	0.6	0.4	0.1	0.0	0.4	0.5	24.3	18.5	5.8	30.7	22.0	3.0	1.9	13.0	0.0	2.1	0.0	0.3	0.0	0.2	0.1	0.0	0.6	2.5	9.4	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.6	2.4	1.3	0.8	3.6	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.9	2.5	0.3	0.0	1.0	0.0	0.0
KCNH4	"elk1, Kv12.3"	ENSG00000089558	"Potassium voltage-gated channel subfamily H member 4"	Q9UQ05	17	42156891-42181278	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;K-562: 6.0;RPMI-8226: 11.4;RT4: 4.3;U-266/70: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.07e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.59e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.36e-6)"	"unprognostic (9.52e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.72e-3)"	1.2	1.0	0.7	2.4	11.2	0.7	0.3	0.0	7.9	0.7	0.3	0.1	0.0	0.7	0.2	0.1	0.1	0.4	0.5	0.7	0.4	0.9	0.2	0.2	0.3	1.0	0.3	1.0	0.2	0.3	0.0	0.4	0.3	0.0	0.5	0.3	0.0	0.8	0.5	0.2	0.4	0.5	0.3	0.1	0.8	0.6	0.9	2.6	0.0	0.2	0.0	1.1	3.1	0.1	0.4	0.6	0.6	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	6.3	0.5	0.9	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.0	1.1	0.0	0.0	1.9	0.0	0.0	1.1	0.0	0.0	0.0	11.4	0.0	4.3	2.6	1.4	0.4	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.1	0.8	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.7	11.2	0.0	7.9	0.4	0.9	0.3	1.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
KCNH5	"eag2, H-EAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699454-63102037	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 4.6;brain: 9.2;retina: 5.7"	"Cell type enriched"	"Detected in some"	15	"Bipolar cells: 64.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 10.1;RT4: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.9	4.6	1.7	0.5	3.6	0.3	0.4	0.2	9.2	0.3	0.4	0.4	0.0	0.3	0.4	0.5	0.3	0.3	0.3	0.3	1.3	3.0	0.4	0.3	0.3	0.3	1.2	4.2	0.3	0.3	0.3	1.5	1.2	6.5	0.7	0.3	5.7	0.3	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	1.7	0.0	0.0	0.3	0.0	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	1.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.1	0.0	1.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.6	0.2	9.2	1.3	3.0	1.2	4.2	6.5	0.0	0.0	0.0	0.0	0.1	0.0	64.7	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.4	0.7	0.0	1.0	0.0	0.0	0.0
KCNH6	"erg2, HERG2, Kv11.2"	ENSG00000173826	"Potassium voltage-gated channel subfamily H member 6"	Q9H252	17	63523334-63548977	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 8.7;kidney: 15.4;pituitary gland: 7.6;retina: 7.6"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 10.0;Cardiomyocytes: 19.6;Cone photoreceptor cells: 29.5;Intestinal endocrine cells: 33.3;Proximal tubular cells: 15.4"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 8.7;SH-SY5Y: 3.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 4.7;pons and medulla: 1.4"	HPA061704	Approved					NA	NA					"HPA061704: "	"unprognostic (8.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.98e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.15e-2)"	0.0	0.2	0.3	0.7	1.1	0.3	0.0	0.1	1.2	0.0	4.2	0.0	0.0	3.9	0.0	0.5	0.0	0.3	0.1	0.6	0.3	2.8	15.4	0.0	0.9	0.1	1.1	0.5	0.1	2.4	0.1	7.6	0.6	1.0	6.2	0.4	7.6	0.1	0.0	0.2	0.3	8.7	0.0	0.7	0.1	1.7	1.4	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.8	0.4	1.7	0.5	0.7	0.5	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.2	0.7	0.0	0.2	0.1	0.1	0.0	0.0	0.3	8.7	3.3	0.0	0.2	0.1	0.2	0.3	0.2	0.0	0.3	1.0	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	1.2	0.5	0.4	0.4	0.3	0.1	0.6	0.2	0.2	0.2	0.8	0.5	0.4	1.7	0.7	0.3	0.4	0.2	0.4	0.3	1.1	0.1	1.2	0.3	2.8	1.1	0.5	1.0	0.3	0.0	0.0	0.0	0.2	0.2	10.0	19.6	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	33.3	0.0	0.0	2.0	0.0	0.0	1.7	0.0	1.6	0.5	0.1	0.0	0.0	15.4	2.7	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
KCNH7	"erg3, HERG3, Kv11.3"	ENSG00000184611	"Potassium voltage-gated channel subfamily H member 7"	Q9NS40	2	162371407-162838730	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.0;pituitary gland: 5.4"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 22.7;Horizontal cells: 20.6;Ito cells: 12.9;Late spermatids: 55.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.5;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.0"	"Group enriched"	"Detected in some"	13	"SCLC-21H: 10.7;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018039	Uncertain					NA	NA					"HPA018039: AB_1852125"	"unprognostic (1.80e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.12e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.52e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.68e-2)"	0.4	1.0	4.4	0.9	6.8	0.8	0.4	6.0	11.0	0.4	0.4	0.0	0.7	0.7	0.4	0.6	0.4	0.5	0.4	1.0	2.6	1.8	0.6	2.7	0.5	0.5	0.7	4.6	0.4	1.0	0.3	5.4	0.6	3.1	0.4	0.3	0.4	0.4	1.5	0.3	0.4	0.5	0.4	0.7	1.1	2.5	1.6	0.3	0.0	0.4	0.0	0.3	0.4	0.4	0.1	0.1	3.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.7	0.7	0.0	9.6	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.0	4.4	6.8	6.0	11.0	2.6	1.8	0.7	4.6	3.1	0.3	0.0	0.0	0.0	0.0	0.0	8.6	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.6	0.0	12.9	1.6	55.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148454-19535646	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.3;pituitary gland: 16.1"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 4.7;Early spermatids: 2.7;Intestinal endocrine cells: 3.5;Melanocytes: 3.3;Muller glia cells: 3.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;OE19: 4.0;SH-SY5Y: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA016586: AB_1852127, HPA077537: , HPA077773: "	"unprognostic (6.68e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.56e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.04e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.71e-5)"	"unprognostic (1.72e-1)"	0.6	7.0	8.4	1.6	22.0	1.4	2.4	1.3	11.4	1.3	1.9	31.3	0.0	2.2	1.2	1.2	0.7	1.4	2.2	1.0	11.8	5.7	0.7	0.7	0.8	3.2	16.4	10.2	0.7	2.7	0.8	16.1	0.6	15.0	2.2	2.5	0.1	3.3	1.4	0.6	1.9	1.8	1.1	9.9	2.6	5.9	4.0	18.1	0.0	1.1	0.0	3.2	0.9	0.5	4.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.8	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.4	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	8.4	22.0	1.3	11.4	11.8	5.7	16.4	10.2	15.0	18.1	0.0	0.0	0.0	1.6	0.5	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.7	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.1	0.0	3.5	0.0	0.0	1.1	0.0	0.0	3.3	0.0	1.7	3.7	0.6	0.0	0.0	0.0	0.9	0.0	0.2	0.7	1.9	0.0	0.1	0.0	0.2	0.2
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium voltage-gated channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"kidney: 123.2"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 165.8"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.3"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	40	"RPTEC TERT1: 51.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced					NA	NA					"HPA026962: AB_10601934"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.81e-3)"	0.1	0.0	0.5	0.2	2.3	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	123.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.3	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.9	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	2.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	36.6	0.0	0.0	165.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium voltage-gated channel subfamily J member 10"	P78508	1	159998651-160070483	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 74.1;kidney: 28.1"	"Cell type enriched"	"Detected in some"	8	"Muller glia cells: 83.5"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	6	"NK-cells: 1.7;T-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 11.7;SK-MEL-30: 3.7;U-266/70: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced					NA	NA					"HPA078302: AB_2732378"	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	1.4	1.5	23.6	3.0	28.1	1.3	1.3	10.5	74.1	1.4	1.7	37.9	0.0	1.5	1.3	1.3	1.4	1.3	1.3	1.3	21.8	13.2	28.1	3.1	1.3	7.1	28.1	15.1	1.3	1.3	1.3	0.3	1.3	25.5	1.3	1.5	0.5	1.5	1.5	1.2	1.6	1.7	1.3	42.9	10.3	2.0	1.8	25.5	0.0	1.5	0.0	2.9	1.5	0.1	0.0	0.0	0.0	0.3	1.7	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.3	0.0	0.2	1.7	0.2	0.0	1.1	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.1	11.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.0	2.2	0.1	0.0	0.0	0.2	0.4	0.0	0.3	3.7	1.0	0.1	0.5	0.1	0.1	0.3	0.9	0.0	3.8	1.7	0.0	0.2	0.2	1.8	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	1.7	0.3	0.0	2.5	0.2	23.6	28.1	10.5	22.2	21.8	13.2	28.1	15.1	25.5	25.5	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	3.5	3.9	0.0	10.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.4	1.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium voltage-gated channel subfamily J member 11"	Q14654	11	17385859-17389331	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 63.1"	"Cell type enhanced"	"Detected in some"	17	"Cardiomyocytes: 11.3;Collecting duct cells: 5.2;Intestinal endocrine cells: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;HEK 293: 13.5;MCF7: 10.8;SCLC-21H: 9.2"	"Low region specificity"	"Detected in all"							HPA048891	Approved					NA	NA					"HPA048891: AB_2680547"	"unprognostic (1.95e-2)"	"unprognostic (6.18e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-5)"	"unprognostic (1.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.72e-3)"	"unprognostic (9.23e-3)"	"prognostic favorable (1.56e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-2)"	2.5	1.1	2.9	1.0	7.8	0.8	2.7	13.6	7.8	1.0	1.1	0.7	4.9	1.4	1.1	2.1	1.7	1.1	1.1	6.2	3.5	2.4	1.3	0.9	1.3	1.2	2.7	5.2	0.8	8.7	2.7	3.3	0.7	3.5	2.5	1.0	0.1	1.2	7.6	63.1	1.0	1.1	0.8	1.7	1.0	4.6	0.8	1.9	0.0	4.1	4.5	1.0	0.9	1.1	0.8	0.4	1.4	0.3	0.8	0.4	0.4	1.5	2.4	0.3	4.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	2.5	0.2	7.1	0.2	0.0	0.3	0.3	4.8	0.1	0.3	1.7	13.5	3.7	0.9	0.8	0.1	0.4	0.3	0.1	0.3	0.0	0.1	0.1	0.0	6.1	3.8	3.8	0.0	10.8	0.7	0.1	1.0	4.2	0.3	1.4	1.7	2.1	0.4	0.9	9.2	0.8	0.0	3.6	0.0	0.0	4.7	0.2	0.0	0.0	1.2	0.0	0.1	0.2	6.0	0.9	0.0	1.0	0.0	1.4	0.3	0.2	0.4	0.3	0.3	0.7	0.4	0.4	0.1	0.8	0.4	0.4	1.3	0.8	0.1	0.4	0.3	0.4	2.9	7.8	13.6	7.8	3.5	2.4	2.7	5.2	3.5	1.9	0.0	2.4	0.0	0.1	0.0	2.4	11.3	0.0	0.0	1.2	5.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	1.0	0.1	0.0	4.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.1
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium voltage-gated channel subfamily J member 12"	Q14500	17	21376197-21419872	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 39.4;skeletal muscle: 47.8"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 84.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 39.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3"	"Low region specificity"	"Detected in all"							HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.2	1.3	1.9	0.9	2.9	0.7	0.9	39.4	5.8	1.2	0.8	1.1	0.5	0.5	0.8	1.4	1.5	2.1	0.7	5.1	0.9	1.4	1.2	0.5	1.3	0.4	1.3	3.4	0.7	0.5	10.6	0.7	0.7	4.0	0.9	0.6	1.7	0.6	0.9	47.8	6.0	0.6	1.0	0.9	1.3	0.9	1.3	0.9	0.0	1.0	7.5	1.1	0.8	1.5	0.0	0.9	0.0	0.5	0.0	0.1	0.0	0.0	1.1	0.4	2.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	3.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	5.9	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.1	0.0	1.5	0.0	6.3	0.0	1.0	1.6	0.0	0.0	7.3	0.4	3.7	0.0	1.5	8.0	0.0	0.0	2.8	0.0	0.5	6.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.9	2.9	39.4	5.8	0.9	1.4	1.3	3.4	4.0	0.9	0.0	0.0	0.0	0.0	1.3	0.8	12.5	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	0.4	1.4	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.2	84.2	1.2	5.5	0.0	0.2	6.9	0.0	0.0	0.0	0.4	11.2	0.0	0.0	3.9	0.6	1.4	0.0	0.5	0.5	1.3	1.9	0.1	0.0	0.6	0.0
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium voltage-gated channel subfamily J member 13"	O60928	2	232766464-232776568	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 22.9;intestine: 49.5;retina: 70.3"	"Group enriched"	"Detected in some"	14	"Melanocytes: 20.3;Muller glia cells: 44.0"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Region enriched"	"Detected in some"	7	"pons and medulla: 22.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;CACO-2: 2.6;SuSa: 3.1;U-2197: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051609			Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA051609: "	"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.2	0.2	0.5	0.0	0.7	0.1	0.3	0.4	0.9	0.2	10.1	7.0	1.3	4.3	0.2	0.3	0.2	0.1	1.6	0.2	3.2	0.5	1.9	0.3	0.2	0.0	0.4	0.4	0.3	0.4	8.5	0.3	0.0	22.9	0.3	0.0	70.3	0.3	1.6	0.2	1.8	49.5	0.0	0.6	0.2	1.1	0.5	0.1	0.0	3.8	0.0	0.0	0.3	0.3	1.1	0.8	5.4	1.1	1.1	2.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.0	0.5	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.3	1.0	3.1	0.2	0.3	0.0	0.1	0.0	4.6	0.3	1.3	0.1	0.8	0.8	0.4	0.0	5.4	1.1	0.9	1.0	0.2	1.2	0.8	1.8	0.7	0.4	1.1	2.1	1.1	0.8	1.1	1.0	0.8	2.7	0.1	0.5	0.7	0.4	0.9	3.2	0.5	0.4	0.4	22.9	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	2.4	0.0	1.0	0.0	1.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	44.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KCNJ14	"IRK4, Kir2.4"	ENSG00000182324	"Potassium voltage-gated channel subfamily J member 14"	Q9UNX9	19	48455509-48466980	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.9"	"Cell type enriched"	"Detected in many"	8	"Rod photoreceptor cells: 311.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071765			Approved	Nucleoli		NA	NA			Nucleoli		"HPA071765: AB_2686444"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.33e-5)"	"unprognostic (5.77e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.05e-4)"	"unprognostic (7.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.02e-6)"	"unprognostic (1.47e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.82e-3)"	"unprognostic (4.41e-2)"	1.0	0.4	1.1	0.9	6.1	4.9	1.8	2.3	2.2	0.9	0.9	0.9	0.9	0.6	0.9	1.8	1.5	1.1	1.0	0.9	1.4	1.3	0.9	0.9	0.9	1.2	1.2	0.9	1.3	1.4	1.0	1.0	1.4	1.4	1.5	0.7	22.9	0.9	0.9	3.3	4.9	0.9	0.9	0.9	0.9	0.6	2.8	0.9	0.9	1.6	0.9	0.9	0.9	1.1	1.5	0.8	3.5	0.8	0.6	1.0	0.2	1.6	3.8	0.8	2.5	1.7	1.7	2.6	0.6	0.3	0.8	1.3	3.9	2.2	1.8	0.8	0.6	2.0	5.5	1.2	0.6	2.1	1.3	2.0	1.1	2.2	1.0	1.0	1.6	3.2	1.6	2.8	2.0	2.3	1.1	0.5	1.7	1.8	2.0	0.5	2.4	0.6	12.4	1.4	2.0	2.2	2.6	1.5	0.4	0.6	4.6	1.4	1.7	1.8	2.6	1.4	1.5	1.8	1.3	1.1	2.7	3.6	2.7	3.0	2.1	3.1	1.3	0.7	4.0	2.8	3.5	0.8	0.6	0.6	0.6	0.5	1.2	0.7	1.0	0.4	1.5	0.8	1.0	2.9	0.6	0.3	0.8	0.6	0.2	1.1	6.1	2.3	2.0	1.4	1.3	1.2	0.9	1.4	0.9	0.0	4.3	0.0	3.7	3.9	15.0	0.4	2.5	1.4	0.0	1.8	39.3	1.3	0.0	0.8	4.1	1.0	0.4	0.0	0.9	2.1	0.8	2.5	0.0	0.5	0.5	14.3	0.0	0.6	0.0	0.0	1.1	0.2	0.0	0.0	1.2	17.5	2.1	0.0	0.4	0.0	311.1	0.0	0.9	3.4	2.7	4.6	0.8	0.0	1.7	2.1
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium voltage-gated channel subfamily J member 15"	Q99712	21	38155549-38307357	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 74.8;kidney: 99.7"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 56.6;Alveolar cells type 2: 153.4;Cholangiocytes: 63.7;Proximal tubular cells: 211.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	21	"neutrophil: 74.8"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 74.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 26.1;GAMG: 37.4;HBEC3-KT: 25.1;RPTEC TERT1: 25.0;RT4: 29.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (1.95e-4)"	6.0	0.3	0.4	5.3	0.3	3.2	1.4	0.2	0.3	3.5	0.4	0.2	27.1	0.2	0.5	12.8	6.0	0.8	17.7	1.0	0.2	0.1	99.7	1.5	34.1	0.8	0.5	0.2	0.6	16.7	0.0	0.3	1.0	0.6	4.0	0.0	0.2	14.4	26.8	1.0	1.7	0.2	0.9	0.4	6.8	10.7	1.1	0.2	0.4	36.8	3.2	1.9	11.3	4.3	0.0	0.2	74.8	3.5	0.0	0.0	0.7	0.6	0.0	0.1	0.2	5.1	26.1	0.2	0.3	1.7	0.0	0.0	0.0	0.2	0.1	0.0	2.7	37.4	8.8	0.0	25.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	7.7	2.5	6.5	1.4	0.5	1.2	0.0	0.0	0.2	11.5	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	25.0	29.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	1.3	0.0	0.6	0.1	0.0	2.1	1.5	0.1	0.0	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	0.7	0.4	0.3	0.2	0.3	0.2	0.1	0.5	0.2	0.6	0.2	56.6	153.4	0.8	8.5	2.5	0.0	1.2	63.7	9.4	52.4	29.6	0.0	0.1	14.9	23.3	1.4	1.4	0.0	0.0	7.8	0.4	0.8	0.4	5.8	0.0	0.3	0.0	0.0	1.3	5.1	1.9	0.6	2.6	1.7	0.0	0.0	0.0	26.3	0.0	0.0	211.6	0.0	0.0	1.0	0.9	1.0	1.4	0.1	0.0	0.0	4.1
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium voltage-gated channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4"	"Cell type enhanced"	"Detected in some"	27	"Cholangiocytes: 43.3;Collecting duct cells: 232.1;Distal tubular cells: 34.9;Proximal tubular cells: 89.7"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.1"	"Cell line enriched"	"Detected in some"	23	"RPTEC TERT1: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.58e-4)"	"unprognostic (3.88e-1)"	0.4	0.3	4.1	0.3	4.4	0.4	1.5	22.6	6.1	0.3	0.4	1.7	12.6	0.4	0.4	6.4	0.3	2.0	6.5	0.4	6.0	7.2	96.5	0.9	0.5	0.4	8.3	3.4	0.4	15.8	59.4	0.8	0.5	25.5	1.0	0.3	0.0	4.1	14.3	0.4	0.5	1.2	0.2	7.5	1.1	7.4	0.8	5.3	0.0	60.4	0.0	0.2	0.3	0.3	1.1	0.5	5.1	0.2	0.9	1.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	80.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.6	0.9	0.1	1.2	1.0	1.0	0.5	0.1	1.1	0.7	0.6	5.1	0.9	0.1	0.5	1.1	0.3	4.1	4.4	22.6	6.1	6.0	7.2	8.3	3.4	25.5	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	43.3	17.4	4.5	232.1	0.0	0.0	34.9	6.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	89.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium voltage-gated channel subfamily J member 2"	P63252	17	70168673-70180048	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease mutation, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;parathyroid gland: 34.8"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 227.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 20.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 7.5;HUVEC TERT2: 5.2;REH: 6.0;RH-30: 24.5;U-138 MG: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029109	Approved					NA	NA					"HPA029109: AB_10602913"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.49e-3)"	3.0	1.5	6.2	6.3	17.9	2.5	6.6	1.3	12.8	1.8	5.0	23.7	5.1	1.6	1.5	1.2	4.7	8.4	2.2	11.4	6.4	4.4	1.7	1.9	3.9	4.4	22.4	8.5	1.4	1.0	34.8	1.6	9.0	11.7	2.6	4.3	3.1	2.7	2.9	10.3	6.0	2.1	1.6	14.9	10.4	2.0	0.9	18.2	0.5	1.9	6.0	2.2	2.6	3.3	0.1	0.7	20.8	4.7	0.0	0.0	0.4	0.0	0.7	1.5	0.0	1.6	0.4	0.0	0.5	3.7	0.0	0.1	0.0	0.0	0.0	0.3	0.4	1.0	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.5	0.0	4.7	0.0	0.0	1.7	0.1	2.3	0.2	7.5	5.2	0.0	0.0	0.0	1.6	0.0	0.5	0.0	0.1	0.6	0.1	6.0	24.5	0.0	0.6	0.0	0.3	0.7	0.4	0.1	0.0	3.1	0.2	0.4	0.1	9.0	0.1	0.0	2.0	0.0	0.0	0.1	1.9	0.0	1.2	1.8	2.5	3.6	0.0	4.7	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	20.8	0.0	4.6	0.1	0.0	0.4	6.2	17.9	1.3	12.8	6.4	4.4	22.4	8.5	11.7	18.2	0.0	2.7	0.8	5.2	7.2	6.6	14.2	0.0	5.3	1.2	1.8	0.0	0.5	0.0	0.0	0.2	8.7	2.6	0.0	0.0	0.1	0.8	1.7	0.0	0.0	5.7	227.2	10.3	3.7	28.3	0.0	1.4	5.2	3.3	1.0	2.8	5.0	0.0	11.2	1.1	0.0	4.6	0.0	2.2	0.0	0.4	2.9	1.1	0.0	6.6	0.1
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium voltage-gated channel subfamily J member 3"	P48549	2	154698299-154858352	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;parathyroid gland: 22.1"	"Cell type enhanced"	"Detected in many"	21	"Cardiomyocytes: 43.7;Horizontal cells: 117.6;Intestinal endocrine cells: 29.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Region enhanced"	"Detected in many"		"cerebellum: 33.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 5.4;SCLC-21H: 1.7;SH-SY5Y: 3.3"	"Low region specificity"	"Detected in all"							HPA024231	Uncertain					NA	NA					"HPA024231: AB_1855558"	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.3	1.0	4.5	0.0	3.4	0.0	0.2	33.8	13.6	1.3	1.5	1.4	0.3	7.9	0.2	0.9	0.1	0.4	0.9	10.8	8.4	4.0	8.0	2.3	0.2	0.4	1.8	4.9	0.2	1.5	22.1	9.0	0.0	3.0	5.1	0.6	1.0	0.1	9.2	3.5	0.2	6.7	0.1	1.5	0.4	0.5	0.2	0.9	0.0	0.2	0.0	0.0	0.5	0.6	1.2	0.9	3.3	1.1	1.8	1.0	0.4	0.2	0.3	0.0	0.1	0.2	0.1	0.4	5.4	0.2	0.0	0.2	0.1	0.3	0.3	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.2	0.4	0.4	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.0	0.7	0.5	0.1	0.5	0.1	0.0	0.4	0.2	0.4	1.7	3.3	0.1	0.6	0.2	0.1	0.4	0.1	0.0	0.3	0.4	0.4	0.3	0.3	0.2	0.1	1.2	0.2	0.5	3.3	0.7	0.9	0.7	0.8	0.9	1.0	0.9	0.6	0.6	1.2	1.0	0.9	1.9	1.8	1.1	0.9	0.7	0.4	4.5	3.4	33.8	12.0	8.4	4.0	1.8	4.9	3.0	0.9	0.0	0.0	0.0	4.4	0.7	4.8	43.7	5.1	0.0	0.0	19.2	13.7	0.0	5.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.6	5.1	0.0	0.9	0.1	117.6	29.9	0.0	0.0	0.0	5.8	0.4	1.7	0.0	0.1	0.7	0.0	0.0	3.9	6.8	3.6	0.0	2.1	0.5	0.1	1.6	0.0	0.0	0.2	4.7
KCNJ4	"HIR, hIRK2, HRK1, IRK3, Kir2.3"	ENSG00000168135	"Potassium voltage-gated channel subfamily J member 4"	P48050	22	38426327-38455199	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"brain: 25.9;heart muscle: 16.9"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 3.2;Horizontal cells: 9.5;Muller glia cells: 5.4"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 16.1"	"Group enriched"	"Detected in many"	10	"amygdala: 105.8;basal ganglia: 143.6;cerebral cortex: 111.8;hippocampal formation: 85.7;olfactory region: 150.7"	"Group enriched"	"Detected in many"	14	"amygdala: 32.2;basal ganglia: 63.2;cerebral cortex: 71.1;hippocampal formation: 59.7;olfactory region: 117.2"							NA	NA							"unprognostic (4.76e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.12e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.07e-1)"		"unprognostic (3.15e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.41e-2)"		0.1	0.2	9.9	0.1	17.9	0.1	0.1	0.0	25.9	0.1	0.1			0.3	0.1	0.1	0.1	0.7	0.8	16.9	9.4	1.7	0.2	0.4	0.1	0.1	0.7		0.1	0.2	0.1	0.0	0.1		0.1	0.1		0.1	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.5			0.1		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.6	1.1	0.0	0.5	0.1	0.1	2.3	0.0	0.2	0.0	0.0	16.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.5	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium voltage-gated channel subfamily J member 5"	P48544	11	128891356-128921035	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cancer-related genes, Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.7;ductus deferens: 54.6;pituitary gland: 23.4"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 10.6;Hofbauer cells: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 17.5"	"Group enriched"	"Detected in many"	6	"basal ganglia: 3.1;hypothalamus: 8.0;midbrain: 2.2;thalamus: 4.0"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Approved					NA	NA					"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.8	40.7	0.8	0.3	1.9	0.2	0.9	0.3	1.2	0.8	0.8	1.9	54.6	0.4	0.3	1.1	0.6	0.6	1.3	8.7	1.6	2.5	2.0	0.3	3.4	0.8	3.7	0.8	0.8	16.6	0.7	23.4	4.3	3.4	0.8	0.4	3.3	0.9	21.7	0.3	0.4	0.5	0.7	4.5	7.7	1.5	0.7	0.9	2.3	0.7	0.4	0.3	1.1	0.5	0.9	0.4	2.9	0.7	0.6	0.4	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.3	0.1	0.4	17.5	0.0	0.2	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.4	0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.5	0.2	0.1	0.1	1.3	0.0	2.2	0.7	0.6	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.9	0.3	0.4	2.9	0.6	0.4	0.4	0.2	0.4	0.8	1.9	0.3	1.2	1.6	2.5	3.7	0.8	3.4	0.9	0.0	10.6	0.0	2.3	1.3	1.7	5.8	0.0	0.0	0.0	1.8	0.0	0.7	0.0	0.0	2.1	0.6	0.0	0.0	3.2	0.6	2.1	0.4	0.0	0.0	37.1	1.6	0.0	0.6	1.8	4.5	0.9	1.9	3.3	1.8	0.0	0.3	1.3	0.0	0.7	0.0	1.4	0.0	0.1	0.2	0.7	1.5	1.0	0.0	0.0	0.5
KCNJ6	"BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2"	ENSG00000157542	"Potassium voltage-gated channel subfamily J member 6"	P48051	21	37607376-38121345	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Congenital generalized lipodystrophy, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;pituitary gland: 12.2"	"Cell type enriched"	"Detected in some"	6	"Horizontal cells: 232.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basophil: 4.2;eosinophil: 3.6;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.2"	"Cell line enriched"	"Detected in some"	7	"LHCN-M2: 25.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.43e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.75e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.96e-10)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.21e-1)"	2.0	1.2	7.7	0.9	8.4	1.0	1.1	24.0	15.6	0.9	1.4	0.8	0.0	1.1	1.4	0.6	0.7	0.7	0.8	1.2	14.6	1.1	1.2	0.9	1.0	1.4	1.3	10.8	0.8	2.7	0.7	12.2	7.4	13.5	1.5	0.9	0.0	0.8	0.6	2.2	1.1	1.1	0.5	1.5	1.6	2.7	2.0	0.4	0.0	0.8	0.0	0.6	0.8	0.8	0.3	0.3	4.2	0.3	0.3	0.2	0.0	0.0	0.0	0.6	0.3	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.8	1.4	0.0	0.0	0.0	2.9	0.1	25.6	0.1	0.0	0.0	0.3	0.0	2.5	0.0	0.1	0.8	3.6	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.3	0.0	0.1	0.2	3.8	1.0	0.0	0.0	0.0	0.0	4.2	0.3	3.6	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	2.0	0.3	0.2	0.3	0.1	0.0	7.7	8.4	24.0	15.6	14.6	1.1	1.3	10.8	13.5	0.4	0.0	0.6	0.0	0.4	0.1	31.8	21.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	232.0	39.7	0.0	0.0	0.0	0.6	0.0	3.3	0.0	0.0	0.9	1.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.1	0.1	0.2	0.0	0.1	0.3
KCNJ8	Kir6.1	ENSG00000121361	"Potassium voltage-gated channel subfamily J member 8"	Q15842	12	21764955-21775581	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 60.1;pancreas: 47.6"	"Group enriched"	"Detected in many"	5	"Sertoli cells: 194.1;Smooth muscle cells: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 42.5;HSkMC: 8.6;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031066	Uncertain					NA	NA					"HPA031066: AB_10602240"	"unprognostic (8.12e-3)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.81e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (4.70e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.54e-3)"	14.6	12.9	3.2	2.7	3.4	0.0	14.7	1.7	5.1	7.7	6.6	2.3	3.6	2.0	10.6	4.5	6.7	5.9	6.3	60.1	2.2	1.7	6.4	29.7	12.4	3.5	2.9	3.0	12.4	47.6	1.7	3.8	4.9	3.7	10.6	1.6	8.8	2.9	15.7	15.0	2.4	3.8	13.2	2.6	3.8	6.5	3.4	2.8	0.9	8.4	7.0	1.2	11.4	5.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	5.2	3.4	0.0	5.7	4.6	6.6	3.4	42.5	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.0	1.9	0.0	2.1	1.3	0.0	0.0	0.2	0.0	0.0	8.6	0.0	2.5	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	4.2	0.0	0.0	0.0	4.2	1.9	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.4	1.7	5.1	2.2	1.7	2.9	3.0	3.7	2.8	3.0	19.8	0.0	0.4	1.1	0.0	24.3	0.0	0.0	1.2	1.8	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	1.1	0.0	6.6	0.3	0.0	22.1	0.2	0.0	1.2	1.8	1.5	0.0	0.3	0.0	1.7	0.0	0.0	12.2	2.0	0.0	0.7	0.0	1.1	194.1	65.3	0.0	0.4	0.6	0.2	0.0	0.0	0.1
KCNJ9	"GIRK3, Kir3.3"	ENSG00000162728	"Potassium voltage-gated channel subfamily J member 9"	Q92806	1	160081570-160090563	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	27	"brain: 52.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 12.8;Horizontal cells: 7.9"	"Cancer enriched"	"Detected in single"	35	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 2.3;SH-SY5Y: 2.7;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070478	Enhanced					NA	NA					"HPA070478: AB_2686270"	"unprognostic (2.35e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-2)"	1.4	1.9	15.6	1.4	15.3	1.4	1.4	32.1	52.0	1.4	1.4	11.9	0.0	1.4	1.4	1.4	1.4	1.4	1.4	1.4	18.4	11.1	1.5	1.4	1.4	1.4	18.3	20.6	1.4	1.4	1.4	0.7	1.4	7.4	1.4	1.4	0.0	1.4	1.4	1.4	1.4	1.5	1.4	11.4	1.4	1.5	1.7	11.6	0.0	1.4	0.0	1.4	1.4	0.0	0.8	0.0	0.0	0.3	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.2	2.3	2.7	0.0	0.1	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.0	2.9	0.2	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.5	0.3	1.1	0.4	0.2	1.1	0.0	0.8	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	15.6	15.3	32.1	27.2	18.4	11.1	18.3	20.6	7.4	11.6	0.0	0.0	0.0	0.0	0.0	12.8	0.6	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.6	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
KCNK1	"DPK, K2p1.1, TWIK-1"	ENSG00000135750	"Potassium two pore domain channel subfamily K member 1"	O00180	1	233614004-233672512	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.3"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 117.0;Glandular cells: 169.9;Horizontal cells: 189.1;Urothelial cells: 247.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 75.3"	"Cell type enriched"	"Detected in single"	98	"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in single"	98	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 21.0;SCLC-21H: 19.8;U-266/70: 45.5;U-266/84: 41.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 236.2"	"HPA016049, CAB022588"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB022588: , HPA016049: AB_1855571"	"unprognostic (7.06e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.64e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.84e-4)"	"unprognostic (4.32e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (7.29e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	1.9	3.3	15.2	2.2	12.7	0.3	4.5	75.3	22.8	5.5	11.5	7.9	5.1	12.5	4.5	22.9	12.0	8.4	9.3	20.8	10.3	5.2	7.2	10.8	3.4	0.8	8.9	11.1	3.8	4.4	2.5	11.3	5.0	22.3	4.6	10.6	2.6	7.2	9.3	0.5	8.7	9.6	3.2	12.3	0.8	28.0	0.7	7.8	0.0	5.6	1.6	3.2	4.3	6.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	10.3	5.6	0.0	0.0	0.0	0.0	15.8	2.8	0.0	0.0	0.0	0.0	17.0	0.0	6.7	2.0	2.3	15.0	2.8	4.9	0.0	0.0	4.9	0.0	21.0	0.0	0.1	0.0	0.5	1.2	5.3	0.0	3.9	0.3	0.0	5.7	2.4	4.5	0.0	3.8	3.7	0.0	3.4	12.1	12.8	0.0	0.8	1.1	4.9	8.6	19.8	3.9	10.3	4.5	0.0	0.3	1.3	0.0	0.0	0.0	8.4	0.0	0.3	45.5	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	15.2	12.7	75.3	17.1	10.3	5.2	8.9	11.1	22.3	7.8	8.9	15.6	0.0	117.0	56.2	1.2	37.7	5.1	28.1	33.0	17.4	3.9	0.2	1.7	19.6	0.9	0.7	34.8	0.0	42.5	13.5	15.3	169.9	0.0	8.2	0.6	189.1	28.2	0.0	0.8	0.0	1.4	0.8	10.1	0.0	45.4	65.8	61.4	22.8	0.0	11.3	5.0	0.0	3.4	0.4	0.7	41.7	0.7	1.5	21.1	247.4
KCNK12	"K2p12.1, THIK-2, THIK2"	ENSG00000184261	"Potassium two pore domain channel subfamily K member 12"	Q9HB15	2	47516581-47570939	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"brain: 22.7"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 8.7;Cone photoreceptor cells: 13.7;Early spermatids: 6.7;Extravillous trophoblasts: 30.7"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 2.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"REH: 22.1;SCLC-21H: 8.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.02e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-6)"	"unprognostic (1.36e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-1)"	1.1	1.7	9.8	5.1	4.6	1.0	0.9	22.7	16.1	0.8	1.1	2.4	0.0	1.0	1.0	1.0	1.0	0.9	0.9	0.9	5.6	3.4	1.0	0.8	1.0	1.6	7.2	4.0	1.2	0.8	0.9	5.5	1.7	8.1	1.0	0.9	0.6	0.9	0.8	1.2	1.0	0.9	0.9	10.1	1.1	1.2	1.5	2.1	0.0	1.0	0.0	1.5	1.0	0.3	0.7	0.1	0.2	0.0	0.4	1.8	0.2	0.0	0.1	0.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.3	0.0	0.5	22.1	0.0	1.6	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.7	1.0	1.8	0.1	0.2	1.1	1.0	0.2	0.4	0.0	0.0	1.1	0.2	9.8	4.6	22.7	16.1	5.6	3.4	7.2	4.0	8.1	2.1	0.0	0.0	1.9	0.0	0.1	8.7	0.8	0.0	0.0	0.0	0.0	13.7	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	30.7	0.2	0.5	0.0	0.0	0.3	1.6	0.0	0.0	0.3	4.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	5.4	0.0	0.5	0.7	1.4	0.0	0.7	2.2	0.0	0.0
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061765-90185857	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.3;parathyroid gland: 14.3;testis: 13.2"	"Cell type enhanced"	"Detected in some"	24	"Hofbauer cells: 5.6;Kupffer cells: 2.5;Macrophages: 5.3;monocytes: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"GAMG: 2.4;RT4: 4.2;SuSa: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Nuclear speckles, Cell Junctions"		"HPA003514: AB_2666978"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.8	1.1	2.9	2.2	3.5	0.1	0.4	0.2	4.2	0.4	0.6	4.0	0.0	0.6	0.3	1.5	0.3	0.4	0.5	2.7	2.9	2.4	4.8	0.7	0.7	1.6	6.3	1.4	0.4	2.7	14.3	0.6	1.2	3.6	0.4	0.7	0.1	1.1	0.7	0.1	0.1	0.7	0.4	8.3	1.1	0.5	13.2	5.4	0.7	2.7	0.0	0.6	0.8	0.1	0.0	3.8	0.0	1.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.9	0.0	0.0	0.8	1.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.4	4.2	1.8	0.5	0.0	1.8	1.2	7.1	0.0	1.6	0.0	0.0	2.1	0.0	0.6	0.6	1.8	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	2.9	3.5	0.2	4.2	2.9	2.4	6.3	1.4	3.6	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	2.5	0.6	0.0	5.3	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.1	0.0	0.0	0.1
KCNK15	"dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5"	ENSG00000124249	"Potassium two pore domain channel subfamily K member 15"	Q9H427	20	44745780-44752313	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 24.2"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 5.1;Collecting duct cells: 8.7;Exocrine glandular cells: 6.4;Leydig cells: 6.1;Urothelial cells: 7.0"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 47.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"MCF7: 32.2"	"Region enriched"	"Detected in single"	18	"olfactory region: 8.4"	"Region enriched"	"Detected in many"	8	"olfactory region: 9.3"	HPA064861	Uncertain					NA	NA					"HPA064861: AB_2685373"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.38e-4)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.11e-1)"	6.0	4.5	0.4	1.3	3.4	0.5	5.9	0.0	1.2	6.2	2.3	0.0	24.2	1.1	4.3	10.6	3.2	15.1	10.7	3.8	0.6	0.4	3.5	7.0	3.0	2.2	0.6	0.0	12.6	7.4	0.6	4.2	1.1	1.1	2.7	0.8	2.1	3.4	9.6	2.6	2.0	0.9	3.8	0.3	0.6	4.1	10.6	0.0	0.0	6.5	0.5	0.9	2.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.3	0.0	0.9	0.4	3.1	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	0.0	1.2	0.6	0.4	0.6	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.6	5.1	0.0	0.0	8.7	0.0	0.0	0.0	3.2	0.2	0.7	0.0	0.0	6.4	0.0	1.3	2.3	0.0	0.0	0.1	0.0	1.2	0.6	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.4	0.6	0.0	0.0	0.8	7.0
KCNK16	"K2p16.1, TALK-1, TALK1"	ENSG00000095981	"Potassium two pore domain channel subfamily K member 16"	Q96T55	6	39314698-39322968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 22.4;stomach 1: 11.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	17	"pancreatic cancer: 13.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"basophil: 4.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.6"	"Cell line enriched"	"Detected in single"	406	"SCLC-21H: 55.9"					"Low region specificity"	"Detected in all"									NA	NA																"unprognostic (3.29e-2)"					"unprognostic (3.48e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.2	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	22.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.1	11.3	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.4	4.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314553	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.1;retina: 20.0"	"Group enriched"	"Detected in some"	4	"Exocrine glandular cells: 7.3;granulocytes: 5.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	34	"plasmacytoid DC: 29.1"	"Lineage enriched"	"Detected in single"	34	"dendritic cells: 29.1"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 42.5"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.7	0.4	0.3	0.6	1.1	1.4	3.3	0.3	0.8	0.7	1.3	0.8	1.9	3.0	1.9	0.5	1.0	1.3	6.5	7.9	0.6	0.6	0.3	4.6	10.4	0.9	2.6	0.8	0.4	6.1	0.4	2.7	6.3	1.9	1.1	0.6	20.0	2.9	1.0	0.2	0.1	1.7	1.5	0.6	1.1	5.4	0.6	0.1	3.4	9.3	2.6	2.4	0.9	0.5	0.0	29.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	29.1	0.0	0.1	0.3	1.1	0.3	0.8	0.6	0.6	2.6	0.8	1.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNK18	"K2p18.1, TRESK, TRESK-2, TRESK2, TRIK"	ENSG00000186795	"Potassium two pore domain channel subfamily K member 18"	Q7Z418	10	117197489-117210299	"Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"brain: 1.5;testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA044739	Uncertain					NA	NA					"HPA044739: AB_10795008"																		0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	1.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNK2	"K2p2.1, TREK-1"	ENSG00000082482	"Potassium two pore domain channel subfamily K member 2"	O95069	1	215005775-215237093	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"adrenal gland: 49.1"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 1.1;Fibroblasts: 1.4;Melanocytes: 3.3;Suprabasal keratinocytes: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 31.4;fHDF/TERT166: 27.6;hTERT-RPE1: 18.9;T-47d: 42.0;U-2197: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.81e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-6)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.46e-3)"	2.9	49.1	4.8	1.1	7.4	0.5	6.1	1.1	6.2	2.3	1.1	2.5	0.0	0.6	0.8	2.6	1.2	1.0	1.6	0.5	5.1	4.3	1.2	0.5	0.7	0.5	2.3	7.3	3.5	2.0	0.5	0.5	0.5	3.3	1.2	1.6	0.0	0.8	3.7	1.2	3.4	2.3	1.5	4.5	0.4	3.7	1.5	3.3	0.0	8.9	2.7	0.4	2.6	3.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	7.9	31.4	0.0	11.0	7.3	3.5	8.3	0.0	0.4	0.0	0.0	27.6	0.0	0.0	4.9	0.0	6.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	8.1	0.0	8.4	0.8	18.9	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.9	1.5	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.8	0.2	0.1	0.0	42.0	0.0	0.0	6.1	0.2	15.0	0.6	0.6	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	7.4	1.1	6.2	5.1	4.3	2.3	7.3	3.3	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.2	1.3	0.0	0.0	0.0	0.0
KCNK3	"K2p3.1, TASK, TASK-1"	ENSG00000171303	"Potassium two pore domain channel subfamily K member 3"	O14649	2	26692690-26733420	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 69.2"	"Cell type enhanced"	"Detected in many"	17	"Collecting duct cells: 97.7;Exocrine glandular cells: 82.2;Pancreatic endocrine cells: 31.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.0;cerebellum: 4.7;cerebral cortex: 6.2;hypothalamus: 4.0;pons and medulla: 13.4"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.7;EFO-21: 10.0;HeLa: 3.4;SCLC-21H: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.16e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (3.09e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.24e-3)"	2.4	69.2	1.3	1.9	4.0	0.6	8.3	4.7	6.2	3.5	4.0	0.8	5.7	1.3	2.4	5.6	1.9	2.0	2.3	10.3	1.0	4.0	1.8	0.7	10.0	0.6	1.5	1.5	4.6	24.7	0.7	3.6	16.6	13.4	8.2	1.1	1.9	0.6	7.7	0.6	0.6	2.6	4.7	1.1	0.9	2.2	0.9	0.0	0.0	2.1	0.0	0.5	3.2	2.3	0.7	0.5	2.5	0.4	1.2	0.4	0.0	0.0	0.6	0.2	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	10.0	0.0	1.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	1.3	0.0	23.5	2.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.4	0.3	0.3	0.3	0.2	0.7	0.4	0.4	2.5	1.2	0.2	0.5	0.2	0.0	1.3	4.0	4.7	6.2	1.0	4.0	1.5	1.5	13.4	0.0	0.0	3.2	0.0	0.2	0.0	11.5	10.0	0.0	0.0	0.0	97.7	0.0	0.2	0.0	0.8	0.4	1.0	0.0	0.0	82.2	0.2	1.9	1.6	0.0	0.0	0.3	1.6	22.5	0.6	0.0	1.3	0.9	0.0	0.0	1.0	0.4	1.2	31.4	0.0	0.0	0.0	3.9	6.5	3.1	0.0	1.3	0.1	0.5	0.0	0.0	0.3
KCNK4	"K2p4.1, TRAAK"	ENSG00000182450	"Potassium two pore domain channel subfamily K member 4"	Q9NYG8	11	64291302-64300031	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 12.3"	"Cell type enhanced"	"Detected in some"	13	"Extravillous trophoblasts: 1.7;Fibroblasts: 1.1;Horizontal cells: 3.2;Muller glia cells: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;MCF7: 1.5;SH-SY5Y: 2.9;U-2197: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA										"unprognostic (1.85e-1)"					"unprognostic (1.58e-1)"				"unprognostic (1.21e-1)"	"unprognostic (2.84e-1)"			0.7	0.5	12.2	0.5	11.6	0.5	0.5	1.0	12.3	1.6	0.6	0.3	0.0	0.6	1.2	0.5	0.5	0.6	0.6	0.6	10.2	3.1	0.7	0.5	0.6	0.6	1.5	4.0	0.5	0.5	0.5	0.0	2.0	2.7	0.9	0.5	1.1	0.5	0.8	0.5	0.5	0.7	0.5	0.3	0.6	0.6	0.9	0.1	0.0	0.6	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.2	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.1	0.2	0.2	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	1.2	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	11.6	1.0	12.3	10.2	3.1	1.5	4.0	2.7	0.1	0.0	0.0	0.0	0.0	0.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0
KCNK5	"K2p5.1, TASK-2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188973-39229450	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.4;intestine: 74.2;kidney: 46.3"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 43.3;Enterocytes: 50.9;Proximal tubular cells: 29.1;Syncytiotrophoblasts: 38.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 18.0;OE19: 14.7;T-47d: 14.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059148	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (4.45e-4)"	2.2	1.3	0.3	4.5	0.4	4.5	3.9	0.4	0.5	4.3	25.5	0.8	2.6	16.1	5.6	4.0	4.3	1.4	48.4	1.5	0.3	0.0	46.3	12.6	3.6	1.1	0.8	0.4	4.0	15.3	1.2	1.0	15.2	0.8	2.3	4.7	3.6	16.0	1.6	0.5	15.8	74.2	1.3	0.6	1.2	9.4	0.9	0.3	2.0	9.0	2.2	4.1	2.2	3.8	0.0	0.9	0.2	0.1	0.0	1.4	0.5	3.4	3.2	4.3	1.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	18.8	7.8	0.0	5.7	0.0	0.4	7.2	3.3	0.1	0.0	0.0	2.4	19.3	1.5	0.1	0.0	3.9	17.8	0.0	0.0	0.1	0.0	0.0	0.0	4.3	18.0	0.0	0.0	6.1	8.7	4.3	7.9	14.7	0.0	0.0	0.8	7.3	3.0	2.9	1.0	0.8	3.1	4.0	0.0	1.7	14.3	6.5	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.3	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.9	1.4	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.9	0.2	0.5	0.3	0.4	0.4	0.5	0.3	0.0	0.8	0.4	0.8	0.3	0.0	19.2	0.0	1.8	3.3	0.0	0.4	43.3	0.0	6.8	1.8	0.0	22.6	5.0	13.0	0.0	0.2	50.9	0.0	10.8	3.9	1.9	1.8	0.0	23.1	1.8	0.0	0.0	0.0	0.3	0.0	0.6	0.7	1.7	1.0	10.8	0.0	7.5	10.5	0.0	29.1	0.0	0.0	0.4	0.0	0.7	2.4	38.1	1.0	6.4	10.7
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319844-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ito cells: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 16.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.9;granulocytes: 16.2;monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HEL: 21.9;HMC-1: 24.6;T-47d: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: AB_2676876"	"unprognostic (7.98e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.45e-6)"	"unprognostic (3.76e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.91e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.59e-3)"	3.0	2.0	2.1	7.4	2.5	2.8	4.9	0.8	2.0	25.3	9.2	1.7	10.6	3.8	20.1	5.2	21.7	8.6	13.1	4.3	2.1	1.0	2.8	2.7	7.1	8.9	2.0	1.3	8.0	21.3	0.2	1.7	11.6	2.3	7.3	8.3	2.3	29.0	13.5	0.9	15.1	10.1	13.4	3.7	12.7	7.0	2.0	2.2	4.2	1.7	17.5	18.8	14.3	12.5	1.2	8.9	16.2	5.4	0.6	1.9	1.5	5.3	2.0	0.3	0.3	3.2	2.1	0.4	4.6	2.3	1.2	1.6	1.5	5.9	0.4	2.2	6.6	1.3	7.0	2.5	10.5	0.8	0.2	0.2	21.9	1.0	0.2	2.9	1.6	24.6	0.5	9.5	1.5	2.9	6.4	3.2	3.6	0.3	1.7	3.4	11.7	1.5	1.4	0.3	11.3	1.3	2.3	0.4	1.6	4.3	0.5	0.3	0.5	0.5	0.5	0.2	1.1	13.8	6.2	3.5	0.4	2.8	2.5	0.2	0.6	0.1	0.6	0.4	7.9	0.2	16.2	5.4	11.7	1.3	4.8	1.1	1.2	1.7	1.6	8.9	1.1	1.5	1.1	4.2	0.6	5.1	2.5	1.9	1.5	2.1	2.5	0.8	2.0	2.1	1.0	2.0	1.3	2.3	2.2	0.0	14.6	13.7	23.5	38.2	2.8	10.2	22.9	6.7	9.1	7.0	5.9	1.3	0.0	19.0	1.1	17.5	33.5	70.0	41.6	3.3	11.7	39.3	21.9	1.0	34.5	0.0	12.1	179.2	66.5	0.5	23.9	52.6	5.0	14.4	56.7	0.9	47.3	39.3	19.1	0.3	5.0	25.8	6.9	9.3	2.7	58.7	2.1	10.1	24.1	88.8
KCNK7	K2p7.1	ENSG00000173338	"Potassium two pore domain channel subfamily K member 7"	Q9Y2U2	11	65592855-65595996	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skin 1: 35.0;tongue: 20.7"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 90.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6"	"Group enriched"	"Detected in many"	12	"B-cells: 2.9;granulocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA077577			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077577: AB_2686845"	"unprognostic (1.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.08e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.11e-2)"	0.6	0.6	0.8	0.3	0.7	3.9	2.6	1.6	2.1	1.4	0.5	0.8	0.3	0.4	0.4	0.3	10.8	0.6	0.3	0.5	0.8	0.4	0.3	0.3	0.3	0.3	0.6	1.1	0.6	0.3	0.1	0.3	0.5	0.4	0.3	0.1	0.3	0.8	0.4	1.8	35.0	0.5	0.3	0.7	0.5	0.3	0.3	0.5	0.7	0.3	20.7	5.7	0.3	3.4	2.9	0.0	4.8	0.2	0.2	0.3	0.1	0.5	2.3	0.1	0.7	0.0	0.0	0.2	0.3	0.0	0.5	0.1	0.3	1.7	0.8	0.7	0.2	0.4	3.8	0.0	0.0	0.0	0.8	2.6	0.8	1.2	1.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.4	0.0	1.6	1.4	2.2	0.7	1.7	0.9	0.7	1.0	1.0	2.2	1.6	0.0	0.4	1.0	0.2	12.4	2.8	0.5	0.7	1.2	0.1	0.7	2.2	0.0	0.6	1.9	1.9	0.1	2.0	1.3	0.5	1.4	1.1	1.0	4.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.9	0.1	0.0	3.6	0.2	0.2	0.0	0.0	0.1	0.8	0.7	1.6	2.1	0.8	0.4	0.6	1.1	0.4	0.5	0.0	0.3	0.0	0.4	16.9	2.3	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.5	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.0	1.2	0.0	1.5	1.3	0.6	0.0	3.3	0.0	0.3	0.2	0.1	2.8	0.0	0.0	0.8	6.5	1.9	0.1	0.5	90.7	0.0	0.0	0.5	1.0
KCNK9	"K2p9.1, TASK-3, TASK3"	ENSG00000169427	"Potassium two pore domain channel subfamily K member 9"	Q9NPC2	8	139600838-139703056	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adrenal gland: 9.4;brain: 15.4"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Exocrine glandular cells: 2.2;Late spermatids: 4.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 6.6;SCLC-21H: 2.9;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075842			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA075842: "	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.96e-8)"	"unprognostic (1.91e-1)"	"unprognostic (8.17e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.12e-6)"	"unprognostic (2.94e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.76e-1)"	0.2	9.4	0.5	0.5	1.0	0.1	0.1	15.4	7.7	1.3	0.5	0.0	0.0	0.1	0.3	0.1	0.2	0.3	0.1	0.2	1.6	1.4	0.1	0.1	0.1	0.1	0.7	1.7	0.1	0.1	0.1	1.1	0.2	6.6	0.1	0.2	0.2	0.1	0.1	1.4	0.1	0.1	0.6	0.6	0.1	0.3	0.5	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	2.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	15.4	3.7	1.6	1.4	0.7	1.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.2	1.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
KCNMA1	"KCa1.1, mSLO1, SLO"	ENSG00000156113	"Potassium calcium-activated channel subfamily M alpha 1"	Q12791	10	76869601-77638369	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Bipolar cells: 372.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 5.5;memory B-cell: 1.7;non-classical monocyte: 3.7"	"Group enriched"	"Detected in many"	5	"B-cells: 1.7;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"BJ: 27.4;hTERT-HME1: 32.2;PC-3: 43.8;U-138 MG: 31.6;U-87 MG: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054648	Approved					NA	NA					"HPA054648: AB_2682556"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.29e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.99e-3)"	6.0	8.1	12.5	8.8	13.6	1.1	7.1	8.2	18.5	36.3	39.0	5.7	27.9	4.8	54.0	19.7	20.7	18.3	15.6	2.7	10.8	8.2	2.0	6.6	4.0	6.2	7.4	16.5	7.0	4.1	0.7	10.1	3.3	10.1	30.1	13.2	6.6	24.0	47.6	37.1	1.8	8.6	55.1	6.8	10.4	14.8	2.6	4.9	0.4	1.4	2.7	2.5	21.7	12.6	1.7	0.6	0.3	5.5	0.0	0.0	0.3	0.0	8.2	0.0	0.1	1.3	7.1	0.1	27.4	24.5	6.6	3.3	1.8	0.1	0.0	0.2	20.4	15.8	0.0	0.0	16.0	4.1	16.2	0.1	0.0	0.0	0.0	12.8	0.0	0.1	4.9	2.9	10.6	32.2	23.5	2.6	0.1	0.0	0.0	11.6	0.3	0.5	0.0	0.5	0.0	43.8	0.0	1.0	0.0	4.2	0.0	2.5	0.3	0.0	0.7	0.0	3.4	3.3	0.0	17.7	31.6	3.5	5.6	24.2	0.0	0.0	0.0	30.8	0.0	12.3	0.0	0.2	0.0	0.0	5.5	0.0	1.7	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	3.7	0.0	0.0	0.3	12.5	13.6	8.2	18.5	10.8	8.2	7.4	16.5	10.1	4.9	0.0	7.0	2.7	41.2	1.8	372.4	2.5	2.5	0.0	6.8	1.8	56.9	0.3	24.9	2.9	55.5	0.9	1.5	0.0	9.7	0.1	4.1	44.9	0.0	23.7	11.3	6.4	4.7	2.5	53.8	46.9	3.4	19.8	45.5	4.6	52.9	48.0	11.6	0.8	1.1	0.8	15.2	6.5	17.9	1.4	1.6	0.3	0.2	0.7	1.1	1.4
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000080	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	12	"brain: 32.5"	"Cell type enhanced"	"Detected in some"	6	"Melanocytes: 5.0;monocytes: 3.6;Spermatogonia: 4.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.3"	"Cell line enriched"	"Detected in some"	12	"REH: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"		Yes	No			"Actin filaments, Cytosol"		"HPA065938: AB_2685582"	"unprognostic (7.55e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.94e-5)"	"unprognostic (3.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.24e-1)"	0.8	0.9	25.8	1.5	11.3	0.9	0.8	3.3	27.0	1.6	1.0	0.5	0.1	1.0	1.7	1.0	1.0	0.9	1.0	1.3	32.5	3.3	0.9	0.8	0.8	1.0	5.0	8.7	2.6	0.9	0.7	0.2	0.8	4.1	1.2	0.8	0.0	1.5	1.3	1.0	0.9	1.2	0.9	1.2	0.9	0.9	2.8	1.6	0.0	0.9	0.0	1.0	0.9	0.0	0.2	0.2	2.3	0.1	0.1	0.2	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	2.1	0.0	0.1	0.1	0.9	1.9	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	58.8	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.0	0.2	0.0	0.0	25.8	11.3	3.3	22.4	32.5	3.3	5.0	8.7	4.1	1.6	0.0	0.0	0.0	2.5	2.3	2.2	0.8	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	1.0	2.3	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.9	0.9	5.0	3.6	0.0	1.3	0.2	0.0	1.8	0.0	0.9	0.0	1.9	0.4	4.3	3.3	0.1	0.7	0.0	1.4
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114360945-114496500	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 25.3;brain: 23.1;liver: 33.2"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 10.8;Hepatocytes: 14.7;Melanocytes: 20.3;Rod photoreceptor cells: 7.2"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 15.0;NTERA-2: 5.7;SK-MEL-30: 10.6;THP-1: 18.7;U-937: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA038221: AB_10673044"	"unprognostic (9.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.25e-1)"	0.8	25.3	12.6	0.8	7.3	0.6	1.1	21.7	15.0	1.7	1.2	9.5	0.0	0.9	3.9	0.9	0.8	1.0	1.0	7.7	23.1	3.6	4.8	33.2	2.5	0.9	4.5	16.9	1.4	3.8	1.0	16.0	0.6	9.1	11.7	1.3	4.2	1.1	5.4	9.9	2.1	0.9	2.8	8.4	1.1	1.1	3.8	6.5	0.0	0.9	0.0	0.8	2.4	1.1	0.3	0.3	0.8	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	15.0	2.3	0.3	0.1	0.0	0.2	0.0	0.5	0.0	2.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.1	0.0	0.2	0.0	1.2	5.7	0.0	0.0	0.1	0.0	0.7	0.3	0.1	1.8	0.0	0.0	0.2	10.6	0.3	0.2	18.7	0.2	0.0	0.4	1.7	0.0	0.1	0.0	0.1	1.8	6.7	0.5	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.3	0.1	0.3	0.8	0.1	0.3	0.3	0.1	0.0	12.6	7.3	21.7	15.0	23.1	3.6	4.5	16.9	9.1	6.5	0.0	0.6	0.0	0.1	0.2	6.8	10.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	5.2	0.0	0.0	0.8	0.0	0.9	4.5	0.0	14.7	0.0	0.0	0.0	6.2	1.0	0.0	0.0	0.0	20.3	0.0	0.5	0.3	1.4	0.0	0.0	0.5	7.2	0.0	0.5	0.5	3.2	0.3	0.0	0.0	0.4	0.1
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870280	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.7"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 11.9;Ciliated cells: 32.1;Endothelial cells: 16.9"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.8;memory B-cell: 4.8"	"Group enriched"	"Detected in many"	9	"B-cells: 4.8;granulocytes: 5.8;monocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.1;HMC-1: 12.5;Karpas-707: 31.0;RPMI-8226: 8.4;U-266/70: 29.9;U-698: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057127	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057127: AB_2683345"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (9.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.80e-2)"	1.7	2.5	20.6	6.5	21.7	1.0	1.8	5.7	26.7	9.3	9.1	12.4	1.1	5.4	12.6	1.7	3.5	10.3	3.1	4.0	21.6	8.0	3.5	1.0	3.1	5.8	12.0	10.9	2.1	1.0	1.5	2.6	0.7	13.3	3.4	4.6	0.1	2.7	2.7	8.5	1.1	3.9	10.6	8.1	5.0	4.4	1.3	15.5	0.2	3.7	3.5	9.2	8.3	4.9	4.8	0.4	5.8	2.7	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	31.0	0.3	0.0	0.1	0.0	0.4	0.0	1.2	0.0	7.7	8.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	29.9	3.9	10.0	0.3	0.0	2.9	5.8	0.0	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.4	20.6	21.7	5.7	10.3	21.6	8.0	12.0	10.9	13.3	15.5	11.9	2.4	0.0	0.5	1.1	0.2	2.2	0.0	32.1	3.4	0.0	2.0	0.0	3.3	0.2	2.6	16.9	0.0	0.0	0.2	0.0	2.3	0.4	0.0	0.0	0.4	0.0	4.1	5.5	0.0	6.2	0.3	0.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.5	0.1	1.5	0.0	0.0	0.0	0.1
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43781257	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 45.7;salivary gland: 82.3"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 196.8;Syncytiotrophoblasts: 638.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.8;hTERT-RPE1: 24.5;SK-BR-3: 27.5;WM-115: 70.6"	"Region enhanced"	"Detected in single"		"olfactory region: 2.3"	"Not detected"	"Not detected"			"HPA053841, HPA059622"	Approved					NA	NA					"HPA053841: AB_2682278, HPA059622: AB_2684085"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (9.96e-3)"	"prognostic unfavorable (1.05e-14)"	"unprognostic (3.70e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.75e-4)"	3.0	0.1	0.5	12.2	2.5	6.5	5.6	0.4	0.5	8.0	5.7	0.7	6.4	2.0	0.9	2.9	2.6	2.6	8.8	0.6	1.4	0.5	0.8	0.3	2.6	5.7	1.7	0.6	1.3	0.3	0.0	0.3	45.7	1.5	11.0	3.8	0.8	82.3	6.8	0.7	10.8	10.0	2.0	1.1	8.4	13.6	0.9	1.0	9.1	0.7	3.6	17.3	10.3	2.4	18.7	14.4	1.9	15.8	0.0	6.9	5.2	5.1	9.6	0.0	0.0	0.0	0.8	13.5	0.2	0.7	0.5	0.1	0.1	27.8	1.5	2.2	0.2	3.2	4.1	0.0	9.8	1.4	9.3	0.0	6.8	12.5	0.2	0.0	0.0	0.1	0.0	1.2	0.6	4.4	24.5	0.0	0.0	1.5	0.8	0.1	5.0	1.5	5.2	0.0	21.9	10.3	4.6	0.1	5.1	8.5	14.4	0.0	0.0	13.8	27.5	8.1	0.6	0.0	5.5	0.3	3.8	19.7	0.1	11.1	0.0	0.3	0.6	13.1	1.2	70.6	1.9	10.2	0.0	0.3	15.8	0.4	18.7	5.1	2.6	14.4	9.4	3.4	3.2	0.5	0.0	8.6	0.4	6.9	5.2	0.5	2.5	0.4	0.5	1.4	0.5	1.7	0.6	1.5	1.0	0.0	3.4	27.2	43.3	2.5	0.1	0.4	7.6	0.0	6.8	1.8	3.9	196.8	0.0	3.0	0.7	2.8	4.2	23.3	3.5	6.8	2.8	66.7	0.0	0.0	43.0	0.0	0.0	0.0	7.5	0.0	0.0	28.3	20.3	0.0	5.9	0.0	37.2	16.9	0.0	0.0	0.3	0.0	1.0	0.0	1.3	1.9	638.3	6.5	43.7	53.5
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849110	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 78.2;ductus deferens: 88.1;seminal vesicle: 83.6"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 32.7;Undifferentiated cells: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 19.9;OE19: 24.0;RPMI-8226: 13.4;U-266/70: 7.9;U-937: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB018656, HPA048553"	Enhanced					NA	NA					"CAB018656: AB_2131551, HPA048553: AB_2680438"	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favorable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	3.0	78.2	1.0	5.1	1.0	3.4	3.1	0.6	1.2	5.0	13.7	4.1	88.1	14.2	1.9	15.9	1.5	2.1	12.2	10.7	1.5	1.0	13.8	1.0	11.4	5.8	1.2	0.8	1.6	25.6	5.6	2.7	1.8	1.8	7.5	4.6	2.5	9.5	83.6	0.8	1.0	18.4	1.5	1.4	5.5	31.2	3.6	1.5	1.6	36.2	0.9	4.8	5.5	3.6	1.2	5.6	5.3	4.7	0.0	1.7	1.4	0.0	0.1	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.4	0.9	3.3	0.0	0.2	0.1	0.4	0.0	0.0	0.2	0.9	0.0	2.4	0.2	0.2	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.7	24.0	0.1	0.1	0.0	13.4	5.0	1.6	0.4	3.7	0.4	0.0	0.0	0.3	0.1	5.1	0.0	0.0	0.1	0.1	0.0	7.9	0.0	0.0	0.0	7.8	0.0	1.6	4.7	4.7	0.0	2.6	0.1	1.2	0.6	0.1	5.6	0.6	1.7	1.7	5.3	0.0	3.7	1.9	0.5	1.4	1.0	1.0	0.6	1.2	1.5	1.0	1.2	0.8	1.8	1.5	3.0	11.7	6.7	6.7	0.6	0.0	15.9	17.8	2.7	5.7	27.9	0.0	1.0	13.3	16.6	1.1	2.9	32.7	0.0	18.8	1.1	1.0	6.2	19.6	0.2	13.9	0.0	6.3	9.2	24.1	0.6	0.3	10.1	1.7	1.8	21.3	0.6	17.8	17.5	0.0	1.6	0.2	6.5	1.0	0.2	0.1	0.9	1.7	1.3	44.9	14.7
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400210-63472677	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 10.8;Horizontal cells: 12.7;Late spermatids: 5.7;Spermatocytes: 6.6;Spermatogonia: 17.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.2;T-reg: 1.5"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"AF22: 8.5;AN3-CA: 14.0;NTERA-2: 7.8;SCLC-21H: 27.5;SH-SY5Y: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: AB_2683339"	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	1.2	10.0	18.7	1.3	21.4	1.2	1.2	24.1	50.8	1.2	1.3	2.4	0.0	1.3	1.2	1.3	1.2	1.7	1.7	1.2	15.4	10.0	1.2	1.2	1.2	1.2	8.4	14.1	1.2	1.9	1.2	9.2	1.2	8.9	2.8	1.2	0.0	1.2	1.2	1.2	1.2	1.3	1.2	2.6	1.2	1.3	6.9	4.2	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	8.5	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	27.5	48.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	1.5	0.0	18.7	21.4	24.1	31.2	15.4	10.0	8.4	14.1	8.9	4.2	0.0	0.0	0.0	0.0	0.1	1.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	12.7	0.0	0.0	0.0	5.7	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	2.1	0.0	0.0	6.6	17.0	0.0	0.0	0.0	0.0	0.0
KCNQ3	"EBN2, Kv7.3"	ENSG00000184156	"Potassium voltage-gated channel subfamily Q member 3"	O43525	8	132120858-132481019	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 29.5"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 9.4;Bipolar cells: 5.7;Cardiomyocytes: 4.5;Exocrine glandular cells: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.1;JURKAT: 5.6;RPMI-8226: 4.1;U-2 OS: 6.6;U-87 MG: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.90e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.65e-5)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.57e-6)"	"unprognostic (5.82e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.71e-4)"	"unprognostic (1.14e-3)"	"unprognostic (3.52e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.50e-2)"	1.8	3.3	10.6	1.5	13.1	0.7	1.4	0.9	29.5	1.4	1.0	1.7	0.0	1.0	1.0	0.9	0.8	1.2	1.3	1.8	8.0	7.3	1.8	0.7	2.0	0.9	7.4	11.5	0.8	1.2	1.2	1.4	1.0	6.5	1.4	1.0	0.0	1.0	1.8	0.7	1.3	1.7	1.6	2.1	1.3	0.9	1.0	4.7	0.0	1.2	0.0	1.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.5	1.6	0.0	0.5	1.6	0.0	0.0	0.0	1.5	0.0	1.8	2.3	3.8	0.0	0.0	3.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	2.6	10.1	0.1	0.0	5.6	0.0	0.2	1.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	4.1	2.4	0.0	1.9	1.7	0.7	0.0	0.0	0.3	0.0	1.4	0.0	0.0	6.6	0.2	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	13.1	0.9	13.3	8.0	7.3	7.4	11.5	6.5	4.7	0.0	9.4	0.0	0.0	0.2	5.7	4.5	0.0	1.4	2.3	0.0	0.0	0.0	0.0	2.9	1.5	0.6	0.0	0.0	5.1	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	1.2	0.0	1.0	0.0	0.2	2.8	0.0	0.0	0.4	0.4	0.0	1.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783814-40840452	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Hearing, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 40.1;retina: 23.0"	"Cell type enhanced"	"Detected in some"	12	"Muller glia cells: 4.1;Sertoli cells: 6.5;Smooth muscle cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.0;HEK 293: 5.9;K-562: 5.9;MCF7: 3.5;REH: 3.1;THP-1: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain					NA	NA					"HPA018305: AB_1855556"	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	2.5	0.9	1.1	1.5	2.9	0.4	1.3	3.8	3.6	2.5	9.1	0.9	1.5	1.5	5.8	0.9	3.5	4.6	2.8	2.1	1.6	0.7	0.4	0.4	1.4	0.4	1.4	2.1	1.6	40.1	0.5	0.6	2.1	1.3	3.3	1.7	23.0	5.4	5.3	5.9	1.1	2.3	7.5	2.0	0.4	2.9	1.2	1.4	0.5	0.6	0.9	0.4	5.3	2.5	0.0	0.5	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.3	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.3	1.6	0.4	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.1	5.9	2.0	0.3	0.0	0.4	0.4	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.9	5.9	0.1	0.0	3.5	0.7	0.0	0.4	0.0	0.1	3.1	0.0	0.0	0.7	0.0	2.6	0.5	0.0	1.5	0.6	0.4	0.3	3.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.4	1.1	2.9	3.8	3.6	1.6	0.7	1.4	2.1	1.3	1.4	0.0	0.0	0.0	0.0	0.1	0.3	1.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	1.2	0.2	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	0.3	0.0	0.7	0.0	0.3	6.5	2.7	0.2	0.5	0.4	0.0	0.0	0.4	0.1
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198851	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 3.2;Cardiomyocytes: 2.0;Horizontal cells: 1.6;Melanocytes: 1.7;Smooth muscle cells: 1.4;T-cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 20.4;HEL: 13.3;HL-60: 17.9;U-251 MG: 13.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016655	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA016655: AB_1855557"	"unprognostic (4.91e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.09e-2)"	"unprognostic (8.55e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.39e-3)"	0.7	2.8	4.2	3.0	14.9	6.6	1.1	0.6	19.6	0.6	0.9	0.0	0.0	0.8	0.7	0.6	1.7	1.0	0.9	0.6	6.9	2.7	0.6	0.8	0.8	3.4	3.0	7.5	0.7	0.6	0.6	0.5	1.0	23.0	2.4	0.9	2.2	2.1	1.9	26.1	0.6	0.9	1.7	0.9	2.0	0.8	2.0	0.7	1.6	6.9	0.4	3.1	1.2	0.7	2.7	0.5	1.2	0.0	2.2	1.7	0.2	2.5	0.6	0.0	0.1	0.0	0.9	0.0	20.4	3.0	3.0	2.6	0.0	0.0	12.2	0.0	6.9	0.3	0.4	0.1	1.2	3.6	0.1	4.3	13.3	0.0	0.0	0.5	17.9	0.0	0.2	0.5	8.7	9.1	2.0	0.0	0.0	0.7	8.4	6.0	0.1	0.0	7.7	0.8	0.0	4.3	0.0	0.7	8.4	1.2	0.0	3.4	1.6	0.0	0.0	8.3	0.1	2.5	1.3	0.0	12.7	5.6	0.1	13.5	8.8	0.2	5.6	0.1	8.6	0.7	1.2	0.0	0.0	0.2	0.0	1.1	2.7	0.5	1.5	0.5	1.4	1.7	1.2	0.0	2.2	0.0	0.0	0.0	0.2	4.2	14.9	0.6	19.6	6.9	2.7	3.0	7.5	23.0	0.7	0.0	0.0	0.8	3.2	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	0.3	0.2	2.2	0.0	0.3
KCNS1	Kv9.1	ENSG00000124134	"Potassium voltage-gated channel modifier subfamily S member 1"	Q96KK3	20	45092310-45101112	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 27.0"	"Cell type enriched"	"Detected in some"	6	"Cholangiocytes: 10.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 6.1"	"Region enhanced"	"Detected in many"		"cerebral cortex: 27.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 3.2;HHSteC: 4.9;hTEC/SVTERT24-B: 2.7;THP-1: 4.1;U-87 MG: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.46e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.11e-4)"	"unprognostic (8.91e-3)"	"unprognostic (6.01e-3)"	"unprognostic (7.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.65e-2)"	"unprognostic (6.35e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.39e-1)"	0.3	0.8	1.4	0.2	4.6	0.4	0.7	0.4	27.0	0.6	0.3	0.0	5.9	0.2	0.2	0.2	0.4	0.3	5.2	0.4	2.1	1.1	0.5	0.3	0.7	0.3	1.0	7.2	0.2	0.3	0.1	0.4	0.3	0.0	0.9	0.2	0.0	3.4	7.0	0.2	2.6	0.3	0.2	0.4	0.3	0.3	2.0	0.0	0.0	0.3	0.0	0.5	0.4	0.6	0.6	0.2	2.5	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.1	0.5	0.0	0.3	0.3	1.0	0.9	0.1	0.4	1.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.2	0.9	0.0	2.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.3	1.8	0.0	2.1	0.5	0.0	4.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.2	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.4	4.6	0.4	27.0	2.1	1.1	1.0	7.2	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.9	10.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.1
KCNS2	Kv9.2	ENSG00000156486	"Potassium voltage-gated channel modifier subfamily S member 2"	Q9ULS6	8	98427022-98432848	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 20.9"	"Cell type enhanced"	"Detected in single"	20	"Leydig cells: 1.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 4.0;SCLC-21H: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051417	Uncertain					NA	NA					"HPA051417: AB_2681478"	"unprognostic (7.83e-2)"	"unprognostic (9.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-5)"	"unprognostic (2.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-3)"	1.6	1.4	2.9	0.6	6.6	0.3	0.7	0.7	20.9	2.0	1.0	0.1	0.5	0.4	1.3	1.7	0.9	1.0	1.5	0.4	1.9	2.8	0.7	0.3	0.7	0.4	0.8	6.4	1.9	0.8	0.8	1.2	4.4	3.4	0.9	0.9	0.1	0.3	3.3	0.2	0.3	0.7	0.6	0.9	0.3	1.5	1.0	0.4	0.0	0.5	0.0	0.3	2.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	1.3	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	6.6	0.7	20.9	1.9	2.8	0.8	6.4	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 26.8;Intestinal endocrine cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 33.8;RPMI-8226: 13.6;RT4: 23.0;U-266/84: 15.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA014864: AB_1852155"	"unprognostic (5.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.47e-3)"	"unprognostic (9.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	2.2	1.1	2.7	5.6	3.2	0.4	14.8	0.5	5.1	6.8	7.9	4.8	1.3	3.1	4.5	2.4	7.2	3.3	5.3	4.6	3.9	3.4	4.2	2.6	17.6	1.2	6.8	1.4	1.1	7.7	1.9	0.8	8.3	15.2	4.4	4.1	9.9	7.6	2.8	54.4	3.7	4.3	9.7	4.7	1.1	7.0	3.9	1.4	0.2	2.4	19.0	3.6	5.0	4.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.7	0.3	0.0	0.8	0.4	1.8	1.3	4.1	0.8	1.0	0.0	8.3	0.0	0.4	1.4	0.9	1.2	10.0	0.0	0.9	0.0	2.6	0.0	0.1	0.0	4.0	0.1	0.3	0.3	6.3	0.0	0.6	7.7	0.2	1.8	0.2	0.0	0.5	1.0	0.0	0.0	5.0	5.4	0.1	1.1	33.8	13.6	0.8	23.0	10.0	0.3	0.0	2.6	2.7	2.4	1.3	0.0	0.1	1.3	0.0	0.1	10.1	0.0	15.7	0.0	7.5	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.2	0.5	5.1	3.9	3.4	6.8	1.4	15.2	1.4	26.8	5.1	0.0	10.1	12.4	0.0	0.4	20.4	0.0	4.5	10.4	0.0	0.5	0.0	16.1	0.2	6.0	3.2	0.0	0.3	2.9	16.6	8.1	1.1	3.2	0.4	0.0	31.2	3.1	0.0	0.2	1.4	0.6	20.3	1.0	3.0	0.1	3.7	3.5	3.5	2.6	0.1	6.5	9.5	0.2	3.1	5.1	0.7	0.0	9.9	5.4
KCNT1	"KCa4.1, KIAA1422, SLACK, Slo2.2"	ENSG00000107147	"Potassium sodium-activated channel subfamily T member 1"	Q5JUK3	9	135702185-135795508	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.7;skeletal muscle: 19.5"	"Cell type enriched"	"Detected in single"	5	"Cardiomyocytes: 4.5"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 5.6;RH-30: 1.9;RPMI-8226: 4.2;SCLC-21H: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059880	Uncertain					NA	NA					"HPA059880: AB_2684149"	"unprognostic (1.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.98e-13)"	"unprognostic (9.26e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.89e-7)"	"unprognostic (9.15e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	1.4	0.8	7.3	1.0	12.4	1.0	0.7	29.7	29.3	0.7	0.9	0.2	0.0	1.0	0.8	0.9	1.2	0.9	1.1	1.8	5.3	4.2	0.7	0.7	0.9	0.8	1.8	12.0	7.3	0.8	0.7	4.7	1.2	6.1	0.8	0.8	0.0	0.7	0.8	19.5	0.8	0.8	0.8	2.1	9.6	1.4	1.9	3.1	0.0	0.8	0.0	0.7	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	5.6	0.0	0.0	1.9	4.2	0.0	0.0	6.3	1.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	7.3	12.4	29.7	29.3	5.3	4.2	1.8	12.0	6.1	3.1	0.0	0.0	0.0	0.0	0.0	0.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.7	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0
KCNT2	"KCa4.2, SLICK, SLO2.1"	ENSG00000162687	"Potassium sodium-activated channel subfamily T member 2"	Q6UVM3	1	196225779-196609225	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 38.7;Early spermatids: 12.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 4.3;hTERT-RPE1: 12.4;SCLC-21H: 9.3;SH-SY5Y: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051218	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA051218: AB_2681392"	"unprognostic (5.06e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.10e-6)"	"unprognostic (1.22e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.18e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (3.30e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.72e-3)"	3.9	2.8	4.8	1.3	5.5	0.6	2.2	1.4	8.3	1.8	2.3	0.6	0.0	2.1	2.2	1.7	4.0	2.7	5.9	6.8	9.4	3.1	1.8	10.5	5.5	1.3	1.8	5.2	14.9	1.1	0.9	14.1	1.8	3.7	4.2	2.5	2.9	2.6	2.5	1.2	1.9	2.1	2.6	5.2	1.4	2.6	3.3	1.0	0.0	4.5	3.4	1.2	3.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.1	0.3	0.0	0.0	1.3	0.3	2.7	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.3	0.0	1.6	0.0	4.3	0.0	0.0	1.0	0.0	0.4	0.1	12.4	0.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.3	0.0	0.2	0.0	0.3	0.0	0.0	0.7	9.3	8.4	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.5	1.4	8.3	9.4	3.1	1.8	5.2	3.7	1.0	38.7	0.6	0.0	0.3	0.3	0.0	1.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.9	0.0	0.0	0.0	2.5	0.0	2.3	6.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1
KCNV1	Kv8.1	ENSG00000164794	"Potassium voltage-gated channel modifier subfamily V member 1"	Q6PIU1	8	109963645-109975847	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 22.4"	"Cell type enriched"	"Detected in single"	7	"Intestinal endocrine cells: 6.8"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA								"unprognostic (1.41e-1)"		"unprognostic (1.81e-2)"			"unprognostic (5.01e-4)"		"unprognostic (2.30e-1)"	"unprognostic (3.76e-2)"		"unprognostic (1.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.17e-2)"		0.5	0.5	10.6	0.6	10.2	1.1	0.6	0.2	22.4	0.4	1.1	0.0	0.0	0.5	0.6	1.2	0.5	0.4	0.5	0.5	3.9	1.6	0.6	0.5	0.5	0.7	0.9	8.2	0.8	1.0	0.4	0.7	0.6	0.9	0.7	0.9	0.0	0.6	0.5	0.5	1.1	0.8	0.4	0.4	0.6	0.5	0.7	0.0	0.0	0.9	0.0	0.5	0.4	0.2	0.8	0.6	2.5	0.9	0.6	0.5	0.1	2.1	2.7	1.9	0.8	0.3	0.3	0.7	0.6	0.0	0.4	0.4	0.5	0.8	0.8	0.6	0.1	1.7	2.1	0.7	0.3	0.5	1.0	0.3	1.3	2.0	0.5	0.1	1.1	1.5	0.3	0.4	0.6	0.5	0.8	0.4	1.1	1.0	2.6	0.3	0.6	0.8	1.3	0.9	0.5	1.2	0.2	1.0	0.3	3.4	1.1	1.5	0.7	0.5	0.4	0.6	2.1	1.0	0.5	1.3	2.3	2.0	1.5	0.6	0.9	0.5	0.4	1.0	0.9	0.9	2.5	0.8	0.3	0.5	0.9	0.4	0.6	0.5	0.5	0.5	0.8	0.5	0.5	1.1	0.6	0.8	0.6	0.3	0.1	10.6	10.2	0.2	19.5	3.9	1.6	0.9	8.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0
KCNV2	Kv8.2	ENSG00000168263	"Potassium voltage-gated channel modifier subfamily V member 2"	Q8TDN2	9	2717502-2730037	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 82.3"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 485.0;Rod photoreceptor cells: 393.2"	"Cancer enriched"	"Detected in single"	78	"testis cancer: 6.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HDLM-2: 2.9;HEK 293: 1.4;HeLa: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031131	Enhanced					NA	NA					"HPA031131: AB_10609996"	"unprognostic (5.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-8)"	"unprognostic (3.01e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-2)"	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	82.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.6	0.0	0.2	0.7	0.2	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.9	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	1.4	0.8	2.3	0.3	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.5	0.7	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.4	0.3	0.0	0.1	0.2	0.1	0.1	0.6	0.0	0.0	0.7	0.4	0.6	0.3	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.2	0.0	0.0	0.0	0.0	485.0	0.0	0.0	0.0	85.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	19.8	0.6	0.0	0.0	0.0	0.0	36.6	0.0	0.0	1.1	0.0	393.2	12.9	0.0	5.9	11.4	0.0	0.0	0.0	0.0	0.0
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522626-7534009	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 91.8;Kupffer cells: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 30.9;monocytes: 28.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	18.9	27.5	10.1	10.3	11.9	10.0	10.3	8.2	19.7	7.7	9.6	11.2	7.2	9.6	8.8	9.5	11.2	8.4	11.7	11.7	9.0	9.2	11.5	20.6	17.9	20.6	10.6	10.0	7.8	10.5	9.8	26.0	17.9	13.6	8.8	6.9	9.7	9.2	8.0	14.2	13.9	8.0	9.5	10.4	38.3	8.9	6.5	9.4	7.0	6.2	7.6	5.1	12.5	8.7	1.3	6.2	30.9	28.9	2.8	2.7	4.4	6.4	6.6	3.2	11.0	18.9	6.1	9.3	12.0	9.7	14.6	12.6	5.0	5.7	3.6	14.8	8.1	12.9	3.0	5.4	4.1	4.3	7.0	12.0	3.2	6.5	4.0	16.6	3.6	14.2	8.6	9.7	13.9	2.4	4.6	6.1	8.1	5.9	16.1	8.4	2.1	4.9	3.6	7.2	3.4	14.2	6.9	5.4	7.7	5.5	5.6	8.4	10.3	5.1	9.1	15.2	3.7	5.5	6.4	7.6	7.0	4.0	28.1	8.9	12.4	19.0	2.5	11.2	5.1	10.4	30.9	13.7	29.7	2.3	27.5	2.0	1.1	2.0	1.9	5.6	1.3	1.9	2.0	12.2	2.8	28.9	6.2	2.7	4.4	10.1	11.9	8.2	19.7	9.0	9.2	10.6	10.0	13.6	9.4	3.0	1.6	10.4	6.1	11.8	26.9	2.0	17.8	4.0	1.2	29.6	21.6	10.4	1.7	20.9	4.9	11.9	19.5	46.7	19.9	15.2	17.9	4.5	1.1	12.4	91.8	55.6	16.1	11.1	81.2	10.8	15.3	42.0	20.3	5.4	8.6	23.6	17.7	20.1	14.9	9.2	37.0	6.5	9.2	10.2	11.9	15.2	24.7	10.2	8.6	4.1
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 34.6;Macrophages: 15.1;monocytes: 53.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 18.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;HAP1: 10.1;HDLM-2: 16.8;THP-1: 20.1;U-698: 12.5"	"Region enriched"	"Detected in single"	5	"amygdala: 0.4"	"Low region specificity"	"Detected in all"			HPA019114	Uncertain					NA	NA					"HPA019114: AB_1853645"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	1.3	12.5	0.4	31.9	0.4	2.2	1.1	0.2	0.4	1.7	8.5	0.5	1.6	1.2	1.4	18.4	1.3	2.9	3.8	2.0	0.6	0.4	1.4	0.6	7.5	18.4	0.6	0.0	1.0	1.8	0.0	1.2	2.1	1.5	1.5	14.0	1.6	3.2	0.9	0.6	1.8	7.5	0.5	1.7	9.7	1.7	2.7	0.4	4.1	1.0	2.8	27.5	2.3	1.3	6.6	18.9	0.2	0.8	0.4	5.9	1.4	1.0	1.1	0.1	3.0	0.6	0.2	0.4	0.7	3.8	0.9	1.2	0.0	0.1	14.1	0.4	0.0	1.8	0.1	10.1	1.2	1.1	16.8	7.5	1.4	0.4	0.0	0.8	0.3	1.3	0.2	0.0	0.9	0.8	0.1	0.1	3.7	0.0	0.3	0.2	0.4	0.2	0.1	1.1	0.0	1.9	0.1	2.3	0.0	0.1	0.3	0.7	0.0	0.1	0.2	6.2	0.2	1.8	20.1	0.1	1.0	1.6	0.1	2.6	0.1	0.0	12.5	0.9	0.1	2.4	0.1	0.2	0.0	4.1	0.8	1.3	6.6	3.3	5.9	4.5	1.9	0.5	3.4	0.2	0.4	0.1	18.9	0.2	1.4	0.4	0.4	0.2	0.4	0.6	0.4	0.6	0.0	1.5	0.4	0.0	1.1	9.8	0.5	3.9	0.0	0.5	0.0	2.7	2.3	1.8	0.0	0.1	0.0	0.0	34.6	0.1	6.0	0.0	1.2	0.1	2.1	0.7	0.0	0.0	0.7	0.0	2.4	1.3	0.6	14.2	0.0	15.1	8.5	53.3	4.1	0.0	0.4	5.8	0.0	0.3	0.0	0.0	0.1	0.2	3.7	2.9	0.2	8.2	2.3	0.1
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048499	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.2;pituitary gland: 38.3"	"Group enriched"	"Detected in many"	8	"Intestinal endocrine cells: 109.0;Melanocytes: 143.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 10.1;HAP1: 10.0;RH-30: 12.2;SK-MEL-30: 21.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 1.7"	"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA018106: AB_1853647, HPA062137: AB_2684695"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	4.7	29.2	1.5	0.8	0.8	0.0	3.0	0.2	0.4	6.1	2.8	0.9	2.1	3.2	5.4	15.6	0.8	1.1	0.6	5.1	3.4	0.3	4.5	0.2	4.1	0.0	0.5	0.0	2.2	6.5	17.9	38.3	1.8	2.7	0.5	0.5	4.5	8.1	0.4	1.9	2.5	1.9	1.1	0.3	0.9	1.6	0.4	0.3	2.6	1.5	0.9	0.4	0.7	2.8	0.0	0.0	0.0	0.0	0.0	2.9	0.7	6.5	1.5	0.0	0.0	5.3	4.8	1.7	0.1	10.1	2.5	7.0	0.5	1.2	0.0	0.7	0.1	2.3	0.0	10.0	3.2	1.6	2.6	5.9	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.2	2.1	1.2	2.6	0.0	0.0	0.0	0.0	4.9	0.6	0.0	0.0	0.7	0.0	0.6	0.0	12.2	0.0	0.3	0.0	0.4	0.0	0.3	0.0	21.6	0.8	4.1	5.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.8	0.2	0.4	3.4	0.3	0.5	0.0	2.7	0.3	14.9	1.7	0.0	3.6	7.7	0.0	6.9	10.2	0.0	1.2	3.5	0.0	6.4	0.0	1.9	0.3	0.5	1.3	0.0	8.4	0.1	5.1	1.1	0.0	0.0	3.4	0.0	109.0	0.0	0.0	0.0	1.7	0.8	143.4	2.8	0.6	0.0	4.9	7.8	0.0	2.2	0.0	6.5	1.2	0.9	1.6	3.0	2.2	0.0	0.6	0.3
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007668-88077777	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 66.3;Peritubular cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 36.9;BJ hTERT+: 56.1;fHDF/TERT166: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB004544: AB_672377, HPA015794: AB_1855437"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	18.4	13.6	8.2	7.7	10.9	5.0	15.1	15.1	10.7	31.4	19.4	15.5	18.5	5.6	42.7	9.8	13.9	25.7	15.3	12.8	9.0	5.2	27.5	7.9	13.4	5.5	12.6	6.4	27.0	9.8	21.9	8.1	12.8	9.2	15.6	7.3	14.1	7.4	22.3	5.4	6.2	9.6	29.3	7.2	5.4	14.8	9.9	12.0	5.5	10.2	3.3	4.9	13.9	21.4	0.5	1.3	4.8	0.8	1.0	1.4	0.4	1.9	10.9	12.3	6.3	28.6	19.1	3.6	36.9	56.1	17.3	17.3	0.5	3.4	1.0	8.1	44.4	6.6	2.4	2.2	5.5	15.2	5.5	1.9	1.7	5.6	1.1	15.9	4.2	3.5	15.8	2.5	13.5	7.3	23.7	7.8	2.0	0.2	2.9	15.0	3.7	2.9	2.0	6.4	1.4	1.8	5.6	7.3	1.5	15.4	4.6	2.5	5.5	6.8	0.3	8.7	13.0	2.6	3.2	12.0	16.4	3.6	4.6	4.9	2.4	0.7	1.2	9.7	0.6	15.0	4.8	0.5	0.9	0.8	0.8	1.4	0.5	0.8	0.6	0.3	0.5	0.9	0.6	0.9	1.0	0.3	1.3	0.4	0.4	8.2	10.9	15.1	10.7	9.0	5.2	12.6	6.4	9.2	12.0	3.0	4.6	1.4	4.2	6.5	14.6	6.3	20.4	16.0	10.3	66.3	9.8	8.7	0.0	10.3	0.3	11.2	0.7	0.0	3.3	3.5	23.9	4.3	1.1	6.8	10.3	25.4	6.4	20.9	4.9	0.7	21.3	8.3	21.9	9.0	2.7	20.1	3.0	5.7	47.7	14.7	1.5	25.8	20.6	0.7	0.9	5.8	2.3	0.7	2.6	2.5
PKD2L1	"PCL, PKD2L, PKDL, TRPP3"	ENSG00000107593	"Polycystin 2 like 1, transient receptor potential cation channel"	Q9P0L9	10	100288154-100330486	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.2;lymphoid tissue: 12.0"	"Cell type enhanced"	"Detected in some"	26	"Early spermatids: 15.0;Hofbauer cells: 12.4;Horizontal cells: 57.2;Late spermatids: 15.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 3.0;non-classical monocyte: 2.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.6;NB-4: 1.8;PC-3: 2.0;RT4: 1.1;SK-MEL-30: 1.6;U-266/70: 1.0;U-266/84: 2.8;U-937: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB022621	Uncertain					NA	NA					"CAB022621: "	"unprognostic (2.67e-1)"	"unprognostic (3.66e-7)"	"unprognostic (8.07e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.49e-4)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	0.3	0.3	0.4	0.6	3.7	1.3	1.4	0.1	6.2	0.1	1.5	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	2.0	0.3	0.5	2.7	4.0	2.3	0.5	4.0	0.2	0.2	0.0	0.2	0.7	1.3	0.4	2.2	1.0	0.3	0.0	0.1	0.1	0.8	0.0	1.5	12.0	0.1	2.3	0.0	0.3	0.1	0.0	2.9	0.4	0.1	0.2	0.3	0.6	3.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	1.6	0.0	0.0	0.0	1.8	0.0	1.0	2.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	0.0	0.0	1.4	0.0	0.0	2.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.6	0.0	2.3	0.0	0.0	0.4	0.4	3.7	0.1	6.2	2.0	0.3	0.5	4.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	12.4	57.2	0.0	0.6	6.6	15.9	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PKD2L2	TRPP5	ENSG00000078795	"Polycystin 2 like 2, transient receptor potential cation channel"	Q9NZM6	5	137887968-137942747	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 7.5;testis: 29.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 25.9;Spermatocytes: 19.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.9;U-266/70: 4.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041903, HPA043634"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA041903: AB_2677734, HPA043634: AB_2678591"	"unprognostic (7.53e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	0.5	1.5	2.0	0.6	2.5	2.2	1.2	1.7	1.9	0.5	0.3	0.7	0.7	0.3	0.5	1.0	0.5	0.4	0.6	1.7	1.0	0.8	0.4	0.3	0.4	1.3	1.2	1.3	0.6	1.1	0.0	1.5	0.2	1.8	0.5	0.1	0.2	0.7	0.0	3.3	0.8	0.3	0.0	0.7	1.0	0.6	29.3	0.4	0.0	1.0	0.0	0.2	0.4	0.6	3.9	3.5	7.5	1.7	1.9	1.9	0.8	1.6	1.2	0.2	0.1	0.4	0.5	1.8	0.6	0.0	0.0	0.0	0.1	3.2	2.3	3.5	0.0	0.1	0.7	0.1	0.0	0.1	1.5	1.1	1.3	4.2	0.1	0.0	0.4	1.8	0.1	0.2	0.0	0.0	0.7	0.6	3.3	1.5	5.9	0.8	0.5	1.1	2.4	0.6	0.1	1.0	0.0	0.1	0.0	0.0	2.3	0.8	0.9	1.5	0.2	0.9	0.7	0.4	0.5	0.5	1.0	1.8	0.7	1.0	4.6	3.4	0.4	2.3	0.7	1.8	7.1	1.7	3.0	1.8	1.2	1.0	2.5	1.6	1.4	0.9	3.9	1.9	1.7	7.5	1.9	1.0	3.5	1.1	0.8	2.0	2.5	1.7	1.9	1.0	0.8	1.2	1.3	1.8	0.4	3.0	2.1	0.5	1.6	1.9	2.3	1.5	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.1	25.9	0.8	0.0	0.0	0.0	0.1	1.3	1.3	1.1	0.2	0.2	3.2	0.0	1.3	0.6	4.7	0.6	0.2	3.3	0.0	0.0	0.9	0.1	0.0	0.4	0.2	3.9	0.0	1.2	19.5	2.2	1.0	0.1	0.7	0.0	0.5
SCN10A	"hPN3, Nav1.8, PN3, SNS"	ENSG00000185313	"Sodium voltage-gated channel alpha subunit 10"	Q9Y5Y9	3	38696807-38816217	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"heart muscle: 1.5;testis: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HUVEC TERT2: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.57e-2)"										"unprognostic (7.85e-2)"		"unprognostic (2.09e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SCN11A	"NaN, Nav1.9, SCN12A, SNS-2"	ENSG00000168356	"Sodium voltage-gated channel alpha subunit 11"	Q9UI33	3	38845769-38950561	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.5;placenta: 5.2"	"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 4.0;Early spermatids: 5.4;Sertoli cells: 6.5;Spermatocytes: 3.9;Spermatogonia: 6.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.8;HDLM-2: 5.0;SCLC-21H: 1.1;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036746, HPA036747"	Uncertain					NA	NA					"HPA036746: AB_10696785, HPA036747: AB_2675287"	"unprognostic (6.11e-2)"	"unprognostic (5.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.79e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.30e-4)"	0.9	0.2	0.8	0.5	0.8	0.0	0.6	0.1	0.3	0.0	1.1			0.4	0.0	1.4	0.0	0.1	0.1	0.0	0.4	0.5	0.4	0.3	0.0	0.2	0.4		0.0	0.1	0.0	0.4	5.2		0.1	1.3		0.0	0.0	0.1	0.8	1.0	0.5	0.6	7.5	0.0	2.6			0.1		0.1	3.4	0.1	0.2	0.4	0.9	0.1	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.1	5.0	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.1	0.6	0.0	0.0	0.0	1.3	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.9	0.1	0.1	0.4	0.0	0.0											0.0	0.0	0.0	0.8	0.7	0.1	0.8	0.0	4.0	1.2	0.0	0.0	0.2	0.0	0.0	5.4	0.6	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.2	0.3	0.0	0.0	2.5	0.0	1.0	0.0	0.0	1.7	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.4	6.5	0.9	3.9	6.0	0.6	0.2	0.0	0.0	0.9
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 33.9"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 26.9;Bipolar cells: 33.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 11.6;Hep G2: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	1.1	1.3	5.2	1.1	13.6	1.0	1.1	10.3	26.6	1.1	1.1	2.3	0.0	1.0	1.1	1.1	1.0	6.8	1.0	1.1	6.9	8.3	1.1	1.1	5.6	1.0	5.7	9.7	1.0	1.0	1.1	2.9	1.2	33.9	1.1	1.1	0.3	1.0	1.0	1.2	1.1	1.1	1.1	3.6	1.1	1.1	1.4	4.2	0.0	1.1	0.0	1.0	1.1	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	11.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.2	13.6	10.3	26.6	6.9	8.3	5.7	9.7	33.9	4.2	6.0	26.9	0.0	0.0	0.0	33.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SCN2A	"HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2"	ENSG00000136531	"Sodium voltage-gated channel alpha subunit 2"	Q99250	2	165194993-165392310	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 68.0"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 48.0;Cone photoreceptor cells: 45.2;Horizontal cells: 14.3"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.4;SH-SY5Y: 3.1;U-138 MG: 5.8;U-266/84: 12.0;U-87 MG: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022567	Enhanced					NA	NA					"CAB022567: "	"unprognostic (1.16e-1)"	"unprognostic (3.56e-4)"	"unprognostic (5.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.97e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.14e-1)"	1.3	3.0	19.1	1.3	36.4	1.1	2.2	68.0	50.3	1.5	1.3	1.1	0.0	1.5	1.9	2.6	1.2	1.3	2.3	1.3	30.3	8.2	4.0	1.4	1.5	1.2	3.8	23.5	1.5	1.3	1.1	8.2	1.3	9.9	1.3	1.3	0.0	1.5	1.8	1.1	1.2	1.5	2.0	3.7	1.3	1.5	1.5	4.1	0.0	1.1	0.0	1.2	1.3	0.5	1.4	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.8	0.0	0.0	2.8	0.0	2.7	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.1	1.0	0.7	0.0	0.4	0.0	0.4	0.0	0.2	3.4	0.1	0.3	0.0	2.4	0.0	0.0	0.0	0.3	1.5	0.0	0.2	0.0	2.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	2.9	3.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	5.8	0.4	0.3	0.0	0.5	12.0	0.0	3.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	19.1	36.4	68.0	43.7	30.3	8.2	3.8	23.5	9.9	4.1	0.0	1.7	0.0	0.1	0.2	48.0	0.6	0.0	0.0	0.0	10.4	45.2	0.1	5.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.0	3.7	0.5	0.0	5.6	0.0	3.4	0.0	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0
SCN3A	Nav1.3	ENSG00000153253	"Sodium voltage-gated channel alpha subunit 3"	Q9NY46	2	165087522-165204067	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 13.6;brain: 28.5;pituitary gland: 13.7"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 55.3"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 8.4;naive B-cell: 13.6"	"Lineage enriched"	"Detected in single"	38	"B-cells: 13.6"	"Cell line enhanced"	"Detected in some"		"JURKAT: 4.9;Karpas-707: 8.7;MOLT-4: 24.4;RPTEC TERT1: 12.3;SH-SY5Y: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035396	Approved					NA	NA					"HPA035396: AB_2674607"	"unprognostic (1.80e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.96e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-4)"	"unprognostic (4.55e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.93e-2)"	2.6	4.0	16.7	1.9	28.5	1.0	2.5	19.6	19.7	2.1	2.1	0.8	0.0	1.2	1.4	0.7	1.5	1.4	1.8	2.1	9.8	11.3	1.8	1.0	1.0	2.7	4.8	9.8	1.8	1.7	2.3	13.7	0.8	9.1	0.9	2.1	0.0	0.7	1.4	0.9	0.5	1.9	1.7	4.0	1.8	2.7	1.8	4.9	2.0	1.3	0.0	3.5	1.7	0.5	13.6	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.2	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.3	0.0	4.9	0.0	8.7	0.1	0.0	24.4	0.0	0.0	0.1	2.0	0.1	1.1	0.0	12.3	0.0	3.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.7	0.0	1.3	0.4	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	13.6	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	16.7	28.5	19.6	17.2	9.8	11.3	4.8	9.8	9.1	4.9	0.0	0.3	1.9	0.1	0.0	0.8	3.2	0.0	0.0	0.0	1.8	11.8	0.0	0.0	0.1	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	8.5	0.0	0.0	5.4	0.3	0.0	1.7	0.0	0.0	0.6	0.2	0.0	0.7	0.0	0.7	12.9	5.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 53.7"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 3.4;Ito cells: 3.1;Late spermatids: 2.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.2"					"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.9"	"Group enriched"	"Detected in some"	11	"REH: 10.1;RH-30: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053992			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA053992: AB_2797249"	"unprognostic (2.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.38e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.45e-2)"	5.9	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2			0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.3	0.3	0.0		0.1	0.0		0.5	0.0	53.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4			1.6		0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	10.1	31.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649673	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 67.3"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 66.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 22.0;RH-30: 18.3"	"Group enriched"	"Detected in some"	5	"amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0"	"Low region specificity"	"Detected in many"			HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2.0	0.4	0.0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0.0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.3	2.7	0.0	0.0	0.0	0.9	0.9	2.7	0.0	0.4	0.0	1.2	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.5	0.0	1.7	3.6	0.4	0.0	0.0	22.0	1.1	0.0	0.0	2.0	0.0	0.0	0.0	18.3	0.0	0.0	2.4	0.3	2.4	0.0	0.0	0.0	0.7	0.0	0.0	4.4	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	3.1	66.1	0.0	0.0	0.0	0.0	13.7	0.1	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.3	0.9	0.0	0.0	0.0	0.0	1.0
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 27.6;pituitary gland: 9.7"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 13.7;Cone photoreceptor cells: 9.8;Intestinal endocrine cells: 10.9;Rod photoreceptor cells: 10.5;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 12.0;ASC TERT1: 12.7;BJ hTERT+: 11.2;WM-115: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	1.1	3.0	9.1	1.5	18.1	1.9	1.9	16.7	27.6	1.0	2.0	1.6	0.0	1.1	1.5	2.0	0.9	1.1	2.5	0.9	12.6	4.5	1.9	4.3	1.0	1.3	3.2	13.7	1.8	3.2	1.5	9.7	0.9	14.8	1.8	2.5	0.9	1.7	1.2	1.0	1.1	1.2	1.0	2.2	1.7	2.7	3.8	1.6	0.0	1.7	0.0	1.2	1.0	0.6	0.4	0.2	0.0	0.0	0.0	1.0	0.0	1.4	1.0	12.0	0.1	1.6	12.7	0.2	6.8	11.2	7.9	7.3	2.0	1.4	0.3	1.6	8.9	3.5	0.0	1.9	0.0	9.3	1.2	0.6	0.1	0.1	0.2	0.1	0.2	0.9	1.7	0.0	5.2	1.1	3.1	8.4	2.8	0.1	0.1	4.9	0.8	2.0	0.1	4.1	0.7	3.8	0.0	0.6	0.0	0.0	0.4	4.8	2.0	3.5	1.8	0.2	1.8	0.3	0.1	2.2	7.7	5.1	2.8	4.3	0.1	0.1	0.0	1.5	1.6	11.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	1.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	9.1	18.1	16.7	25.0	12.6	4.5	3.2	13.7	14.8	1.6	0.0	0.0	0.0	0.4	0.0	13.7	1.2	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.2	0.0	3.4	0.0	4.8	10.9	1.3	0.0	0.2	0.0	0.0	0.0	0.0	1.3	5.3	0.5	0.0	0.7	0.5	10.5	0.0	0.3	1.9	10.0	0.0	0.0	0.0	0.6	0.1
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 27.7;Hofbauer cells: 50.6;Intestinal endocrine cells: 31.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	17	"plasmacytoid DC: 18.6"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 18.6"	"Cell line enhanced"	"Detected in many"		"BJ: 17.2;BJ hTERT+: 12.8;HHSteC: 14.8;hTERT-RPE1: 12.0"	"Region enriched"	"Detected in some"	5	"hypothalamus: 10.9"	"Low region specificity"	"Detected in all"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"	6.6	4.2	3.8	2.8	9.1	4.2	2.7	0.9	4.4	1.8	10.2	0.5	0.1	1.4	0.9	3.8	2.6	1.2	5.8	2.9	2.8	15.9	4.8	8.3	4.5	3.5	4.1	2.3	2.1	4.8	0.6	11.3	9.2	7.3	2.0	7.0	1.7	1.8	1.9	0.9	1.8	4.2	5.2	2.5	12.4	1.7	16.2	0.4	10.3	1.4	1.9	1.2	3.6	1.8	0.0	18.6	0.7	0.1	0.4	0.0	0.0	0.0	1.9	0.1	0.0	7.4	6.5	0.0	17.2	12.8	4.0	1.3	0.5	0.0	0.0	0.0	2.1	0.2	0.0	4.9	0.6	6.6	0.0	1.6	1.3	1.5	1.4	14.8	0.0	0.0	0.4	0.2	6.8	1.3	12.0	0.8	0.9	4.3	5.0	0.6	0.0	2.6	0.0	1.5	0.0	0.5	0.7	2.5	6.5	1.8	7.2	0.8	7.2	0.0	0.0	0.3	3.8	0.2	0.0	0.0	0.0	1.1	0.1	0.3	0.1	0.0	0.0	2.5	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.4	0.1	18.6	0.0	0.0	3.8	9.1	0.9	4.4	2.8	15.9	4.1	2.3	7.3	0.4	11.9	18.4	0.9	0.2	0.9	0.2	1.6	5.1	4.0	7.9	5.2	0.0	0.2	3.3	14.9	1.7	2.2	11.3	0.0	27.7	0.4	1.2	0.2	3.5	6.0	50.6	0.0	31.7	20.3	1.5	1.9	1.1	4.3	3.3	0.0	14.6	1.3	18.8	8.6	0.0	12.2	0.0	0.0	1.0	0.0	0.4	0.4	0.9	0.0	10.7	0.1
TPCN1	"FLJ20612, KIAA1169, TPC1"	ENSG00000186815	"Two pore segment channel 1"	Q9ULQ1	12	113221050-113298585	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 49.6;hTERT-RPE1: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039757	Approved					NA	NA					"HPA039757: AB_10795156"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.47e-3)"	18.1	28.6	16.0	15.8	24.8	9.7	17.7	67.8	28.1	19.1	19.1	30.8	23.6	17.0	23.9	19.7	21.8	19.2	25.3	46.5	18.0	11.4	31.2	15.2	18.6	13.6	34.4	17.9	25.6	30.3	28.5	25.0	16.4	28.4	16.3	17.5	26.7	29.9	28.7	28.4	13.2	19.4	16.9	22.1	18.0	11.3	9.7	27.8	5.4	32.5	16.1	24.8	17.4	15.5	5.5	9.3	5.0	13.7	8.6	3.4	3.8	4.8	14.8	1.7	2.1	13.3	15.1	5.0	6.9	49.6	3.7	4.4	10.9	16.9	11.2	10.5	7.1	12.1	6.1	3.9	12.4	5.0	1.3	3.0	4.2	7.5	6.0	17.3	1.4	9.5	14.3	6.3	7.2	12.7	41.5	5.6	3.2	4.7	4.0	4.5	5.9	0.4	22.1	2.8	6.0	7.5	0.8	2.1	21.8	11.9	17.9	2.1	3.3	5.6	14.5	5.8	3.6	4.6	13.5	2.3	5.5	2.7	7.5	4.3	6.7	4.0	9.7	16.2	3.5	4.1	5.0	13.7	1.2	1.7	2.3	2.1	3.5	2.4	2.3	9.3	5.5	3.4	2.1	0.5	8.6	0.3	4.9	1.1	3.8	16.0	24.8	67.8	28.1	18.0	11.4	34.4	17.9	28.4	27.8	8.9	18.7	3.7	4.9	4.0	16.8	28.8	12.7	12.0	9.1	26.2	15.7	5.9	1.7	11.7	10.3	4.4	26.0	0.0	15.9	2.6	8.7	9.8	31.1	17.1	18.6	47.7	27.6	19.6	17.3	8.7	19.8	9.6	6.8	4.6	24.8	20.4	10.4	19.9	20.1	17.5	13.4	0.0	10.3	3.0	2.0	3.4	5.5	6.1	15.8	14.8
TPCN2	TPC2	ENSG00000162341	"Two pore segment channel 2"	Q8NHX9	11	69048897-69162440	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Melanocytes: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 21.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA016561, HPA027080"	Supported		Approved	Nucleoli		NA	NA			Nucleoli		"HPA016561: AB_1858207, HPA027080: AB_10600917"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (7.60e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.88e-2)"	11.0	6.2	6.3	8.7	11.1	9.2	9.4	14.5	14.0	18.0	18.0	9.2	11.3	15.0	22.4	12.4	11.2	13.8	12.1	7.5	6.2	4.9	11.6	15.7	8.7	10.4	6.0	7.7	12.1	6.8	6.4	7.2	7.1	8.8	13.1	7.4	20.7	8.1	17.8	8.1	16.1	13.7	15.6	6.0	10.9	11.4	8.5	4.9	6.4	7.3	7.4	10.1	11.0	11.2	2.0	7.5	7.1	9.9	6.9	3.2	3.6	3.4	8.9	2.7	4.2	2.6	2.1	11.7	3.9	4.7	4.7	2.8	7.6	10.9	4.5	5.6	4.8	3.7	8.0	2.2	4.4	1.4	2.8	2.3	6.1	9.5	2.5	2.5	4.3	8.3	3.3	2.3	2.4	2.5	1.9	3.2	7.4	2.9	21.1	2.9	8.1	3.6	10.3	3.2	10.1	3.2	3.4	2.2	5.5	4.7	5.6	2.4	3.2	4.5	10.2	15.7	4.1	6.6	5.7	2.9	3.2	4.7	5.9	3.6	5.5	2.3	2.3	5.2	4.6	6.7	4.3	9.8	2.9	1.0	9.8	0.9	2.0	2.1	2.1	7.5	1.5	1.7	2.0	7.1	6.9	9.9	3.2	3.2	3.6	6.3	11.1	14.5	14.0	6.2	4.9	6.0	7.7	8.8	4.9	8.9	1.0	7.5	2.1	3.5	1.5	3.2	7.6	0.0	1.2	12.2	2.0	2.3	14.9	6.0	16.2	2.9	6.2	23.3	7.6	3.7	3.5	1.2	2.3	12.9	10.5	0.0	0.0	6.2	15.4	1.7	5.8	7.4	33.7	4.6	2.9	2.5	3.7	3.5	6.3	9.6	4.2	6.5	5.9	1.9	3.8	3.0	1.6	2.6	3.4	1.4
TRPA1	ANKTM1	ENSG00000104321	"Transient receptor potential cation channel subfamily A member 1"	O75762	8	72019917-72075617	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 20.8;urinary bladder: 20.1;vagina: 12.1"	"Group enriched"	"Detected in some"	10	"Early spermatids: 6.4;Mucus-secreting cells: 5.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"HHSteC: 24.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.14e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.11e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.16e-4)"	"unprognostic (2.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.90e-1)"	0.3	0.2	0.2	9.1	0.2	0.0	0.2	0.2	0.4	0.4	16.8	0.3	0.0	4.8	0.2	0.3	2.2	0.2	5.7	0.3	0.2	0.2	0.2	0.2	0.3	0.8	0.3	0.0	0.4	0.2	0.0	0.2	0.3	0.1	4.7	7.5	0.0	0.2	0.0	0.2	0.2	20.8	3.8	0.2	0.4	7.9	0.4	0.0	0.6	0.2	0.3	1.4	20.1	12.1	0.5	0.6	0.1	1.1	0.3	2.6	0.2	0.0	2.5	0.7	0.0	0.0	0.1	0.0	0.3	2.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.8	0.4	1.4	0.1	0.0	0.5	0.0	24.5	0.0	0.2	1.6	0.0	1.1	0.2	5.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	2.4	0.2	0.0	0.3	0.0	0.1	3.8	1.1	0.0	0.3	0.3	0.0	1.8	0.0	1.7	0.0	0.0	0.0	0.3	0.0	1.1	0.5	0.5	2.6	0.0	0.5	0.0	0.4	0.1	0.3	1.1	0.6	1.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0
TRPC1	HTRP-1	ENSG00000144935	"Transient receptor potential cation channel subfamily C member 1"	P48995	3	142724074-142807888	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 18.1;Cone photoreceptor cells: 15.7;Horizontal cells: 12.7;Rod photoreceptor cells: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009387, HPA021130"	Supported		Approved	Vesicles		NA	NA			Vesicles		"CAB009387: AB_2240941, HPA021130: AB_1858361"	"unprognostic (1.66e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.37e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (1.44e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.49e-2)"	6.8	8.3	8.5	3.5	13.4	1.2	6.8	23.0	15.9	17.7	8.3	11.4	4.3	2.6	20.4	9.2	6.5	10.1	9.1	15.9	10.0	11.4	6.0	2.0	5.4	3.3	9.4	12.2	24.5	3.0	12.2	14.4	6.1	14.7	12.3	4.9	13.0	3.7	13.6	2.4	6.2	4.7	17.6	11.4	5.0	4.4	8.0	7.9	0.4	8.9	3.9	2.3	9.3	8.9	0.6	0.0	0.0	0.0	0.3	1.3	0.3	3.2	4.6	8.4	1.0	7.6	18.7	3.8	5.1	8.1	6.5	9.6	1.4	0.9	0.0	1.7	5.3	11.4	0.3	2.3	2.4	9.4	0.8	3.4	5.1	1.9	2.2	3.1	0.2	0.0	9.0	2.4	6.0	7.3	11.0	3.7	0.0	0.2	0.0	9.1	2.0	0.3	0.4	4.7	0.0	2.4	0.0	4.0	0.0	4.5	0.1	5.4	4.0	6.3	0.0	1.1	8.0	2.6	0.0	3.4	8.2	1.3	11.0	6.9	3.4	1.4	1.6	6.2	0.1	2.4	0.0	0.0	0.0	0.2	0.0	1.2	0.6	1.3	0.6	0.0	0.3	1.2	1.3	0.0	0.3	0.0	0.0	0.0	0.3	8.5	13.4	23.0	15.9	10.0	11.4	9.4	12.2	14.7	7.9	3.0	0.3	0.0	2.2	2.6	18.1	10.1	0.0	2.7	0.0	5.2	15.7	0.1	0.0	0.2	2.1	2.9	0.0	0.0	0.2	0.2	7.2	0.8	0.0	0.0	0.1	12.7	1.7	4.3	0.0	1.7	7.8	0.0	1.7	0.0	0.0	6.8	0.1	0.0	10.3	0.3	15.0	0.0	9.0	10.3	2.1	1.0	0.2	0.0	0.0	0.2
TRPC3		ENSG00000138741	"Transient receptor potential cation channel subfamily C member 3"	Q13507	4	121879027-121951754	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 9.3;pituitary gland: 12.0;smooth muscle: 9.4"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.7;HEL: 5.6;Karpas-707: 5.9;U-2 OS: 3.7;U-251 MG: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.12e-3)"	"unprognostic (9.80e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.42e-3)"	1.4	0.4	1.8	0.7	9.3	0.3	0.5	5.8	7.4	3.3	0.8	1.7	0.8	0.8	1.6	1.2	0.6	1.1	7.3	0.5	1.8	2.3	0.7	0.5	2.9	0.5	2.3	1.9	0.8	0.2	0.6	12.0	4.2	7.3	1.1	0.8	0.3	0.8	2.5	0.6	0.5	1.2	9.4	1.1	1.0	0.9	1.6	3.6	0.0	0.6	0.0	0.4	3.6	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	1.0	1.5	0.6	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.9	0.0	0.1	0.0	3.7	5.6	0.1	0.0	0.2	1.5	0.5	0.6	0.0	0.1	0.0	2.5	0.0	0.2	0.0	5.9	1.3	0.0	1.6	0.0	1.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	3.7	0.0	3.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	9.3	5.8	7.4	1.8	2.3	2.3	1.9	7.3	3.6	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	28.1	0.0	0.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0
TRPC4	"HTRP4, TRP4"	ENSG00000133107	"Transient receptor potential cation channel subfamily C member 4"	Q9UBN4	13	37636636-37870425	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.0;smooth muscle: 17.2"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 2.4;Smooth muscle cells: 1.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.2;BJ: 16.7;BJ hTERT+ SV40 Large T+: 7.2;fHDF/TERT166: 15.9;U-2197: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.52e-4)"	"unprognostic (9.99e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-6)"	"unprognostic (3.73e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-2)"	1.3	0.8	4.6	1.2	4.0	0.2	0.6	2.1	4.0	5.5	4.1	0.6	6.9	0.8	31.0	2.1	0.4	1.9	4.5	1.9	4.8	2.1	3.0	0.5	4.2	0.3	2.5	0.4	3.8	1.8	0.7	0.5	4.6	3.9	9.5	1.1	0.1	0.5	12.6	0.4	0.5	1.6	17.2	2.5	0.5	3.6	0.8	2.5	0.0	1.1	0.0	0.3	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	1.1	2.4	0.0	16.7	2.3	7.2	3.8	0.0	0.2	0.0	0.0	15.9	2.4	0.0	0.1	0.0	3.6	0.0	0.1	0.0	0.3	0.0	2.8	0.0	0.0	1.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	7.6	1.5	4.0	1.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.0	2.1	4.0	4.8	2.1	2.5	0.4	3.9	2.5	0.0	0.0	0.0	0.4	0.0	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TRPC5	PPP1R159	ENSG00000072315	"Transient receptor potential cation channel subfamily C member 5"	Q9UL62	X	111774315-112082776	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"brain: 5.3;liver: 3.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"testis cancer: 0.8;thyroid cancer: 2.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"NTERA-2: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA										"unprognostic (3.29e-2)"		"unprognostic (6.15e-2)"	"unprognostic (7.32e-2)"			"unprognostic (2.60e-3)"		"unprognostic (3.68e-2)"	"unprognostic (5.69e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.78e-2)"		0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.6	5.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.3	0.4	3.2	0.0	0.0	0.9		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 35.3;placenta: 20.6"	"Cell type enhanced"	"Detected in some"	16	"Club cells: 19.4;Leydig cells: 5.8;Smooth muscle cells: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.5"	"Cell line enhanced"	"Detected in some"		"A549: 4.7;ASC diff: 8.8;BJ hTERT+: 4.7;HEL: 4.4;RPTEC TERT1: 21.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6"	HPA045098	Approved					NA	NA		140000			"HPA045098: AB_10959600"	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	6.0	0.5	1.5	0.6	2.4	0.1	9.7	0.8	2.0	7.6	3.9	1.1	7.5	1.1	6.6	7.0	10.8	5.3	3.2	1.1	2.0	1.5	1.6	0.4	35.3	0.9	2.2	3.4	2.2	1.0	1.0	0.6	20.6	2.9	2.3	1.6	0.3	3.3	7.2	0.8	3.0	1.9	3.9	0.7	2.0	1.5	1.0	0.1	0.1	9.6	2.7	1.1	1.6	3.8	0.0	1.0	5.5	0.5	0.0	0.0	0.3	0.0	4.7	0.2	0.0	8.8	2.2	0.0	3.0	4.7	0.7	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.3	1.5	2.4	0.8	2.0	2.0	1.5	2.2	3.4	2.9	0.1	0.0	1.6	0.0	1.7	2.1	0.8	0.4	0.0	1.4	19.4	3.5	0.0	0.9	0.0	0.0	0.6	0.8	0.0	0.0	0.2	0.0	1.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.8	2.6	1.7	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	9.8	0.0	0.0	3.0	0.3	0.0	0.0	1.0
TRPC7		ENSG00000069018	"Transient receptor potential cation channel subfamily C member 7"	Q9HCX4	5	136213320-136365545	"Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.8;SCLC-21H: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022592, HPA031126"	Uncertain		Uncertain	"Actin filaments,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Actin filaments"	"CAB022592: , HPA031126: AB_10603221"			"unprognostic (1.49e-1)"		"unprognostic (2.08e-1)"					"unprognostic (3.03e-2)"	"unprognostic (2.89e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.78e-2)"		0.0	2.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0			1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0	2.2	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.4			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001061-31161273	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 99.0"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 705.2"	"Cancer enriched"	"Detected in single"	179	"melanoma: 14.6"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	113	"SK-MEL-30: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"		NA	NA			"Centriolar satellite"	"Golgi apparatus, Plasma membrane"	"HPA014779: AB_2669090, HPA071139: "	"unprognostic (5.28e-2)"	"unprognostic (1.35e-1)"		"unprognostic (9.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.84e-2)"	"unprognostic (6.20e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.63e-2)"	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.3	0.1	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	99.0	0.4	0.0	0.2	10.4	0.0	0.1	1.9	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.1	0.3	0.7	0.2	1.6	0.0	0.3	0.1	0.0	0.0	0.0	0.0	3.8	705.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	30.8	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	12.7	0.0	0.0	0.0	2.4	0.0	0.0	150.1	0.0	0.0	10.0	0.0	0.0	0.0	0.6	18.1	0.0	0.0	7.9	3.8	0.9	0.8	0.0	0.0	0.0
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529063-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 36.6;kidney: 28.0;retina: 105.2"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 278.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.1"	"Cell line enriched"	"Detected in some"	4	"HAP1: 19.4"	"Low region specificity"	"Detected in all"							"HPA072650, HPA074393"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.9	1.7	6.0	0.7	4.5	1.1	0.8	36.6	5.1	0.8	0.7	9.6	2.1	1.8	2.4	3.0	0.7	1.3	1.3	1.4	9.4	6.0	28.0	0.9	0.8	0.7	8.3	3.5	5.3	1.5	0.7	6.8	0.8	34.8	1.4	0.7	105.2	0.8	5.0	1.1	0.8	0.7	1.0	8.1	1.1	1.6	5.3	5.9	0.0	2.1	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.1	0.1	1.3	3.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	19.4	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.2	0.0	0.0	1.2	4.5	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.2	0.0	1.0	0.0	1.3	0.0	0.2	0.0	0.4	0.2	0.0	0.0	3.6	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.0	4.5	36.6	3.8	9.4	6.0	8.3	3.5	34.8	5.9	3.0	4.0	0.0	0.9	0.3	9.5	4.8	2.5	1.4	4.5	15.7	62.8	0.0	5.0	0.0	3.9	1.3	0.0	0.0	0.2	0.0	1.5	0.4	0.0	0.0	0.2	1.6	14.8	0.6	0.0	1.7	5.2	1.1	0.0	0.0	0.0	278.6	0.1	0.0	8.5	25.8	4.7	0.0	1.0	1.5	0.4	0.6	0.2	0.8	0.0	0.3
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 120.1;Mucus-secreting cells: 88.2;Paneth cells: 80.4;Undifferentiated cells: 78.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"OE19: 15.6;RT4: 32.4;SK-BR-3: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		6500	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	6.7	3.8	3.5	13.7	3.7	4.3	8.5	3.0	6.8	8.2	25.2	4.5	8.6	20.6	7.9	9.1	7.7	5.4	24.8	9.3	2.7	2.2	14.2	23.6	9.4	3.5	2.6	5.7	2.7	17.4	3.4	3.3	5.0	6.9	20.2	11.4	10.6	16.2	13.2	16.4	16.1	26.8	9.4	2.5	3.4	18.3	4.2	2.2	0.4	10.1	11.5	6.8	9.9	8.6	1.1	5.4	4.9	6.8	1.0	0.7	2.1	6.0	4.5	1.1	5.0	3.8	3.6	3.6	5.1	3.0	1.4	1.9	3.3	9.5	0.2	1.3	3.4	1.9	7.9	0.7	1.5	0.6	0.1	1.6	1.0	1.9	2.0	3.4	0.1	6.6	4.3	7.0	2.6	1.2	1.7	2.4	0.5	2.4	1.2	3.5	9.0	0.4	0.5	0.6	15.6	6.9	2.2	1.0	0.3	2.4	32.4	0.4	1.1	2.1	21.3	1.1	0.4	11.6	2.0	6.1	7.6	4.2	4.2	0.1	2.2	2.2	0.2	4.3	3.9	2.8	2.7	6.8	1.1	0.6	4.0	0.5	0.8	0.5	0.4	5.4	1.1	0.6	0.7	4.9	1.0	1.5	4.9	0.3	2.1	3.5	3.7	3.0	6.8	2.7	2.2	2.6	5.7	6.9	2.2	29.8	1.6	11.7	13.4	11.1	2.1	14.9	22.9	2.7	3.4	14.0	0.0	5.3	16.6	7.6	2.1	9.2	120.1	0.0	16.1	5.7	6.6	47.1	5.7	64.7	16.1	0.0	20.8	15.4	9.7	3.1	6.4	7.9	37.1	14.4	88.2	6.3	25.2	80.4	6.7	3.8	2.4	32.3	9.1	6.6	11.9	10.0	2.9	0.0	78.1	25.3
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2423045	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0"	"Cell type enhanced"	"Detected in single"	14	"Undifferentiated cells: 1.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 2.6;OE19: 3.6;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.47e-5)"	"unprognostic (6.81e-4)"	"unprognostic (7.90e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.91e-2)"	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			6.1	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0		0.0	4.5	0.0	0.5	0.0		0.2	0.5		0.0	4.0	0.0	0.0	6.3	0.0	0.0	0.0	0.5	0.9			3.1		0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	3.6	0.1	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.1;intestine: 19.5"	"Group enriched"	"Detected in many"	4	"Enterocytes: 28.8;Paneth cells: 10.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 16.1;neutrophil: 6.6"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;HeLa: 4.5;Karpas-707: 2.6;RT4: 7.4;U-266/70: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	2.9	0.0	1.3	0.5	1.2	2.5	1.1	1.3	1.2	0.8	13.3	0.2	1.0	7.2	0.4	0.2	0.6	0.4	1.0	0.5	1.9	1.2	3.1	0.2	1.5	0.2	2.6	0.0	0.4	0.2	3.8	4.9	0.2	1.6	1.7	17.5	0.4	1.1	0.0	1.6	0.8	19.5	0.7	5.0	3.9	0.2	1.7	0.5	1.6	0.3	1.1	2.1	0.5	0.6	0.3	0.3	16.1	0.1	0.5	0.1	0.0	0.1	1.7	0.2	0.2	0.0	0.0	7.7	0.1	0.0	0.0	0.1	2.1	0.2	0.6	0.0	0.1	0.3	0.3	0.5	0.5	0.0	0.1	0.2	0.2	4.5	0.3	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.1	0.2	0.3	0.0	2.6	0.1	0.9	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.3	0.0	7.4	0.3	0.0	0.0	0.1	0.1	0.4	0.3	0.0	0.0	0.2	1.1	0.2	0.0	2.8	0.0	0.2	0.1	0.1	0.3	16.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	6.6	0.5	0.1	0.3	0.0	0.0	1.3	1.2	1.3	1.2	1.9	1.2	2.6	0.0	1.6	0.5	0.0	1.7	0.0	1.7	0.1	0.2	0.6	0.0	1.4	2.3	3.5	0.0	0.2	0.0	0.0	2.5	0.7	28.8	0.0	0.0	0.1	0.3	1.1	0.0	0.0	0.0	0.0	3.5	4.9	0.3	0.4	0.0	0.2	0.0	0.0	3.3	0.1	0.0	10.5	0.4	0.0	2.3	0.0	0.3	1.5	2.3	0.9	0.1	0.0	2.6	0.9
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 91.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	13.3	10.8	6.6	14.7	9.0	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11.0	8.2	19.1	5.5	4.9	16.0	20.0	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10.0	14.5	12.6	6.9	12.6	12.9	12.3	7.0	4.7	4.4	3.4	5.7	7.6	2.0	8.5	8.5	7.1	7.9	20.6	15.5	8.7	10.8	15.0	6.9	9.1	11.7	4.7	18.6	5.3	12.4	17.8	14.4	9.5	7.9	9.9	10.3	5.7	14.8	13.1	6.1	18.8	15.3	11.5	14.4	9.4	7.8	14.7	10.1	5.5	11.8	16.7	14.3	12.5	13.4	9.8	7.5	5.4	11.8	5.3	10.8	9.9	9.1	9.6	20.2	5.9	7.5	7.4	11.9	14.5	13.1	7.4	16.7	8.4	11.0	5.2	50.9	12.4	9.7	21.5	17.9	11.9	31.3	10.2	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7.0	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2.0	6.6	9.0	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10.0	17.9	25.3	18.2	14.9	28.0	22.9	21.4	28.1	24.1	7.9	12.2	11.8	18.5	3.3	9.7	25.2	18.5	16.9	23.3	11.1	8.0	17.0	21.2	16.3	35.0	12.7	20.6	17.7	15.4	18.6	17.9	24.5	17.0	18.6	14.4	17.3	9.1	12.8	12.9	19.1	9.6	21.5	12.9	13.7	13.6	19.4	21.1	13.6	17.5	16.3	9.0
TRPM8		ENSG00000144481	"Transient receptor potential cation channel subfamily M member 8"	Q7Z2W7	2	233917398-234019522	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"liver: 16.7;prostate: 44.1"	"Group enriched"	"Detected in some"	7	"Glandular cells: 24.4;Hepatocytes: 42.4"	"Cancer enriched"	"Detected in some"	27	"prostate cancer: 72.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.4;Karpas-707: 7.1;RPTEC TERT1: 10.7;SK-MEL-30: 10.7;WM-115: 6.5"	"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.41e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (7.15e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.88e-3)"	"unprognostic (7.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.36e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.53e-2)"	3.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	44.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.2	3.0	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	7.1	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.6	0.7	10.7	0.0	0.7	0.4	0.0	0.1	10.7	0.0	0.4	0.7	0.0	0.0	0.1	0.3	0.1	1.6	2.5	0.0	0.9	0.0	6.5	0.5	0.2	0.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.4	0.3	0.3	0.9	3.0	0.1	0.2	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.9	0.0	0.0	0.0	5.0	0.3	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	1.6	0.0	0.0	24.4	0.0	42.4	0.2	0.0	0.0	1.3	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	1.1	0.4	0.1	0.0	0.0	0.0	2.5
TRPV1	VR1	ENSG00000196689	"Transient receptor potential cation channel subfamily V member 1"	Q8NER1	17	3565444-3609411	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 11.7"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 25.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (3.96e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.21e-4)"	"unprognostic (9.90e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.43e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.97e-4)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.12e-3)"	1.4	1.2	3.5	0.7	2.9	0.3	1.7	2.7	2.1	2.1	1.4			6.5	2.3	1.5	0.8	2.8	1.1	1.9	3.2	3.6	2.5	11.7	0.7	1.3	4.7		5.1	2.5	1.0	2.0	1.2		1.5	1.7		2.1	1.0	2.8	4.7	5.1	0.9	2.3	1.2	2.2	1.2			1.3		0.8	1.2	1.1	1.1	1.4	1.5	0.8	0.5	2.2	0.3	3.0	5.6	4.5	5.0	4.9	4.7	4.1	1.7	2.4	2.6	2.4	1.4	1.7	1.2	2.3	1.8	1.8	13.2	2.8	0.9	1.9	7.3	6.7	0.7	2.9	5.6	2.2	0.4	5.7	5.6	3.0	3.8	1.5	2.5	0.5	2.9	0.3	2.2	1.5	3.8	2.1	1.0	3.0	0.6	2.7	6.2	2.9	0.9	2.2	2.7	1.9	4.2	2.3	4.4	2.2	3.5	8.3	2.3	1.7	1.1	2.7	4.5	2.2	1.9	1.3	0.5	1.9	2.4	2.4	0.9	0.8	1.5	0.7	0.2	0.9	0.4	0.6	0.2	0.1	1.1	0.8	2.2	1.5	0.5	0.3	1.4	0.2	0.3											0.0	1.6	0.0	0.4	0.0	8.6	0.2	2.5	4.0	2.3	5.2	15.7	1.0	0.0	0.4	1.8	0.0	2.6	0.0	0.6	0.3	0.4	0.6	0.0	6.4	0.7	6.4	1.2	2.5	0.6	0.2	4.4	1.2	0.0	0.0	1.5	2.8	0.4	0.0	3.5	1.4	25.1	0.0	0.1	0.7	0.7	0.0	0.7	0.0	2.2	0.3
TRPV4	"CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC"	ENSG00000111199	"Transient receptor potential cation channel subfamily V member 4"	Q9HBA0	12	109783085-109833401	"Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Charcot-Marie-Tooth disease, Disease mutation, Dwarfism, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 32.6"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 15.3;Cytotrophoblasts: 16.0;Syncytiotrophoblasts: 17.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	11	"pons and medulla: 15.0"	"Cell type enriched"	"Detected in single"	7	"classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.0;BJ hTERT+: 9.3;EFO-21: 8.2;HaCaT: 14.8;HUVEC TERT2: 8.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007150	Uncertain					NA	NA					"HPA007150: AB_1080393"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.25e-3)"	"unprognostic (1.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	1.3	0.9	0.3	0.9	0.4	0.1	3.3	0.2	0.6	2.3	0.4	3.2	0.0	0.6	0.8	3.7	9.5	5.6	5.2	1.6	1.3	0.2	11.6	7.8	2.6	1.8	0.2	0.0	0.6	7.1	0.1	4.3	11.1	15.0	6.2	0.3	12.6	32.6	1.4	0.2	6.5	0.3	0.9	0.3	3.5	0.9	0.7	0.1	0.2	0.9	2.6	8.7	2.6	1.7	0.0	0.4	0.0	3.0	0.0	0.0	0.4	2.6	0.1	0.0	0.0	1.9	1.9	9.0	4.3	9.3	1.3	0.5	0.0	6.4	0.0	8.2	5.5	0.0	14.8	1.1	0.0	0.3	0.0	2.1	0.0	0.0	3.6	0.7	0.0	0.0	3.3	2.0	3.3	0.0	0.5	8.4	0.0	0.8	0.0	0.4	5.4	0.0	0.0	1.7	0.0	0.3	0.0	0.5	0.0	0.0	5.2	0.0	0.0	0.3	0.6	2.6	4.1	1.2	0.4	5.1	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.2	0.6	1.3	0.2	0.2	0.0	15.0	0.1	0.0	0.0	1.3	8.2	3.0	0.0	1.1	15.3	5.3	6.8	10.4	0.0	16.0	3.3	2.2	0.2	0.5	0.0	0.0	8.4	4.3	0.7	3.7	0.0	6.4	3.6	0.0	0.0	0.6	10.7	0.0	0.9	1.6	6.8	1.0	0.0	0.0	1.5	0.0	0.0	11.1	0.0	0.0	0.8	0.2	1.3	3.3	17.6	0.0	0.0	2.0
TRPV5	"CaT2, ECAC1"	ENSG00000127412	"Transient receptor potential cation channel subfamily V member 5"	Q9NQA5	7	142908101-142933808	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"kidney: 26.0"	"Cell type enriched"	"Detected in single"	8	"Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in single"		"RT4: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA063175	Uncertain					NA	NA					"HPA063175: AB_2684954"	"unprognostic (7.44e-2)"	"unprognostic (3.93e-2)"		"unprognostic (1.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"		"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.73e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-1)"	"unprognostic (7.76e-3)"	0.1	0.0	0.8	0.4	0.7	0.5	0.5	0.1	0.8	0.1	0.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0.1	0.1	1.1	0.7	26.0	0.1	0.1	0.2	1.6	0.4	0.1	0.3	0.0	0.1	0.1	0.7	0.1	0.0	0.1	0.3	0.1	0.2	0.1	0.1	0.1	3.5	0.2	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.5	1.1	0.7	1.6	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPV6	"CaT1, ECAC2"	ENSG00000165125	"Transient receptor potential cation channel subfamily V member 6"	Q9H1D0	7	142871203-142885762	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 26.1;placenta: 65.1;salivary gland: 34.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 25.5;Collecting duct cells: 26.2;Ductal cells: 63.7;Early spermatids: 26.4;Late spermatids: 28.8"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.7;HaCaT: 10.5;RT4: 18.7;SK-BR-3: 13.8;T-47d: 30.8"	"Low region specificity"	"Detected in some"							HPA062864	Approved					NA	NA					"HPA062864: AB_2684885"	"unprognostic (9.85e-2)"	"unprognostic (1.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.53e-2)"	0.3	0.0	0.3	0.3	0.3	0.0	2.1	0.3	0.3	0.4	1.2	0.3	0.3	4.1	0.3	0.4	1.7	0.1	4.1	0.3	0.3	0.2	2.5	0.6	0.8	0.3	0.8	0.3	0.3	26.1	0.0	0.4	65.1	0.4	12.6	0.0	0.4	34.2	0.7	0.3	3.7	1.0	0.5	2.0	0.3	2.4	0.7	0.3	0.3	0.7	0.6	1.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	1.1	0.0	0.0	13.8	0.3	0.6	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.8	0.3	0.4	0.3	3.0	0.0	0.0	0.9	0.5	0.4	1.6	25.5	1.4	2.3	26.2	0.0	13.3	0.0	63.7	26.4	0.0	0.0	0.0	2.8	0.6	0.4	14.3	0.0	0.0	1.4	3.2	0.0	0.0	0.0	28.8	0.9	0.0	0.0	3.6	0.0	0.8	13.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.6	5.0	0.0	0.0	3.1
